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 Microbial infection involves complex and dynamic interplay of host defense and 
pathogen virulence pathways that requires new methods for mechanistic investigation. 
Towards this goal, I have developed chemical reporters of nucleic acid and protein 
synthesis and posttranslational modifications to explore their functions in bacterial 
pathogenesis as well as basic biological pathways. 
 Initially, I developed amino acid chemical reporters that allow the cell-selective 
labeling of bacterial proteomes to facilitate the analysis of bacterial protein expression 
during infection of host cells. These reporters are based on unnatural amino acids that are 
incorporated into the bacterial proteome instead of methionine or phenylalanine when 
used in combination with mutant aminoacyl-tRNA-synthetases. This technology allows 
the visualization of bacterial protein synthesis during infection as well as the enrichment, 
identification and proteomic analysis of bacterial proteins from infected host cells.  
 Additionally, I developed a chemical reporter for the study of protein 
AMPylation, a key posttranslational modification used by various bacterial pathogens to 
rewire host-signaling pathways. This reporter is used by all of the known AMPylation 
enzyme classes and allows the proteomic identification of enzyme-specific substrates in 
cell lysates. This project also stimulated the development of a chemical reporter for RNA 
synthesis, which in contrast to previous RNA reporters allows labeling of mRNA 
polyadenylation tails.  
 In conclusion, I have developed chemical reporters for the cell selective labeling 
of bacteria in the presence of mammalian cells, a chemical reporter for protein 
AMPylation, and a chemical reporter for RNA synthesis and mRNA polyadenylation. 
These reagents should help to identify bacterial proteins that are differentially expressed 
during infection, new AMPylation substrates and the analysis of mRNA polyadenylation 
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The genomic revolution has offered unique opportunities to understand basic biology and 
human disease. With increasingly high-throughput and cost-effective sequencing 
methods, the genomes of many organisms and mutations associated with human diseases 
have been annotated (Cooper & Shendure 2011). In parallel, large-scale gene deletion 
and overexpression studies as well as protein-protein interaction screens have uncovered 
complex signaling networks (S. J. Dixon et al. 2009; Choudhary & Mann 2010). These 
studies have not only revealed the genetic basis for many fundamental biological 
processes but have also presented new possibilities for personalized medicine. 
Nonetheless, significant challenges lay ahead for translating genetically encoded 
information into biological function and therapeutic development. Starting at the nucleic 
acid level, many biological phenotypes are controlled by multiple genes that many not be 
readily apparent by perturbation of individual genes or alleles. Furthermore, the 
phenotype of interest may only be transient or controlled by epigenetic mechanisms not 
evident by reading the genetic code (Goldberg et al. 2007; M. Guttman & Rinn 2012). To 
complex matters further, the genome of most organisms encode protein and enzyme 
families that exhibit overlapping biochemical activities and crosstalk (López-Otín & 
Hunter 2010), which are regulated by specific interactions with other factors in time and 
space inside of cells (Seet et al. 2006). Beyond nucleic acids and proteins, glycans, lipids 
and other small molecule cofactors provide important regulators of cellular function by 
direct modification of substrates (Walsh et al. 2005), which are directly coupled to 
primary metabolism that has become increasing important in human disease (Vander 
2 
Heiden et al. 2009). The resulting signaling pathways are therefore often not linear and 
typically comprise more complex  
 
Figure 1 Two-step labeling of biomolecules.  a) Bioorthogonal chemical reporters and 
chemoselective reactions allow covalent labeling of biomolecules with detection or 
affinity tags for imaging or proteomics applications, respectively. b) Staudinger ligation 
allows labeling of alkyl-azides with triarylphoshine reagents. c) Cu(I)-catalyzed 
cycloaddition between alkyl-azides and terminal alkynes affords triazole adducts, which 
can operate in both orientations.  d) Activated cyclooctynes can react with alkyl-azides 
for Cu-free labeling. 
 
positive and negative feedback networks to amplify or shutdown cellular functions 
(Nurse & Hayles 2011). These complex and regulated properties allow cells to response 
to changes their environment and interact with other cells in higher organisms that can 
3 
give rise to remarkably biological phenotypes but when misregulated can yield disease.  
These biological challenges demand a better understanding of the chemistry inside cells 
and animals that is ever changing in response to mutation and environmental cues. The 
integration of intrinsic factors encoded within genomes with extrinsic factors in the 
environment is therefore crucial and require new approaches to evaluate changes in 
nucleic acid biosynthesis, protein turnover and modifications. As new technology has 
accelerated the advances in genomics, here we highlight advances in bioorthogonal 
chemical reporters that have enabled the imaging and functional analysis of nucleic acids, 
proteins, glycans, lipids as well as other metabolites in biology. 
 The last decade has seen the remarkable development of highly selective chemical 
reactions, which have allowed specific labeling of molecules in diverse biological 
contexts (Fig. 1) (Prescher & Carolyn R Bertozzi 2005; Sletten & Carolyn R Bertozzi 
2011). This two-step labeling and detection strategy involves metabolic or enzymatic 
installation of a chemical reporter that can be selectively reacted with specifically 
functionalized probes for the visualization or identification of target molecules (Fig. 1a).  
Central to this chemical labeling strategy is the introduction of azide and alkyne groups 
as abiotic, minimally perturbing functionalities onto small molecules and their selective 
covalent reaction with activated phosphine-, alkyne- or azide-modified probes (Fig. 1). 
Since these functional groups are foreign to living organisms and uniquely reactive with 
each other, this class of chemical reactions has been described as bioorthogonal (Prescher  
& Carolyn R Bertozzi 2005). The first example of these bioorthogonal reactions was the 
Staudinger ligation introduced by the Bertozzi laboratory (Fig. 1b) (Saxon & C R 
Bertozzi 2000). These studies demonstrated that alkyl-azides can react with ester-
4 
functionalized triphenylphosphine reagents to form covalent adducts in aqueous solution 
and on the surface of mammalian cells (Saxon & C R Bertozzi 2000) as well as in living 
animals (Prescher et al. 2004). Alternatively, the Sharpless and Meldal laboratories 
showed that catalytic amounts of Cu(I) can accelerate the [3 + 2] cycloaddition of alkyl-
azides with terminal alkynes to form stable triazole products (Fig. 1c)(Tornøe et al. 2002; 
Rostovtsev et al. 2002a), which elaborates on thermal reactions originally described by 
Huisgen and coworkers (Huisgen 1963). The Cu(I)-catalyzed azide-alkyne cycloaddition 
(CuAAC, Figure 58) is highly chemoselective and represents the prototypic click 
chemistry reaction, which is widely used in chemical synthesis and bioorthogonal 
reactions since the azide and alkyne groups can be used in either orientation, are 
relatively stable and readily accessible. Notably, the terminal alkyne is comparable in size 
with the azide and when used as a primary chemical reporter in combination with azide-
functionalized probes provides the optimal signal-to-noise for bioorthogonal labeling 
(Fig. 1c) (Speers & Cravatt 2004; Charron et al. 2009a). While the cytotoxicity of Cu(I) 
can preclude in vivo applications, the development of activated cyclooctyne reagents has 
circumvented this limitation and has enabled imaging of bioorthogonal chemical 
reporters in living organisms (Fig. 1d) (Laughlin et al. 2008a; Laughlin & Carolyn R 
Bertozzi 2009b). 
The significant advances made in bioorthogonal chemistry have inspired a series 
of azide- and alkyne-functionalized chemical reporters as molecular global positioning 
systems for nucleic acid and protein synthesis as well as other biomolecules. Key to this 
bioorthogonal labeling strategy is the ability of native or engineered enzymes to accept 
azide or alkyne-functionalized chemical reporters. Provided the activity and selectivity of 
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the enzymes are not significantly altered by chemical reporters, this approach allows the 
visualization and biochemical analysis of endogenous biomolecules. This approach 
provides several important advantages for biological applications. First, the separation of 
metabolic or enzymatic incorporation and detection decouples sterically-demanding 
fluorophores or affinity tags, which often interfere with biological activity, from 
enzymatically processed metabolites. Secondly, in comparison to protein-based reagents 
(e.g. antibodies), bioorthogonal chemical reporters provide direct detection of the 
modified substrates and are relative independent of adjacent functional groups, which 
may confound the specificity of protein reagents. Lastly, the ability to pulse-label specific 
populations of molecules in cells with bioorthogonal chemical reporters provides an 
important means to monitor dynamics akin to classic radioactive tracers, but provides 
much more sensitive detection and allows the identification of labeled targets. Since 
newly synthesized molecules can be easily separated from the steady state population in 
this manner, chemical reporters are excellent tools for monitoring the dynamics of 
biomolecules in response to extrinsic stimuli. Bioorthogonal chemistry has also 
facilitated the analysis of small molecule inhibitor interactions with proteins for 
biochemical target identification and activity-based protein profiling, which is beyond the 
scope of this review and summarized elsewhere (Nomura et al. 2010). Herein we will 
review the currently available chemical reporters and highlight how they can be applied 
to monitor temporal changes in cellular activity (Fig. 2a), profile different cell types, 
states or mutations (Fig. 2b) and identify targets of specific enzymes in vitro (Fig. 2c). 
We close with an outlook on future developments that should expand the utility of 
bioorthogonal chemical reporters in even more complex biological settings in vivo. 
6 
 
Figure 2 Chemical reporters can be used for comparative analysis in vivo and in vitro. a) 
Pulse-labeling of isolated cells or organisms with a chemical reporter leads to the 
metabolic incorporation of the reporter into a defined biomolecule population. Chasing 
this population with the native metabolites or differentially labeled reporter enables the 
monitoring of specific turnover rates. b) Pulse-labeling of two distinct cellular 
populations or organisms allows the comparative analysis of their metabolically labeled 
biomolecule pools. c) The application of chemical reporters in cell lysates, with purified 




1.1 Bioorthogonal chemical reporters for nucleic acid turnover and modifications 
Gene expression arrays and deep-sequencing methods provide important profiles of 
steady state DNA and RNA expression, but understanding the rate of nucleic acid 
synthesis, degradation and modification is crucial for elucidating their function in 
different biological contexts. The modification of nucleosides with alkynes has afforded 
bioorthogonal chemical reporters of DNA and RNA synthesis. For example, Salic and 
coworkers have demonstrated that 5-ethynyl-2’-deoxyuridine (EdU) (Salic & Mitchison 
2008) and 5-ethynyluridine (EU) (Jao & Salic 2008) can be metabolized by mammalian 
cells and incorporated into DNA and RNA for bioorthogonal detection and pulse-chase 
experiments, respectively (Fig. 3a,b). These nucleic acid reporters function in animals 
and provide sensitive reagents to compare DNA and RNA turnover in different tissues 
using fluorescence. More recently, fluorinated arabinosyl-EdU has also been developed 
to improve the sensitivity of DNA labeling with reduced cytotoxicity compared to EdU 
(Fig. 3c) (Neef & Luedtke 2011). In addition to uridine derivatives, 5-ethynyl-2’-
deoxycytosine (EdC) (Guan et al. 2011) and N-6-propargyladenosine (N6pA) (Grammel 
et al. 2012) can be utilized by mammalian cells to label DNA and RNA, respectively 
(Fig. 3d,e). In addition, N6pA labeling allows the pulse-chase analysis of RNA 
polyadenylation. Alternatively, He and coworkers have employed a specific 
glycosyltransferase to install 6-azido-glucose onto 5-hydroxymethylcytosine (5-hmc) 
marks in DNA for subsequent bioorthogonal detection (Fig. 3f) (C.-X. Song et al. 2011). 
This chemoenzymatic bioorthogonal detection of 5-hmc has provided an important 
method for characterizing the mechanism of DNA oxidation and demethylation catalyzed 
by Tet1-3 proteins in eukaryotic cells (He et al. 2011; Ito et al. 2011). As the turnover and 
modification of nucleic acids is becoming increasingly relevant in dissecting epigenetic 
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Figure 3 Chemical reporters for nucleic acid synthesis and modifications. a) 5-ethynyl-
2’-deoxyuridine (EdU) is incorporated into DNA. b) 5-ethynyluridine (EU) is 
incorporated into RNA. c) 5-ethynyl-2’-deoxyfluorouridine (F-ara-EdU) is incorporated 
in to DNA. d) 5-ethynyl-2’-deoxycytosine (EdC) in incorporated into DNA. e) N-6-
propargyladenosine (N6pA) is incorporated into RNA and into mRNA polyadenylation 
tails. f) The DNA modification 5-hydroxymethylcytosine (5-hmc) can be enzymatically 
labeled with 6-azido-glucose for subsequent bioorthogonal detection. 
 
1.2 Bioorthogonal chemical reporters for protein turnover 
Azide- and alkyne-bearing amino acids allow the co-translational labeling of newly 
synthesized proteins and provide a direct measure of the translational activity in cells 
(Fig. 4). Two strategies for unnatural amino acid incorporation have been developed that 
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enable site-specific or residue-specific labeling of proteins. The site-specific approach 
pioneered by the Schultz laboratory allows the incorporation of an unnatural amino acid 
at a predetermined position in a protein of interest using amber suppression (C.-X. Song 
et al. 2011). This technique is based on engineering an orthogonal triad of tRNA, 
aminoacyl-tRNA-synthetase (aaRS) and unnatural amino acid, which allows the site-
specific installation of azide- and alkyne amino acids on individual proteins in bacteria, 
yeast and mammalian cells (C. C. Liu & P. G. Schultz 2010). For example, the 
pyrrolysine (Pyl) system has been particularly useful for site-specific incorporation of 
amino acid reporters such as PCL (Hancock et al. 2010) or ACPK (S. Lin et al. 2011) 
(Fig. 4a). For the global analysis of translation, the Tirrell laboratory has developed 
residue-selective incorporation of azide and alkyne amino acids such as 
azidohomoalanine (AHA) and homopropargylglycine (HPG) that substitute for 
methionine (Met) in newly synthesized proteins (Fig. 4b) (Johnson et al. 2010). AHA and 
HPG are readily taken up and utilized by the wild type methionyl-tRNA-synthetase 
(metRS) in prokaryotic and eukaryotic cells, which enables the analysis of newly 
synthesized proteins by bioorthogonal labeling with fluorescence and affinity probes. The 
availability of two uniquely reactive orientations (azide versus alkyne) also makes it 
possible to label and visualize two distinct protein populations with AHA and HPG, 
respectively (L. Wang & P. G. Schultz 2004; C. C. Liu & P. G. Schultz 2010). In contrast 
to metabolic labeling with isotopically labeled amino acids, AHA and HPG labeled 
proteins can be bioorthogonally reacted with affinity tags and selectively recovered from 
total cell lysates for mass spectrometry-based protein identification using gel-based 
methods or multi-dimensional protein identification technology (MudPIT) (Beatty & 
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Tirrell 2008). Quantitative elution of selectively captured proteins can be challenging 
using biotinylated affinity tags and streptavidin beads due to the strength of this 
interaction (KD ~ 10-15), thus several cleavable linker systems (disulfide (Nessen et al. 
2009), acid-sensitive (Szychowski et al. 2010), azobenzenes (Y.-Y. Yang, Grammel, et 
al. 2010), and proteolytic cleavage sites (Speers & Cravatt 2005)) have been developed to 





































Figure 4 Amino acid reporters can co-translationally incorporated into proteins. a) 
Analogs of the amino acid pyrrolysine (Pyl) with alkyne (N
ε
-[(2-propynyloxy)carbonyl]-
lysine, PCL) or azide (azido-cyclopentyl-carboxy-lysine, APCK) groups can be site-
selectively incorporated into individual proteins through the expression of orthogonal 
aminoacyl-tRNA-synthetase and tRNA. b) Various analogs of the amino acid methionine 
(Met) can be selectively incorporated instead of Met throughout the bacterial or 
mammalian proteome to install an alkyne (homopropargylglycine, HPG) or azide 
(azidohomoalanine, AHA) group. c) O-propargyl-puromycin (OP-puro) covalently labels 
the C-terminus of nascent peptides.  
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The ability to differentiate newly synthesized from pre-existing proteins with 
AHA and HPG has revealed important biological insights. For example, Henikoff and 
colleagues have used AHA pulse labeling for enrichment of newly synthesized 
nucleosomes (Deal et al. 2010). It is generally appreciated that nucleosome turnover 
erases histone marks and serves as an important epigenetic mechanism (S. Henikoff 
2008). Previous studies measured histone H3.3 incorporation as a surrogate for 
nucleosome turnover or used overexpressed histone transgenes to follow nucleosome 
dynamics (Mito et al. 2005; Dion et al. 2007). In contrast, AHA allows pulse labeling of 
endogenous histones and provides an affinity handle for enrichment and subsequent 
analysis of nucleosome-associated DNA with tiling arrays. This approach, termed 
CATCH-IT by the authors, provides better temporal resolution compared to previous 
histone replacement methods and revealed more rapid turnover of nucleosomes at active 
genes, specific epigenetic marks and replication origins (Deal et al. 2010). Dynamic 
protein synthesis is also particularly important in neurons, as localized translation is 
believed to shape axon growth, guidance and regeneration in the brain for synaptic 
plasticity and memory (Gkogkas et al. 2010; Jung et al. 2011). To explore these issues, 
Schuman and colleagues have used AHA and HPG labeling to visualize specific sites and 
measure rates of protein synthesis in primary neurons after bioorthogonal labeling with 
fluorescent dyes and quantum dots (Dieterich et al. 2010). Another application of AHA 
labeling in primary neuronal cultures revealed localized protein synthesis adjacent to the 
transmembrane receptor DCC (Tcherkezian et al. 2010). These studies show how 
bioorthogonal amino acid reporters provide valuable tools for monitoring discrete protein 
populations and imaging protein synthesis at high resolution. 
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1.2.1 Cell-selective labeling of proteomes.  
Studying cells in their native environment and in interaction with other cell types is 
crucial in many areas of biology.  Methods for cell-selective proteome labeling would 
therefore be valuable for dissecting the activity of heterogeneous cell populations. While 
AHA and HPG do not provide a means to separate proteomes of individual cell types, 
Tirrell and colleagues have identified a number of metRS mutants (metRS*) that 
facilitate the incorporation of the otherwise translationally inactive amino acid reporters 
such as azidonorleucine (ANL) (Fig. 5a) (Link et al. 2006; Tanrikulu et al. 2009). Since 
ANL incorporation is dependent on metRS* activity, ANL can be selectively directed to 
certain cell types by expression of metRS* (Ngo et al. 2009). For example, bacterial cells 
expressing metRS* can be selectively labeled with ANL in the presence of mammalian 
cells (Ngo et al. 2009). To differentiate bacterial proteins from host proteins during 
infection, our laboratory developed 2-aminooctynoic acid (AOA) (Fig. 5a), which is also 
activated by metRS* to label the Gram-negative bacterial pathogen Salmonella 
typhimurium inside murine macrophages (Grammel et al. 2010). AOA appears to provide 
better signal-to-noise than ANL and enables the proteomic identification of endogenously 
expressed S. typhimurium proteins during infection (Fig. 5b) (Grammel et al. 2010). In 
addition to these Met reporters, an alkyne phenylalanine (Phe) analog, para-
ethynylphenylalanine (PEP) (Fig. 5c) can also function as a cell-selective amino acid 
reporter in combination with a phenylalanine-tRNA-synthetase mutant (A294G of pheS) 
(Grammel et al. 2012). Amino acids such as Phe are present in higher frequencies than 
Met and the possible combination of these reporters may allow greater coverage of 
proteomes or even selective labeling of two different proteomes. An extension of these 
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strategies and especially translation to eukaryotic systems might allow selective labeling 











Figure 5 Cell selective proteome labeling with engineered tRNA synthetases. a) 
Engineered methionyl-tRNA-synthetase reporters: azidonorleucine (ANL) and 2-
aminooctynoic acid (AOA). b) para-ethynylphenylalanine (PEP) can be incorporated 
residue-selectively instead of the amino acid phenylalanine (Phe) through the expression 
of an engineered phenylalanyl-tRNA-synthetase. c) The expression of engineered tRNA 
synthetases allows the selective incorporation of the bioorthogonal amino acid reporters 
ANL, AOA or PEP into bacterial proteomes during infection – alkynyl reporter is shown.   
 
1.2.2 Bioorthogonal labeling and capture of nascent polypeptides.   
Notwithstanding the advances made possible with amino acid reporters, some limitations 
should be noted. First and foremost, the global replacement of natural amino acids with 
unnatural counterparts might destabilize proteins and interfere with activity. Short pulse-
labeling periods can minimize this issue and prevent toxicity effects. Secondly, the Met 
and Phe amino acid reporter incorporation is proportional to the number of residues per 
protein, which could misrepresent the abundance of proteins. To address these issues, 
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Salic and colleagues have shown that O-propargyl-puromycin (OP-puro) (Fig. 4c), an 
alkyne analog of the covalent translational inhibitor puromycin, can be used to label 
nascent polypeptide chains in mammalian cell culture as well as in mice (J. Liu et al. 
2012). OP-puro labeled proteins can be imaged by fluorescence microscopy and captured 
to retrieve nascent polypeptide chains. In contrast to amino acid reporters, which are 
incorporated into the proteome with a certain bias, exactly one OP-puro is attached to 
each nascent polypeptide, an important feature for comparative proteomic studies. It 
should be noted that OP-puro-protein conjugates are rapidly degraded by the proteosome 
(J. Liu et al. 2012), a fact to be considered for future proteomic studies. Collectively, 
these bioorthogonal protein synthesis reporters have provided more sensitive methods for 
monitoring protein dynamics and have already revealed important biological 
mechanisms, which should complement recent large-scale ribosome profiling methods 
(Ingolia et al. 2011; Heiman et al. 2008). 
1.3 Bioorthogonal chemical reporters for posttranslational modifications 
In addition to nucleic acid and protein synthesis, bioorthogonal chemical reporters have 
been developed for diverse posttranslational modifications (PTMs) in bacteria, 
eukaryotes and plants (Fig. 6-8). 
1.3.1 Glycosylation.  
The covalent modification of proteins with mono or oligosaccharides is one of the most 
ubiquitous and most complex forms of PTMs in biology (Varki 1999). Glycoproteins 
decorate the exterior of eukaryotic cells and mediate a wide range of interactions with 
soluble extracellular factors, neighboring cells and microbes. Additionally, glycosylation 


















































































































O-GlcNAc-modified proteins azide-tagged-O-GlcNAc-modified proteins  
Figure 6 Chemical reporters can be used to probe different glycans. a) Peracetylated N-
azidoacetyl-D-mannosamine (Ac4ManNAz) is metabolically incorporated into sialic acid 
glycans. b) Peracetylated N-azidoacetyl-D-galactosamine (Ac4GalNAz) is metabolically 
incorporated into mucin type O-linked glycans. c) Peracetylated 6-ethynyl-L-fucose 
(Ac46-ethynyl-L-fucose) is metabolically incorporated into fucosylated proteins. d) 
Peracetylated N-alkynylacetyl-D-glucosamine (Ac4GlcNAlk) is metabolically 
incorporated into O-GlcNAc modified proteins. e) O-GlcNAc modified proteins can be 
chemoenzymatically labeled using a 1,4-β-galactosyltransferase that transfers GalNAz 
onto O-GlcNAc modified proteins.  
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transduction. Indeed, the complex roles of glycans and the challenges associated with 
their detection and synthesis was a major driving force for the development of 
bioorthogonal ligation reactions (Prescher & Carolyn R Bertozzi 2006; C R Bertozzi & 
Kiessling 2001). The Staudinger ligation reaction and the first azide monosaccharide 
reporter, N-azidoacetyl-D-mannosamine (ManNAz, Fig. 6a) was developed in the context 
of monitoring cell surface sialic acid-containing glycans (Saxon & C R Bertozzi 2000). 
This landmark study has spurred the development of many bioorthogonal chemical 
reporters highlighted in this review and in particular other azide- and alkyne-
functionalized monosaccharides for sialic acid glycoconjugates (Chang et al. 2009; 
Luchansky et al. 2004), mucin-type O-linked glycoproteins (Fig. 6b) (Hang et al. 2003; 
Zaro, Bateman, et al. 2011), fucosylated glycans (Fig. 6c) (Rabuka et al. 2006; Sawa et 
al. 2006), and intracellular O-GlcNAc modified proteins (Fig. 6d) (Khidekel et al. 2003; 
Vocadlo et al. 2003; Zaro, Y.-Y. Yang, et al. 2011), which have improved the detection 
and proteomic analysis of these glycoprotein families (Zaro, Y.-Y. Yang, et al. 2011; 
Hanson et al. 2007). In addition to profiling glycoproteins, the metabolic incorporation of 
chemical reporters into cell surface glycans can be used to select cell populations with 
aberrant glycosylation levels (Yarema et al. 2001). An early example of this strategy 
using a ketone-functionalized sialic acid precursor and hydrazide labeling revealed 
mutations in glycan biosynthetic enzymes associated with congenital human diseases 
such as sialuria (Yarema et al. 2001). Remarkably, these glycan reporters in combination 
with activated cyclooctyne probes have now enabled the dynamic imaging of cell surface 
glycans in live developing zebrafish embryos and in worms (Laughlin & Carolyn R 
Bertozzi 2009a; Laughlin et al. 2008b), which opens the door for differential analysis of 
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glycan biosynthesis in specific tissues and cell types in vivo. Beyond eukaryotes, glycan 
chemical reporters have also been incorporated into bacteria such as Campylobacter 
jejuni (F. Liu et al. 2009), Helicobacter pylori (Koenigs et al. 2009) and Escherichia coli 
(Dumont et al. 2012) as well as plants (Anderson et al. 2012). 
 Metabolic and chemoenzymatic chemical reporters are providing new insight into 
O-GlcNAc modification of cytoplasmic and nuclear proteins. The discovery of GlcNAc 
on serine (Ser) and threonine (Thr) residues was unexpected, but this dynamic and 
regulated PTM is emerging as an important sensor of metabolic state of cells and is 
associated with diseases such as diabetes, neurodegeneration and cancer (Hart et al. 
2011). Initial studies demonstrated that chemical reporter GlcNAz could be utilized by the 
hexosamine salvage pathway and incorporated into O-GlcNAc modified proteins in 
mammalian cells (Vocadlo et al. 2003) and even be used for proteomic studies (Sprung et 
al. 2005). More recently, an alkyne-modified GlcNAc analog (GlcNAlk, Fig. 6d) has 
enabled more sensitive bioorthogonal detection as well as greater proteomic coverage and 
uncovered glycosylation of the E3 ubiquitin ligase NEDD4 (Zaro, Y.-Y. Yang, et al. 
2011). Alternatively, Hsieh-Wilson and colleagues have developed a chemoenzymatic 
method that allows labeling of O-GlcNAc modified proteins in tissue/cell lysates with a 
ketone (Khidekel et al. 2003) or azide (Clark et al. 2008) group using an engineered beta-
1,4-galactosyltransferase (Fig. 6e). The tagged O-GlcNAc-modified proteins can then be 
evaluated by fluorescence (Clark et al. 2008), mass-shift western blotting (Rexach et al. 
2010) and quantitative proteomic s(Khidekel et al. 2007), which has revealed differential 
dynamics of O-GlcNAc modified proteins in neurons and O-GlcNAc regulation of 
CREB-mediated gene expression in vivo (Rexach et al. 2012). Beyond these studies, 
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azide- and alkyne sugar nucleotide reporters have also been useful for in vitro profiling 
glycosyltransferase substrate specificities (Pratt et al. 2004) as well as in vivo imaging of 
glycans (T. Zheng et al. 2011; Baskin et al. 2010). These studies highlight the utility of 
bioorthogonal chemical reporters for monitoring glycan biosynthesis, glycoproteomics 
and in vivo imaging of glycans in model organisms. 
1.3.2 Lipidation.  
Lipid modifications of proteins modulate their membrane affinity, localization and 
trafficking for cell signaling (Resh 2006). Even though some forms of protein lipidation 
can now be predicted based on conserved amino acid motifs (Resh 2006), direct 
biochemical detection of lipidated proteins is still required for functional studies, 
discovery of unannotated substrates and novel types of lipidation. For example, S-
farnesylation or geranylgeranylation of cysteine (Cys) residues on the C-terminus of 
proteins can be predicted by bioinformatics based on conserved CaaX or CC motifs 
(Resh 2006), respectively. However, biochemical detection of S-prenylation is still 
crucial since many of these lipidated proteins are small GTPases (e.g. K/H/N-Ras) that 
control cell signaling and when mutated are major drivers of oncogenesis (Karnoub & 
Weinberg 2008). The corresponding prenyltransferases are thus active targets of drug 
development for cancer and other human diseases (Berndt et al. 2011; Meta et al. 2006).  
To this end, azide(Kho et al. 2004) and alkyne (Charron et al. 2011; DeGraw et al. 2010) 
isoprenoid reporters have been developed that allow bioorthogonal detection and 
proteomic analysis S-prenylated proteins in mammalian cells. Interestingly, our 









Figure 7 Different forms of protein lipidation can be analyzed with chemical 
reporters. a) Alk-FOH allows metabolic labeling of S-farnesylated and S-
geranylgeranylated proteins in mammalian cells. b) und c) Alkynyl-fatty acid 
reporters of different chain length enable selective metabolic labeling of N-
myristoylated or S-palmitoylated proteins. d) An azide analog of cholesterol can 
be metabolically incorporated onto the C-terminus of sonic hedgehog. e) Alkynyl-
fatty acid reporters can also be metabolically incorporated into bacterial 
lipoproteins. f) The azido-decanoic acid can function as a substrate for lipoic acid 
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macrophages has enabled large-scale profiling of S-prenylated proteins and revealed 
isoform-specific S-farnesylation of zinc-finger antiviral protein (ZAP) is crucial for the 
membrane targeting and antiviral activity of this interferon-induced effector (Charron G 
et al submitted). 
Azide and alkyne fatty acids are also utilized by native enzymes in bacteria and 
eukaryotes(Hang et al. 2011). Myristoylation of N-terminal glycine (Gly) residues by N-
myristoyltransferases that occurs primarily cotranslationally (Farazi et al. 2001), is 
readily labeled and visualized by myristic acid reporters in mammalian cells (Fig. 7b) 
(Hang et al. 2007; Charron et al. 2009a; D. D. O. Martin et al. 2008). In contrast to N-
myristoylation, which is stable and constitutive, the S-palmitoylation of Cys residues can 
be reversible, regulated by a family of DHHC-palmitoyltransferases (DHHC-PATs), not 
readily predicted by primary amino acid sequence and particularly challenging to 
biochemical analyze (Linder & Deschenes 2007). Metabolic labeling with alkyne 
palmitic acid reporters (Fig. 7c) in combination with bioorthogonal detection by our 
laboratory (Charron et al. 2009a) and others (B. R. Martin & Cravatt 2009; Hannoush & 
Arenas-Ramirez 2009; Yap et al. 2010) has largely solved this problem, enabling 
fluorescence visualization and proteomic analysis of S-palmitoylated proteins (B. R. 
Martin & Cravatt 2009; B. R. Martin et al. 2011; J. P. Wilson et al. 2011; Yount et al. 
2010). Notably, bioorthogonal palmitoylome profiling and hydroxylamine-mediated acyl 
biotin exchange (ABE) proteomics (Wan et al. 2007; Roth et al. 2006) has significantly 
increased the diversity of S-palmitoylated proteins in eukaryotes (Hang & Linder 2011) 
and even revealed new fatty-acylated proteins in innate immunity (Yount et al. 2010) and 
neuronal activity (Kang et al. 2008). In addition to lipidation of cytoplasmic proteins, 
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secreted proteins are also lipid-modified and readily labeled by chemical reporters as 
highlighted by fatty acid and cholesterol reporter labeling of Wnt (Gao et al. 2011) and 
sonic hedgehog proteins (Fig. 7d) (Heal et al. 2011), respectively. It should be noted that 
bioorthogonal chemical reporters have also been developed for monitoring the 
metabolism and trafficking of free, unconjugated lipids in mammalian cells (Neef & 
Carsten Schultz 2009; Milne et al. 2010). 
Bioorthogonal lipid reporters have been especially useful for monitoring protein 
S-palmitoylation dynamics. For instance, tandem pulse-chase labeling of T cells with 
protein synthesis and palmitoylation reporters provides a robust method for quantifying 
S-acylation dynamics relative to protein turnover, which revealed accelerated 
depalmitoylation of signaling kinases such as Lck upon T cell activation (M. M. Zhang et 
al. 2010). In addition, the large-scale analysis of S-palmitoylation dynamics using 
bioorthogonal labeling and SILAC showed that many proteins are stably fatty-acylated 
while other proteins involved in cell signaling undergo rapid S-acylation cycles (B. R. 
Martin et al. 2011). To understand how specific S-palmitoylated proteins are regulated, 
our laboratory has employed palmitate chemical reporters in the model system 
Schizosaccharomyces pombe (fission yeast) to evaluate the distinct functions of different 
DHHC-PATs. Through pulse labeling of synchronized cell populations and proteomic 
analysis of wild type and mutant S. pombe strains, we have discovered that the regulated 
expression of a single DHHC-PAT can control S-palmitoylation of specific protein 
substrates, cell signaling and ultimately the ability of fission yeast to undergo meiosis or 
cellular differentiation (Mingzi M Zhang n.d.). These early applications of bioorthogonal 
23 
lipid reporters are beginning to reveal the differential modification of S-palmitoylated 
proteins and their mechanisms of regulation as well as their impact on cellular function. 
Lipid reporters also allow labeling of bacterial proteins and sequence-specific 
tagging of engineered proteins. Protein lipidation in bacteria involves the installation of a 
diacylglyceryl group onto N-terminal Cys residue within a well-defined lipobox-motif 
(Sankaran & Wu 1994). Although algorithms are available for the prediction of canonical 
bacterial lipoproteins(Babu et al. 2006), the majority of lipidated proteins in bacteria are 
poorly characterized and may exist in other forms. For example, the E. coli protein toxin 
hemolysin is activated through fatty-acylation of a lysine (Lys) residue (Issartel et al. 
1991). In this regard, the application of fatty acid reporters to bacteria allows both the 
rapid profiling of canonical bacterial lipoproteins as well as the discovery of 
unconventionally lipidated proteins in bacteria (Fig. 7e) (Rangan et al. 2010). In addition 
to fatty acids, phosphopantetheinyl reporters can be directly transferred onto bacterial 
proteins involved in polyketide biosynthesis (Mercer et al. 2009). For protein tagging 
applications, these lipid reporters also allows site-specific labeling of recombinant 
proteins containing N-myristoylation and S-prenylation motifs by co-expression of the 
associated lipid transferases in bacteria (Heal et al. 2008; Gauchet et al. 2006; Wollack et 
al. 2009; Yi et al. 2010). Alternatively, lipoic acid ligase tagging has been developed for 
sequence-specific tagging of proteins in mammalian cells for fluorescence imaging 
applications (Fig. 7f) (Yao et al. 2012; Uttamapinant et al. 2010). As specific antibodies 
for lipid modifications have been difficult to generate, bioorthogonal chemical reporters 
have been valuable for the detection and discovery of lipidated proteins, analysis of 
lipidation dynamics and regulation as well as protein engineering (Hang et al. 2011). 
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1.3.3 Acetylation.  
Protein acetylation of Lys residues plays important roles in epigenetic regulation of 
transcription, signaling and metabolism (X.-J. Yang & Seto 2008; Kouzarides 2007). 
With the explosion of Lys acetylated proteins from recent proteomic studies in 
mammalian cells and bacteria (Choudhary et al. 2009; Q. Wang, Y. Zhang, et al. 2010), 
unraveling what substrates are regulated by specific Lys acetyltransferases (KATs) and 
deacetylases (KDACs) in various signaling pathways is a major challenge. In this regard, 
alkyne analogs of acetate and acetyl-CoA such as 4-pentynoate and 4-pentynoyl-CoA can 
function as chemical reporters of Lys acetylation in cells and in vitro, respectively (Fig. 
8a) (Hang & Linder 2011). Metabolic labeling of mammalian cells with 4-pentynoate 
readily labels known Lys acetylated proteins such as histones, which allows simple 
fluorescence profiling of acetylated proteins in different cell types (Y.-Y. Yang, Ascano 
& Hang 2010). In addition, 4-pentynoyl-CoA is utilized by the KAT p300 for in vitro 
bioorthogonal profiling of candidate protein substrates in cell lysates (Y.-Y. Yang, 
Ascano & Hang 2010). As acetylation also occurs on the N-terminus of 
proteins(Polevoda & Sherman 2003) and Ser/Thr residues (Mukherjee et al. 2007), 
acetylation reporters should also facilitate the analysis of these modifications and their 
associated enzymes. Other forms of Lys acylation such as propionylation, butrylation, 
malonylation, succinylation and crotylation have also been reported (M. Tan et al. 2011; 
Z. Zhang et al. 2011; Chen et al. 2007; Du et al. 2011), which may also benefit from 












Figure 8 Many posttranslational modifications can be analyzed with cofactor 
analogs or selective chemical modification reagents. a) Sodium-4-pentynoate 
allows metabolic labeling of acetylated proteins, while 4-pentynoyl-CoA can be 
used for in vitro analysis of acetyltransferase substrates. b) Numerous S-adenosyl-
L-methionine reporters have been developed (AdoEnYn, Hey-SAM, Pob-SAM), 
whose extended side chains are transferred by protein methyltransferases onto 
their native substrates. c) 6-alkynyl-NAD is a chemical reporter for ADP-mono 
and poly-ribosylation. d) N6pATP serves as a chemical reporter for protein 
AMPylation. e) N6benzyl-ATPγS serves as a substrate for engineered kinases and 
allows chemical substrate modification with a nitrobenzyl-hapten for antibody 
detection. f) The oxidative modification of cysteines to sulfenic acid can be 
monitored by reaction with an alkynyl-dimedone reagent for subsequent 


















































































































































































1.3.4 Methylation.  
The modification of Lys or arginine (Arg) residues with one or more methyl groups is a 
common PTM in epigenetics and various signaling pathways (Y.-Y. Yang et al. 2011). 
The general cofactor for nearly all cellular methylation reactions is S-adenosyl-L-
methionine (AdoMet or SAM), from which the methyl group is transferred onto proteins, 
nucleic acids or other substrates. The development of bioorthogonal methylation 
reporters has therefore attracted considerable interest by many groups.  Initially, 
Weinhold and colleagues demonstrated that various DNA methyltransferases are able to 
transfer allylic or propargylic groups from SAM reporters onto DNA substrates (Bedford 
& Clarke 2009; Rathert et al. 2008). The authors hypothesized that the improved 
reactivity of these reagents could be explained by the conjugative stabilization of the 
forming p orbital on the reactive carbon during the SN2-reaction. This observation was 
instrumental in the development of the first alkyne SAM reporter for site-selective 
labeling of protein methyltransferase substrates such as histone H3 (AdoEnYn) (Fig. 8b) 
(Dalhoff et al. 2006). AdoEnYn possesses an extended unsaturated pentameric side chain, 
with a double bond in the β-position relative to the sulfonium center and a terminal 
alkyne group. A suite of additional AdoMet reporters capable of labeling Lys and Arg 
methyltransferase substrates with terminal alkyne groups was subsequently reported (W. 
Peters et al. 2010). A propargyl AdoMet reporter with the smallest alkyne substituent was 
utilized by the Lys methyltransferase SETDB1 but unfortunately not active with other 
tested methyltransferases such as SET7, PRMT1, PRDM8 (Binda et al. 2011; R. Wang, 
W. Zheng, et al. 2011; Islam et al. 2011). Alternatively, Luo and colleagues have 
identified protein methyltransferase mutants that can utilize other SAM chemical 
reporters. After screening a small panel of cofactor analogs against a series of active site 
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methyltransferase mutants, a G9a mutant that is able to accept (E)-hex-2-en-5-ynyl-SAM 
(Hey-SAM) and modify recombinant histone H3 was identified (Fig. 8b) (Binda et al. 
2011). In addition to Lys methyltransferases, a double mutant of protein Arg 
methyltransferase PRMT1 that can utilize 4-propargyloxy-but-2-enyl-SAM (Pob-SAM) 
was developed (Fig. 8b) (Islam et al. 2011). Interestingly, when added to cell lysates, the 
double mutant of PRMT1 in combination with Pob-SAM specifically labeled a number of 
proteins. In both cases the most active SAM reporters carried an β-unsaturation 
consistent with the studies by Weinhold and coworkers. This approach in combination 
with mass spectrometry-based protein identification should facilitate the identification of 
specific methyltransferase substrates in the future.  
1.3.5 ADP-Ribosylation. 
Proteins can be reversibly modified with mono-ADP-ribose on a range of different 
residues (R. Wang, W. Zheng, et al. 2011). This modification was initially described as 
the virulence mechanism for a number of different bacterial toxins, but is now 
appreciated as a common PTM with many important biological functions in eukaryotes as 
well (Hottiger et al. 2010; Hassa et al. 2006). Protein mono-ADP-ribosylation is carried 
out by a diverse set of mono-ADP-ribosyltransferases (MARTs) that require the cofactor 
nicotinamide adenine dinucleotide (NAD), from which the ADP-ribose moiety is 
transferred onto the protein substrate. Additionally, in eukaryotes the ADP-ribose 
modification can be extended by addition of ADP-ribosyl groups to the 2’-OH of the 
ribose moieties to form poly-ADP-ribosylated proteins. This modification is carried out 
by poly-ADP-ribosylpolymerases (PARPs) that also use NAD as donor for the ADP-
ribosyl group. The growing list of ADP-ribosylation substrates and potential new 
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ribosylation enzyme classes has motivated the development of ADP-ribosylation 
reporters for substrate detection and identification (Hassa et al. 2006). Lin and colleagues 
initially generated 8-alkyne-NAD and 6-alkyne-NAD (Fig. 8c) and showed that both of 
these chemical reporters are accepted by diphteria toxin (DT), a well-characterized 
MART that modifies elongation factor eEF-233. The analysis of these chemical reporters 
with PARPs, PARP-1 and Tankyrase-1, revealed 6-alkyne-NAD was most effective for 
monitoring the modification of p53 and TRF-1, respectively (Du et al. 2009; Jiang et al. 
2010). Incubation of cell lysates with recombinant PARP-1 and 6-alkyne-NAD enabled 
bioorthogonal detection and identified of poly-ADP-ribosylated proteins, demonstrating 
the utility of these reagents for ADP-ribosylation analysis. 
1.3.6 AMPylation.  
Though originally discovered in the context of glutamine synthetase regulation in E. coli 
(Jiang et al. 2010), AMPylation (adenylylation) has become more widely appreciated 
since the discovery of secreted bacterial effector enzymes that modify host small 
GTPases during infection (Kingdon et al. 1967, Woolery et al. 2010). AMPylation 
describes the enzymatic transfer of an adenosine monophosphate (AMP) from ATP onto 
hydroxyl protein side chains under the formation of a phosphodiester bond. The 
conserved protein domains (fic domain, adenylyl transferase domain) responsible for the 
AMPylation activity are widely present among prokaryotes and eukaryotes, suggesting a 
ubiquitous role for this PTM (Yarbrough et al. 2009; Worby et al. 2009; Müller et al. 
2010). Recent studies have also revealed specific phosphoesterases that can remove the 
AMP moiety suggesting that this modification can be dynamic and regulated (Kinch et al. 
2009). The re-emergence and prevalence of potential AMPylation enzymes has motivated 
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the development of specific antibodies (Hao et al. 2011), mass spectrometry detection 
methods (Li et al. 2011) as well as an bioorthogonal AMPylation reporter from our 
laboratory. Modification of ATP at the N6-position with a propargyl group provides an 
alkyne-decorated AMPylation reporter (N6pATP) (Fig. 8d) that can be enzymatically 
transferred onto specific sites of cognate protein substrates by all known classes of 
AMPylation enzymes (Yan Li et al. 2011). Furthermore, N6pATP can be used to 
proteomically identify AMPylation substrates at endogenous levels in cell lysates 
(Grammel et al. 2011), which should facilitate the characterization of AMPylated 
proteins in diverse organisms. 
1.3.7 Phosphorylation.   
The reversible addition of phosphate onto Ser, Thr or tyrosine (Tyr) residues on proteins 
are perhaps the best studied PTMs (Pawson & Scott 2005; Tarrant & Cole 2009), for 
which specific antibodies and quantitative proteomic methods have been 
developed(Macek et al. 2009). Nonetheless, the large number of phosphoproteins and 
regulatory enzymes (kinases and phosphatases) with potential overlapping biochemical 
activity makes dissecting phosphorylation-dependent signaling pathways still very 
challenging. Robust biochemical methods for directly monitoring enzyme-specific 
phosphorylation events are desirable. The identification of adenosine triphosphate (ATP) 
analogs that can be utilized by engineered kinase mutants by Shokat and coworkers has 
been instrumental in breaking the degeneracy of kinase activities and allowed the 
identifying specific protein substrates (Fig. 8e) (Shogren-Knaak et al. 2001; C. Zhang et 
al. 2005). To distinguish kinase-specific phosphorylation events from existing 
phosphoproteins in cell lysates, γ-thioATP was employed as substrate such that the 
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unique reactivity of the sulfhydryl group could be selectively alkylated with detection and 
enrichment reagents (Carlson et al. 2010; Allen et al. 2005; Allen et al. 2007; Blethrow et 
al. 2008). The alkylation of thiophosphate groups with a nitrobenzyl-hapten allowed 
specific antibody recognition of this semisynthetic epitope over alkylated Cys residues 
for identification of kinase-specific substrates (Allen et al. 2005; Allen et al. 2007).  
Although this system does not utilize alkyne- or azide-functionalized reagents, this two-
step labeling protocol is itself bioorthogonal and showcases the utility of bump-hole 
approaches for identifying enzyme-specific substrates in systems with overlapping 
biochemical activity.  
1.3.8 Oxidation.   
The oxidation of amino acid side chains can result in significant rearrangements of 
protein structure as in the case of the green fluorescent protein (GFP) or more subtle 
changes such as hydroxylation of amino acid residues. These PTMs are perhaps the least 
amendable to bioorthogonal labeling methods, nonetheless, specific chemical reagents 
have been identified that enable bioorthogonal detection of some protein oxidation 
reactions.  For example, the functionalization of dimedone with an azide or alkyne 
enabled the selective labeling sulfenic acid modified proteins in cells and subsequent 
bioorthogonal detection and proteomic analysis (Fig. 8f) (Leonard et al. 2009; Paulsen et 
al. 2012). Interestingly, Carroll and coworkers demonstrated that stimulation of the 
epidermal growth factor receptor (EGFR) results in elevated hydrogen peroxide levels 
which in turn oxidizes Cys797 of EGFR to enhance its tyrosine kinase activity. These 
observations suggest an interestingly positive feedback loop to amplify EGFR-dependent 
signaling (Paulsen et al. 2012). By taking advantage of the unique chemical reactivity, 
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bioorthogonal reporters can be developed for specific forms of protein oxidation and 
reveal previously unappreciated mechanisms of cell signaling.  
1.3.9 Summary and Future Outlook. 
Bioorthogonal reactions in conjunction with chemical reporters are providing powerful 
ways of tracking biomolecules in living systems and illuminating new aspects of biology. 
While the past decade has seen incredible advances in bioorthogonal reactions and 
specific chemical reporters (Carolyn R Bertozzi 2011), equally momentous leaps will be 
necessary to apply these chemical tools to complex biological problems. Some of the 
limitations of bioorthogonal detection are already being addressed with faster and more 
selective chemical reactions (Jewett & Carolyn R Bertozzi 2010) as well as label-free 
chemical imaging methods (Pezacki et al. 2011). On the chemical reporter end, many of 
the cofactor-based reporters only work with enzymes in vitro and would benefit from the 
development of caged precursors or engineered enzymes for in vivo labeling applications. 
Moreover, the generation of enzyme-specific chemical reporters akin to the systems 
developed for kinases is needed for several PTMs to characterize specific protein targets. 
These two-component systems for bioorthogonal chemical reporters could then be 
introduced into model organisms for cell-specific imaging and proteomics applications. 
By virtue of their specific and dynamic incorporation into biomolecules, bioorthogonal 
chemical reporters can provide snapshots of the chemistry inside of cells that integrate 
the activity of metabolic pathways and specific enzymes in response to environmental 
cues. The development of new bioorthogonal chemical reporters and their application 
should help translate genomic information into biological function and uncover key 
mechanisms of human diseases. 
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2 Cell-selective labeling of Salmonella typhimurium with 2-amino-7-octynoic acid 
(AOA) during infection1 
2.1 Abstract 
2.2 Background 
Bacterial pathogens have evolved sophisticated mechanisms to evade host defenses and 
cause disease (Bhavsar et al. 2007). The emergence of new and antibiotic-resistant 
bacterial pathogens demands a better understanding of virulence mechanisms for 
antibacterial drug discovery. While the discovery of bacterial toxins, quorum sensing and 
protein secretion pathways has revealed some key virulence mechanisms, the precise 
mechanisms by which intracellular bacterial pathogens subvert host immune responses 
are still unclear (Bhavsar et al. 2007). The analysis of individual virulence factors has 
demonstrated that bacterial pathogens alter their protein expression to infect and replicate 
in host tissues (Haraga et al. 2008). However, the system-wide identification and analysis 
of bacterial proteins that are uniquely expressed or secreted during infection is paramount 
for understanding mechanisms of bacterial pathogenesis (Haraga et al. 2008; Rodland et 
al. 2008). Comparative genomics and mutagenesis studies have revealed bacterial genes 
that are important for infection, but their precise biochemical mechanisms and temporal 
expression pattern can be elusive due to post-transcriptional regulation. Direct 
biochemical analysis of bacterial proteomes during infection is needed. The large excess 
                                                
1 This work was carried out in collaboration with Mingzi M Zhang (The Rockefeller 
University), who cloned metG from E. coli into pCOLAduet-1. Mass spectrometry runs 
for proteomic analysis were carried out by the Proteomics Resource Center of The 
Rockefeller University.  
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of host proteins in mixed pathogen-host lysates presents a significant challenge for 
proteomic analysis of bacterial proteins during infections and even after physical 
isolation of intact bacteria significant amounts of host proteins still remain (Rodland et al. 
2008; Shi et al. 2006). This is particularly important since many bacterial virulence 
factors are often expressed at low levels (Haraga et al. 2008). New strategies are therefore 
required to selectively enrich bacterial proteins from host proteomes for their analysis 
during infection.  
The incorporation of unnatural amino acids in bacteria has provided new methods 
to differentiate bacterial proteins from host proteomes. For example, the incorporation of 
phenylalanine analogs in mycobacteria by amber stop codon suppression technology has 
enabled the selective labeling of green fluorescent protein expressed in M. tuberculosis 
during intracellular infection of macrophages (F. Wang et al. 2010). Alternatively, 
alkyne- or azide-functionalized methionine (Met) surrogates can be incorporated by the 
endogenous methionyl-tRNA synthetase (MetRS) into bacterial proteomes (Beatty et al. 
2005; Kiick et al. 2002). These amino acid chemical reporters allow the metabolic 
labeling of newly synthesized proteins, which in combination with bioorthogonal ligation 
methods, such as Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) can be used to 
detect and identify Met-containing proteins (Dieterich et al. 2006). Additionally, MetRS 
mutants have been identified in E. coli (MetG) that can incorporate azidonorleucine 
(ANL, Figure 9a), a Met surrogate that is not efficiently activated by the wild-type 
MetRS or other endogenous aminoacyl-tRNA synthetases (Link et al. 2006; Tanrikulu et 
al. 2009). ANL can therefore be used as an orthogonal amino acid reporter to selectively 
label proteins in non-pathogenic E. coli by bacterial expression of MetRS mutants in the 
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presence of mammalian cells (Ngo et al. 2009). While these studies have demonstrated 
selective targeting of bacterial proteomes in the presence of host cells, the analysis of 
endogenously expressed bacterial proteins during infection has not been achieved using 
unnatural amino acid reporters (F. Wang et al. 2010; Ngo et al. 2009). The following 
chapter of this thesis describes a new orthogonal alkynyl-amino acid reporter (2-amino-7-
octynoic acid, AOA, Figure 9a) for specific imaging and enrichment of bacterial 
proteomes during infection of mammalian cells, which we applied to the intracellular 
bacterial pathogen Salmonella typhimurium (Figure 9b). 
 
Figure 9 Orthogonal (cell-selective) amino acid reporters for bacterial translation. 
 
2.3 Results 
2.3.1 Expression of MetG in Escherichia coli and in vitro labeling with 2-amino-7-
octynoic acid (AOA) 
Based on the reported superior selectivity of azide- compared to alkyne-functionalized 
secondary CuAAC reagents (Speers & Cravatt 2004) and our own experience with fatty 
acid chemical reporters (Charron et al. 2009) we evaluated whether an alkynyl-isostere of 
ANL, 2-amino-7-octynoic acid (AOA, Figure 1a), could be accepted by previously 
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reported MetRS mutants (Link et al. 2006; Tanrikulu et al. 2009). MetRS mutants were 
generated from the E. coli metG gene (L13G, L13N Y260L H301L: NLL, L13P Y260L 
H301L: PLL) by site-directed mutagenesis and ligated into pCOLAduet-1 for over-
expression in E. coli (only L13G and NLL were cloned in pCOLAduet-1, PLL was 
directly cloned in pWSK29, see below). AOA was synthesized by alkylation of diethyl 
acetamidomalonate with hex-5-ynyl-4-methylbenzenesulfonate followed by 















1) 10 % (w/v) NaOH
2) H2O, H+ 2 N HCl
 
Figure 10 Synthesis of 2-amino-7-octynoic acid (AOA). 
 
E. coli pCOLAduet_MetGNLL and E. coli pCOLAduet_MetGL13G overnight 
cultures were diluted 1:30 into M9 minimal and grown for 3 h. The cultures were 
pelleted, resuspended in an equal volume of M9 minimal medium with or without IPTG 
and with or without AOA or ANL, and grown for 3 h at 37 °C with aeration. Cells were 
lysed with SDS lysis buffer and reacted with azido-rhodamine (az-rho) or alkyne-
rhodamine (alk-rho) by CuAAC and analyzed by SDS-PAGE and in-gel fluorescence 
scanning (Charron et al. 2009). Over-expression of MetGNLL or MetGL13G facilitates 
                                                
2 Due to the racemic nature of AOA, any indicated concentration refers to the effective 
concentration of the L-isomere, unless otherwise noted. 
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incorporation of AOA into the E. coli proteome (Figure 11) (further analysis of AOA 
incorporation was carried out in S. typhimurium, see below). As reported previously, 
MetGNLL provides better ANL incorporation than MetGL13G, however this difference is not 
as pronounced with AOA, which is incorporated less efficiently in E. coli than ANL. 
These results were encouraging to test AOA incorporation in the bacterial pathogen S. 
typhimurium. 
 
Figure 11 Expression of MetGNLL or MetGL13 facilitates AOA incorporation in E. coli. E. 
coli pCOLAduet_MetGNLL and E. coli pCOLAduet_MetGL13 (induced with 1 mM 
IPTG) was labeled with 1 mM azidonorleucine (ANL) or 1 mM 2-amino-7-octynoic acid 
(AOA) for 3 h in M9 minimal medium. Cells were lysed, reacted with az-rho or alk-rho 
by CuAAC and analyzed by in-gel florescence screening. AA: amino acid, IPTG: 
Isopropyl β -D-1-thiogalactopyranoside, NLL: MetGNLL, L13: MetGL13G, Fluor.: 






2.3.2 Expression of MetG in Salmonella typhimurium and in vitro labeling with 2-
amino-7-octynoic acid (AOA) 
Since the metG gene in E. coli and S. typhimurium are 95 % identical, overexpression of 
E. coli metG in S. typhimurium should facilitate amino acid activation. To allow mutant 
MetG overexpression in S. typhimurium MetGL13G, MetGNLL, and MetGPLL were cloned in 
the low copy number plasmid pWSK29 under the expression control of the lac promoter, 
which provides constitutive expression in S. typhimurium. All plasmids were transformed 
into the S. typhimurium strain IR715. For the in vitro analysis of the S. typhimurium 
strains expressing MetRS mutants, bacteria were grown in full Luria-Bertani (LB) 
medium to stationary phase and diluted into M9 minimal medium containing Met, AOA, 
or ANL. Protein lysates were reacted with the az-rho detection tag by CuAAC and 
analyzed by SDS-PAGE and in-gel fluorescence scanning.  
To determine the most efficient MetG mutant and orthogonal amino acid reporter 
combination for selective labeling of the S. typhimurium proteome, we compared the 
three MetG mutants MetGL13G, MetGNLL, and MetGPLL for ANL and AOA incorporation in 
S. typhimurium in vitro. All three MetRS mutants permit incorporation of ANL and AOA 
into the S. typhimurium proteome (Figure 12a).  Expression level of all MetG mutants 
were comparable as judged by S-tag Western blot analysis of the epitope tag fused to all 
MetRS constructs (Figure 12a). Both triple mutants (NLL, PLL) conveyed more efficient 
incorporation of ANL and AOA over the single mutant (L13G). In addition, AOA 
showed superior signal-to-noise ratios compared to labeling with ANL for all three 
MetRS mutants (Figure 12b). These data demonstrate that both orthogonal amino acid 
reporters function in S. typhimurium expressing MetG mutants, but MetGNLL or MetGPLL 
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in combination with AOA affords the optimal orthogonal enzyme-substrate pair for 
metabolic labeling of S. typhimurium proteins. 
 
Figure 12 Triple mutants (MetGNLL and MetGPLL) in combination with 2-amino-7-
octynoic acid (AOA) provide optimal signal-to-noise in S. typhimurium. a) S. 
typhimurium pWSK29_MetG, pWSK29_MetGL13G, pWSK29_MetGNLL, or 
pWSK29_MetGPLL was labeled with ANL or AOA in minimal medium. b) Quantification 
of fluorescence signal. AA: amino acid, STM: S. typhimurium IR715, az-rho: azido-
rhodamine, alk-rho: alkyne-rhodamine, CB: coomassie blue, α-S-Tag: anti-S-Tag 
Western blot, NI: normalized fluorescence intensity, normalized for negative control and 
coomassie blue staining. 
 
To confirm selectivity of AOA for newly synthesized Met-containing proteins, we 
conducted protein synthesis inhibitor and Met competition experiments. Pre- and co-
incubation of S. typhimurium pWSK29_MetGNLL with the protein synthesis inhibitor 
tetracycline (Tet) effectively abrogated AOA-labeling (Figure 13a). Met efficiently 
competed away AOA-incorporation in a dose-dependent manner (Figure 13b). The 
synthetic route of AOA results in a racemic mixture. Some D-amino acids can be 
translationally incorporated into proteins and D-amino acids can be toxic to various 
organisms (Champney & Jensen 1970; Friedman 1999). Therefore we wanted to know 
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whether D-AOA interferes with AOA labeling of S. typhimurium. Pig acylase I was used 
to kinetically resolve the racemic mixture of AOA (Chenault et al. 1989), which afforded 
enantiomerically enriched (ee) L-AOA (Figure 14). The purity of ee L-AOA was not 
further quantified, but the NMR analysis revealed that L-AOA was the predominant 
species present. Racemic AOA was used at 2 mM and compared to 1 mM ee L-AOA. 
Both preparations showed identical labeling efficiencies at comparable effective 
concentrations (Figure 13c) and we could not detect any growth differences of S. 
typhimurium between the racemic and the enantiomerically pure AOA preparation. These 
data demonstrate that AOA can selectively label newly synthesized Met-containing 





















Figure 13 2-amino-7-octynoic acid (AOA) serves as a co-translational chemical reporter 
for methionine (Met) in S. typhimurium. a) S. typhimurium pWSK29_MetGNLL was 
treated with Met (1 mM) or AOA (1 mM), in the presence or absence of tetracycline 
(Tet) for 30 min. b) S. typhimurium pWSK29_MetGNLL was incubated with increasing 
concentrations of Met and AOA (1 mM). c) Comparison of the labeling efficiency of D/L-













Figure 14 Determination of the absolute stereochemistry of kinetically resolved 2-amino-
7-octynoic acid (AOA). The methyl ester of AOA (racemic mixture) and kinetically 
resolved AOA were formed using thionyl chloride in anhydrous methanol.  Both methyl 
esters were reacted with R-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride (MTPA 
chloride) to form S-MTPA-S/R-1-COOMe and S-MTPA-S-1-COOMe (as determined 
subsequently by 1H NMR), respectively. 1H NMR spectra were taken of both MTPA 
derivatives as well as a 1:3 mix of the two. The singlet signal of the methyl ester 
(COOMe) protons experiences a characteristic chemical shift depending on the absolute 
stereochemistry of the chiral center of the amino acid moiety. The signal of the S-S-
diastereomer experiences a greater chemical shift than the S-R-diastereomer. 
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2.3.3 Labeling Salmonella typhimurium with 2-amino-7-octynoic acid (AOA) 
during infection of mammalian cells 
We then evaluated the efficiency of ANL and AOA-labeling of S. typhimurium 
proteomes during intracellular infection of mammalian cells. To analyze selective 
incorporation of orthogonal amino acid reporters in intracellular S. typhimurium, 
RAW264.7 murine macrophages were infected with S. typhimurium pWSK29_MetGNLL 
at a multiplicity of infection (MOI) of 100 for 30 minutes. Following infection, extra- 
cellular bacteria were killed by addition of gentamicin, a cell-impermeable antibiotic. 
After two hours, infected and non-infected macrophages were labeled with different 
concentrations of Met, ANL or AOA in the growth medium for 3 hours. Cell pellets 
containing bacteria and mammalian cells were lysed with 4% SDS lysis buffer, reacted 
with alk-rho or az-rho and analyzed by in-gel fluorescence. Samples infected with S. 
typhimurium pWSK29_MetGNLL, validated by S-tag Western blot analysis, and labeled 
with ANL or AOA displayed a strong fluorescence signal above background in contrast 
to the non-infected samples labeled with ANL or AOA (Figure 15a). Comparison of the 
Met control samples revealed the considerably higher background signal of alk-rho, as 
observed in vitro. Close inspection of AOA-treated non-infected macrophages showed 
marginal concentration dependent labeling with AOA, while ANL incorporation could 
not be observed. Quantification of the relative fluorescence intensities of ANL and AOA 
suggested that AOA, at an effective concentration of 1 mM, affords the most sensitive 
labeling of S. typhimurium proteins during infection (Figure 15b). These results strongly 
suggested that ANL and AOA can be selectively incorporated into S. typhimurium during 
infection of mammalian cells by the cell selective expression of MetGNLL. We found that 
44 
AOA in combination with azide-detection reagents displayed superior labeling sensitivity 
at all tested concentrations (Figure 15b).  
To confirm selective labeling of Salmonella with AOA inside mammalian cells, we 
performed fluorescence imaging studies of infected cells.  HeLa cells were infected with 
S. typhimurium pWSK29_MetGNLL (MOI = 100), 16 h post-infection cells were pulse-
labeled with AOA or Met for 1 hour, fixed, permeabilized, reacted with az-rho and 
stained with anti-Salmonella serum. Imaging of rhodamine fluorescence demonstrated 
robust and selective labeling of intracellular bacteria with AOA (Figure 16a). No 
rhodamine fluorescence was observed in host cells or S. typhimurium pWSK29_MetGNLL 
-infected cells treated with Met under these conditions. AOA-labeled S. typhimurium co-
localized with anti-Salmonella serum, validating selective incorporation of AOA into the 
bacterial proteome and exclusion from host proteins. In addition, we analyzed S. 
typhimurium-infected RAW264.7 macrophages by LAMP-1 antibody staining, a marker 
for the Salmonella containing vacuole (SCV) of infected host cells (Haraga et al. 2008). 
AOA-labeled S. typhimurium pWSK29_MetGNLL inside RAW264.7 macrophages were 
enclosed in LAMP-1 positive compartments (Figure 16b), suggesting that AOA labeling 
does not significantly disturb intracellular trafficking of Salmonella in host cells. These 
data further validate the utility of AOA for selective metabolic labeling of Salmonella 




Figure 15 AOA and ANL allow labeling of S. typhimurium pWSK29_MetGNLL infected 
macrophages. a) RAW264.7 cells were infected with S. typhimurium pWSK29_MetGNLL 
and pulse-labeled with different concentrations of AOA or ANL 16 hours post-infection. 
b) Quantification of fluorescence signal. AA: amino acid, STM: S. typhimurium IR715, 
az-rho: azido-rhodamine, alk-rho: alkyne-rhodamine, CB: coomassie blue, α-S-Tag: anti-
S-Tag Western blot, NI: normalized fluorescence intensity, normalized for negative 









Figure 16 2-amino-7-octynoic acid (AOA) allows selective labeling of S. typhimurium in 




2.3.4 Proteomic analysis of 2-amino-7-octynoic acid (AOA) labeled proteins of 
Salmonella typhimurium 
After selectivity and efficiency of AOA labeling was established, we compared S. 
tyhimurium proteins that are metabolically labeled by AOA during growth in liquid 
culture to S. tyhimurium proteins that are labeled during infection of macrophages. For 
this comparative analysis, S. typhimurium pWSK29_MetGNLL grown in liquid culture (in 
vitro) (Figure 18b) and RAW264.7 macrophages infected with S. typhimurium 
pWSK29_MetGNLL (16 h post infection) (Figure 18c) were pulse-labeled with AOA or 
Met for 1 hour. Generated cell lysates were reacted with azido-azo-biotin (Y.-Y. Yang, 
Ascano & Hang 2010), affinity purified with streptavidin and eluted from beads for 
protein identification by gel-based proteomics (Figure 18a). The generated raw data was 
searched against a concatenated mouse-S. typhimurium database for protein 
identification. Only proteins that contained two unique peptides and were not detected in 
the Met control were considered for this study. The analysis of infected RAW264.7 
macrophages identified a total of 218 proteins that sufficed our filter criteria (Appendix 
Table 3). Amongst these proteins, 185 were assigned to the S. typhimurium proteome 
(85%), the remainder were mouse proteins (Figure 18d). Additionally, we identified 472 
proteins from S. typhimurium pWSK29_MetGNLL pulse-labeled with AOA in minimal 
medium (Appendix Table 4). Between the in vitro Salmonella and the intracellular 
Salmonella datasets we could identify 96 common proteins, while 89 proteins (48%) 
were exclusively observed in the sample derived from infected macrophages (Figure 
18e). Interestingly, at least 5 Salmonella proteins (SodM, SsrB, SseA, PipB2 and PhoP) 
from infected RAW264.7 cells were previously described as virulence factors (J. Yang et 
al. 2008).  
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Compared to other proteomic datasets generated from macrophages infected with S. 
typhimurium (Shi et al. 2006), our results demonstrate that AOA-pulse-labeling in 
conjunction with bioorthogonal ligation methods allows greater enrichment of bacterial 
proteins (85% Salmonella proteins with AOA-labeling compared to ∼45% under 
comparable conditions without AOA) and reveals additional bacterial proteins that may 
be preferentially expressed during infection (Figure 18f). Although the use of AOA and 
MetGNLL only targets Met-containing proteins, 96% of the S. typhimurium LT2 proteome 
contains one or more Met residues in addition to the N-terminal initiator Met residue.  
Hence, the majority of the Salmonella proteome is amenable to labeling with AOA 
(Figure 17). Our preliminary proteomic studies demonstrate that AOA-pulse-labeling in 
combination with CuAAC allows efficient enrichment and identification of endogenously 
expressed bacterial proteins that are differentially synthesized by Salmonella during 
infection of host cells. 
 
Figure 17 Methionine distribution in S. typhimurium. Chart shows S. typhimurium 
proteome fractions binned by number of methionines per protein (exclusive the N-







Figure 18 2-amino-7-octynoic acid (AOA) allows enrichment and identification of S. 
typhimurium proteins from infected mammalian cells. a) Cell lysates were reacted by 
CuAAC with azido-azo-biotin (cleavable affinity tag), affinity purified on streptavidin 
beads, and selectively eluted with Na2S2O4 by reduction of the azo-bond. The eluate was 
separated by SDS-PAGE and subsequently analyzed by mass spectrometry based 
proteomics. b) S. typhimurium pWSK29_MetGNLL was labeled with 1 mM AOA or 1 mM 
Met in MgM minimal medium. Cell lysates were analyzed by CuAAC mediated in-gel 
fluorescence scanning. c) RAW264.7 cells were infected with S. typhimurium 
pWSK29_MetGNLL and labeled with 1 mM AOA or 1 mM Met 16 hours post-infection. 
Cell lysates were analyzed by CuAAC mediated in-gel fluorescence scanning. Cell 
lysates were also reacted by CuAAC with azido-azo-biotin, affinity purified and 
selectively eluted by Na2S2O4. Eluate was separated by SDS-PAGE and subsequently 
analyzed by mass spectrometry based proteomics. d) A total of 218 S. typhimurium 
proteins were identified from infected RAW264.7 cells. Of these proteins, 185 (85%) 
were Salmonella proteins and 33 were mouse proteins. e) Comparison of Salmonella 
proteins identified from infected macrophages and Salmonella grown in minimal liquid 
culture: 376 proteins were identified in liquid culture only, 89 proteins were identified in 
infected macrophages only, and 96 were identified in both samples. f) Comparison of 
proteins identified from AOA-pulse-labeled infected RAW264.7 cells (amino acid 
reporter) and a previously published dataset (Shi et al. 2006) of Salmonella proteins 
identified from infected RAW246.7 cells under comparable conditions without AOA 
labeling (no amino acid reporter): 100 proteins were exclusively identified in our dataset, 
85 proteins were identified in both datasets, and 49 proteins were only identified in the 











2.4 Materials and Methods 
2.4.1 General Methods and Materials 
Unless otherwise noted all chemical reagents were purchased from Sigma-Aldrich or 
Fisher Scientific. 1H and 13C NMR spectra were acquired on a Bruker DPX-400 or Bruker 
UltraShield-600 Plus instrument. Chemical shifts are reporter in ppm, and J values are 
reported in Hz. MALDI-TOF mass spectra were acquired on a Applied Biosystems 
Voyager-DE mass spectrometer or a LC-MS. In-gel fluorescence scanning was 
performed with a Amersham Biosciences Typhoon 9400 variable mode imager 
(excitation 532 nm, 580 nm filter, 30 nm band-pass). All contrast or brightness 
adjustments were applied to the entire gel or blot, including the different controls.  
Images adjustments were done in Adobe Photoshop CS.  
2.4.2 Synthesis of 2-amino-7-octynoic acid (AOA) 
2.4.2.1 Diethyl 2-acetamido-2-(hex-5-yn-1-yl)malonate  
Diethyl acetamidomalonate (1.05 g, 4.75 mmol) was dissolved in 30 ml anhydrous 1,4-
dioxane in a previously flame-dried round bottom flask equipped with a condenser and 
set under Argon atmosphere.  Potassium tert-butoxide (0.59 g, 5.23 mmol) was added to 
the vigorously stirred solution and it was incubated for 2 hours at 60 °C. Hex-5-ynyl-4-
methylbenzenesulfonate was added drop wise to the stirring solution and the reaction was 
refluxed for 24 h. The suspension was cooled to room temperature and solid material was 
filtered and washed with diethyl ether.  Filtrate was evaporated under reduced pressure, 
resulting in a brown oil. This material was purified by column chromatography on silica 
gel (30% ethyl acetate/70% hexanes to 40% ethyl acetate/60% hexanes) to afford 520 mg 
pure product 1 (37%). Rf = 0.4; 1H NMR (600 MHz, CDCl3): δ = 1.15-1.20 (m, 8H), 
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1.44-1.49 (quint., J=7.2 Hz), 1.85 (s, 1H), 1.97 (s, 3H), 2.10-2.13 (m, 2H), 2.25-2.28 (m, 
2H), 4.16-4.20 (q, J=7.2 Hz, 4H), 6.75 (s, 1H); 13C NMR (600 MHz, CDCl3): δ = 13.88, 
17.95, 22.41, 22.86, 27.80, 31.43, 62.34, 66.36, 68,50, 83.77, 167.97, 168.92; MS (ESI): 
calc. for C15H23NO5 [M-H]+ requires 298.16, found 298.05. 
2.4.2.2 2-acetamidooct-7-ynoic acid  
Diethyl 2-acetamido-2-(hex-5-yn-1-yl)malonate (520 mg, 1.75 mmol) was dissolved in 
10 ml 10% NaOH and refluxed for 5 hours. The solution was cooled to room temperature 
and acidified to pH 2 with 6 N HCl.  Solvent was evaporated under reduced pressure and 
the resulting residue was taken up in 10 ml of H2O and refluxed for 5 hours. The reaction 
mix was cooled to ambient temperature, acidified to pH 2 with 1 N HCl and extracted 
with three portions of ethyl acetate. The organic layers were combined, dried over 
MgSO4, filtered, and evaporated under reduced pressure, yielding 240 mg of pure product 
2 (70%). 1H NMR (600 MHz, CD3OD): δ = 1.46-1.53 (m, 4H), 1.64-1.70 (m, 1H), 1.80-
1.86 (m, 1H), 1.96 (s, 3H), 2.15-2.17 (m, 3H), 4.33-4.35 (dd, J=5.4, 3.6 Hz, 1H); 13C 
NMR (600 MHz, CD3OD): δ = 17.50, 21.02, 24.61, 27.80, 30.76, 52.20, 68.38, 83.36, 
172.00, 174.13; MS (ESI): calc. for C10H15NO3 [M-H]+ requires 198.11, found 198.03. 
2.4.2.3 2-amino-7-octynoic acid (AOA) 
2-acetamidooct-7-ynoic acid (240 mg, 1.22 mmol) was dissolved in 10 ml 2 N HCl and 
refluxed for 2 hours.  The solution was cooled to ambient temperature and loaded on an 
equilibrated DOWEX 50WX4-100 cation-exchange resin.  The resin was extensively 
washed with water and eluted with 1 M NH4OH. The eluate was evaporated under 
reduced pressure to afford 138 mg of 1 (73%). 1H NMR (600 MHz, D2O): δ = 1.40-1.49 
(m, 4H), 1.82-1.93 (m, 2H), 2.11-2.16 (m, 2H), 2.27-2.28 (t, J=2.4 Hz, 1H), 3.98-4.00 (t, 
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J=6 Hz, 1H); 13C NMR (600 MHz, D2O): 17.21, 23.49, 27.22, 29.97, 54.73, 69.34, 85.75, 
175.00; MS (ESI): calc. for C8H13NO2 [M-H]+ requires 156.10, found 155.98. 
2.4.2.4 Enantioselective hydrolysis of 2-acetamidooct-7-ynoic acid with acylase I  
2-acetamidooct-7-ynoic acid (750 mg) was dissolved in 70 ml H2O and pH was adjusted 
to pH 7.5 with 1 M LiOH.  6 mg acylase I (acylase I from porcine kidney) was added and 
solution was slowly stirred at 37 °C for 24 hours. The material was lyophilized and 50% 
mass was resuspended in 10 ml H2O. Activated charcoal (45 mg) was added and 
incubated for 5 min. Charcoal was filtered over Buchner funnel. Aqueous filtrate was 
washed twice with diethyl ether.  Aqueous phase was evaporated under reduced pressure 
at 45 °C. Resulting residue was dissolved in 1 M HCl and purified over DOWEX 
50WX4-100 cation-exchange resin. Eluate was evaporated under reduced pressure at 45 
°C. 1H NMR (600 MHz, D2O) data was identical to AOA. 
2.4.2.5 Determination of the absolute stereochemistry of kinetically resolved AOA  
The absolute stereochemistry of enantioselectively hydrolyzed 2-acetamidooct-7-ynoic 
acid was determined by formation of the MTPA-amide (S-α-methoxy-α-
(trifluoromethyl)phenylacetyl-amide, Mosher-amide) of the methylester of 
enantioselectively hydrolyzed 2-acetamidooct-7-ynoic acid (Dale & Mosher 1973). The 
methylester of enantioselectively hydrolyzed 2-acetamidooct-7-ynoic acid was formed as 
follows. Enantioselectively hydrolyzed 2-acetamidooct-7-ynoic acid was dissolved in 
anhydrous methanol under Argon atmosphere. Solution was cooled to 0 °C and 50 
equivalents of thionyl chloride were added.  Reaction mix was allowed to warm up to 
room temperature over night.  Reaction was quenched with H2O and solvent was 
evaporated under reduced pressure. Crude material was purified by column 
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chromatography on silica gel (10% methanol/89% dichloromethane/1% acetic acid). The 
methylester of AOA was formed accordingly, however, the reaction was refluxed over 
night with 30 equivalents of thionyl chloride.  
The S-MTPA-amides of both species were formed as follows. The methyl ester was 
dissolved in anhydrous pyridine under argon atmosphere. Three equivalents of R-MTPA 
chloride was added and the reaction was stirred at room temperature for 90 min.  
Reaction completion was assessed by absence of ninhydrin signal. The reaction was 
quenched with H2O and the aqueous phase was extracted with diethyl ether. The organic 
phase was washed twice with 10% HCl and twice with sat. NaHCO3. The organic phase 
was dried over MgSO4, filtered, and evaporated under reduced pressure. The material was 
directly analyzed by 1H NMR.  
2.4.3 Synthesis of S-2-amino-6-azidohexanoic acid (azidonorleucine, ANL) 
2.4.3.1 S-6-azido-2-((tert-butoxycarbonyl)amino)hexanoic acid 
S-6-azido-2-((tert-butoxycarbonyl)amino)hexanoic acid was basically synthesized as 
previously reported with modifications (Link et al. 2004). Instead of trifluoro-
methanesulfonyl azide we used imidazol-1-sulfonyl azide hydrochloride as the 
diazotransfer reagent (Goddard-Borger & Stick 2007). Imidazol-1-sulfonyl azide 
hydrochloride (3.06 g, 14.61 mmol) was added to a stirred solution of BOC-lysine (3 g, 
12.18 mmol), K2CO3 (4.55 g, 32.89 mmol), and CuSO4⋅5H2O (30.4 mg, 0.12 mmol) in 60 
ml of methanol. The reaction mix was stirred at ambient temperature over night and 
diluted with phosphate buffer (0.25 M KH2PO4, 0.25 M K2HPO4). The solution was 
carefully acidified to pH 3 and extracted with 3 portions ethyl acetate. The organic layers 
were combined, dried over MgSO4, filtered, and evaporated under reduced pressure. The 
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resulting crude material was purified by column chromatography on silica gel (25% ethyl 
acetate/74% hexanes/1% acetic acid) and afforded 1.95 g product. 1H NMR (600 MHz, 
CDCl3): δ = 1.43-1.48 (m, 11H), 1.59-1.65 (m, 2H), 1.67-1.71 (m, 1H), 1.86-1.89 (m, 
1H), 3.26-3.28 (t, J=6.6 Hz, 2H), 4.10-4.11 (m, 0.4H), 4.32-4.33 (m, 0.6H), 5.20-5.21 (d, 
0.6H), 6.69-6.70 (d, 0.40). 
2.4.3.2 S-2-amino-6-azidohexanoic acid (ANL)  
ANL was prepared from S-6-azido-2-((tert-butoxycarbonyl)amino)hexanoic acid as 
previously reported (Link et al. 2004). 1H NMR (600 MHz, D2O): δ = 1.36-1.50 (m, 2H), 
1.55-1.60 (m, 2H), 1.83-1.96 (m, 2H), 3.27-3.29 (t, J=6.6Hz, 2H), 3.98-4.00 (t, J=6Hz, 
1H). 
2.4.4 Plasmids and bacterial strains 
S. enterica typhimurium IR715 was transformed with different pWSK29 derived 
plasmids, expressing different mutants of the E. coli methionyl-tRNA synthetase gene 
(MetRS, metG). MetG was amplified from E. coli K12 (GAAGATCTTCATG 
ACTCAAGTCGCGAAGAA, CTCGAGTTTCACCTGATGACCCGG) and cloned into 
pCOLAduet-1 (Novagen) with BglII and XhoI to create a C-terminal S-tagged fusion of 
MetRS and the plasmid pMetG1. Three mutant versions of MetRS were created using the 
QuikChange XL Site-Directed Mutagenesis Kit or the QuikChange Multi Site-Directed 
Mutagenesis Kit (Stratagen): L13G (MetRS-L13G), L13N-Y260L-H301L (MetRS-NLL), 
and L13P-Y260L-H301L (MetRS-PLL). MetRS was amplified from pMetG1 
(CCTGAGCTCCATGACTCAAGTCGCGAAG, CCGGAATTCATTACGAGT 
CCATGTGCTGGCGTTC) and cloned into pWSK29 using SacI and EcoRI, creating 
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pMetG2. pMetG2 encodes a C-terminal S-tag fusion of MetRS under the expression 
control of the lac promoter. 
2.4.5 Infection of mammalian cells 
HeLa cells (5 x 104 cells/well) or RAW264.7 macrophages (5 x 105 cells/well) were split 
into a 24 well plate 10 hours before infection. S. typhimurium was grown over night in 
full LB with 100 µg/ml Carbenicillin (Cb). Overnight cultures were diluted 1:100 into 
fresh LB (Cb) and grown to stationary phase (OD600 = 2). Bacteria were washed once in 
PBS and incubated for 30 min in DMEM (10% FBS) on ice. Bacteria were added to 
mammalian cells in DMEM (10 % FBS) at MOI = 100 and centrifuged (400 g, 5 min, 4 
°C) for spin infection.  Subsequently, cells were incubated for 25 min at 37 °C, 5% CO2. 
Cells were washed 4x with PBS and DMEM (10% FBS) with 100 µg/ml gentamicin was 
added for 90 min to kill all extracellular bacteria. After 90 min medium was exchanged to 
DMEM (10% FBS) with 10 µg/ml gentamicin for the remainder of the experiment. 
2.4.6 Metabolic labeling (in vitro, during infection)  
Over night cultures of bacteria were grown in full LB with 100 µg/ml Carbenicillin (Cb).  
Over night cultures were diluted 1:100 into fresh LB (Cb) and grown to stationary phase.  
Bacteria were collected by centrifugation (10,000 rpm, 3 min) and resuspended in MgM 
(100 mM MES pH 5, 1 mM KH2PO4, 10 µM MgCl2, 5 mM KCl, 7.5 mM NH4OH, 0.5 
mM K2SO4, 38 mM glycerol) minimal medium or M9 (1x M9 salts, 20 mM glucose, 2 
mM MgSO4, 100 µM CaCl2) minimal medium (Cb). Bacteria were grown in minimal 
medium for 15 min and collected by centrifugation. Bacterial pellets corresponding to 
500 µl culture volume were resuspended in MgM or M9 minimal medium (Cb) 
containing chemical reporter. Bacteria were labeled for 1 hour and collected by 
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centrifugation, washed once in PBS, and stored at -80 °C. For tetracycline (Tet) protein 
synthesis inhibition, bacteria were grown for 30 min in LB (40 µg/ml Tet) before being 
labeled for 30 min in M9 minimal medium (40 µg/ml Tet).  
For metabolic labeling of infected mammalian cells, cells were labeled with amino acid 
reporter in DMEM (methionine free) for 3 hours, 90 min after infection or labeled for 1 
hour (fluorescence microscopy), 16 hours after infection. Subsequently, medium was 
aspirated and cells were washed multiple times with PBS. 
For proteomic analysis infected macrophages were pulse-labeled with 1 mM AOA or 1 
mM Met 16 h after infection for 1 h pulse time. For proteomic analysis of S. typhimurium 
labeled in liquid culture, bacteria were grown as described above in MgM minimal 
medium and pulse labeled for 1 h with 2 mM AOA or 1 mM Met. 
2.4.7 Cell lysis 
Bacterial cell pellets and cell pellets of infected mammalian cells were lysed with 
CuAAC compatible SDS lysis buffer as previously reported with slight modifications 
(Rangan et al. 2010). For this study cells were lysed without lysozyme present in the lysis 
buffer and lysed cells were centrifuged at 20,000 g for 15 min at 18 °C to remove cell 
debris 
2.4.8 CuAAC for fluorescence in-gel profiling 
50 µg of cell lysate was brought up to 15 µl with CuAAC buffer (4% SDS, 150 mM 
NaCl, 50 mM TEA). CuAAC components were added as a master mix to adjust the total 
volume to 50 µl with final concentrations as reported previously. CuAAC was carried out 
at room temperature for 1 hour. Protein was precipitated by adding >10 volumes of 
methanol and incubation at -20 °C for at least 1 hour. Precipitated protein was pelleted by 
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centrifugation at 20,000 g for 15 min at 4 °C. Protein pellets were washed once with cold 
acetone and dried on air. Protein pellets were resuspended in 1x Laemmli buffer, 
denatured at 95 °C for 5 min and separated by SDS-PAGE (4-20% Tris-HCl, Bio-Rad 
Criterion). 
2.4.9 Fluorescence microscopy 
For fluorescence imaging experiments infections were carried out as described above, 
however cells were grown on cover slips. 16 h after infection cells were labeled with 2 
mM AOA, or Met for 1 hour in DMEM (methionine free). After metabolic labeling cells 
were fixed for 10 min with 3.7% PFA in PBS. Cells were washed 3x with PBS and 
permeabilized with 0.1% Triton-X-100, 0.2% saponin in PBS for 10 min. Cells were 
washed 3x with PBS and blocked with 10% FBS in PBS for 1 hour at room temperature. 
Cells were washed 3x with PBS and subsequently tagged by CuAAC. 300 µl of a 
CuAAC master mix (20 µM azRho, 1 mM TCEP (tris(2-carboxyethyl)phosphine 
hydrochloride), 100 µM TBTA (tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine), 1 
mM CuSO4) was added to each well and CuAAC was carried out for 1 h at room 
temperature. Subsequently, cells were washed with 1% Tween20, 0.5mM EDTA in PBS 
and PBS. Cells were incubated with primary antibody (LAMP-1, 1:1000. Abcam 24170; 
anti-Salmonella serum 1:250) in 0.2% saponin in PBS for 30 min. Cells were washed 3x 
with 0.2% saponin in PBS. Then cells were incubated with secondary antibody (Alexa 
Fluor® 488 goat anti-rabbit IgG (H+L), 1:1000 , Invitrogen) in 0.2% saponin in PBS for 
30 min. Cells were washed 3x with 0.2% saponin in PBS and finally incubated with TO-
PRO-3 (1:1000) in 0.2% saponin in PBS, before being washed 3x with 0.2% saponin in 
PBS. Cover slips were mounted on ProLong Gold (Invitrogen). 
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2.4.10 Quantification of in-gel fluorescence scanning 
In-gel fluorescence profiles were quantified in ImageJ 1.40g by measuring the mean 
intensity of an equally sized square of each gel lane. The observed intensity was 
normalized by protein load as measured by coomassie stain intensity and the F.I. 
(normalized fluorescence intensity) was formulated as the quotient of this normalized 
intensity and the normalized intensity of the empty vector control or the uninfected 
sample with equal amino acid reporter concentration. 
2.4.11 CuAAC for capture and retrieval 
Cell lysates were brought up to a final concentration of 1 mg/ml with 50 mM TEA, 4% 
SDS and 150 mM NaCl. CuAAC components were added to 100 µM azido-azo-biotin, 1 
mM TCEP, 100 µM TBTA, 1 mM CuSO4 final concentrations and incubated for 1.5 
hours at room temperature. Subsequently, protein was precipitated by methanol-
chloroform precipitation. Before streptavidin bead capture, protein pellets were initially 
resuspended in 4% SDS in PBS and finally diluted to 0.2% SDS, 10 mM EDTA in PBS. 
2.4.12 Streptavidin bead capture 
Streptavidin beads (100 µl/5 mg protein; high capacity streptavidin agarose resin - 
Thermo Scientific) were washed 3x with PBS and equilibrated with 0.2% SDS, 10 mM 
EDTA in PBS. Dissolved protein pellets were added to beads in 0.2% SDS, 10 mM 
EDTA in PBS and incubated on turning wheel for 1 h at room temperature. Beads were 
washed with 2x 10 ml 2% SDS, 10 mM EDTA in PBS, 2x 10 ml of 6 M urea in 250 mM 
ABC (ammonium bicarbonate), 2x 10 ml 1 M NaCl in PBS, and 2x 50 mM ABC. Bound 
proteins were reduced with 10 mM TCEP in 50 mM ABC for 30 min at room 
temperature and subsequently alkylated with 20 mM iodacetamide in 50 mM ABC for 30 
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min at room temperature.  Proteins were specifically eluted with 400 µl 50 mM Na2S2O4, 
0.5% SDS in 50 mM ABC for 1 h in shaker at room temperature. Flow through was 
collected and remaining proteins were eluted a second time for 30 min under equal 
conditions. Combined eluates were concentrated in Microcon YM-10 centrifugal filters 
(Millipore) as per manufactures protocol. Microcon filters were rinsed twice with 50 µl 
1% SDS/75 mM β-mercaptoethanol (BME) to collect proteins. Samples were dried under 
reduced pressure. Samples were resuspendend in 25 µl 1x LDS sample buffer (5% BME), 
heated for 5 min at 95 °C and separated by SDS-PAGE. Gels were stained with GelCode 
Blue Stain Reagent (Thermo). 
2.4.13 In-gel digestion 
Each gel lane was cut into 15 pieces. Each piece was cut into cubes of approximately 1 
mm3, washed once in 50 mM ABC, twice in 1:1 50 mM ABC to acetonitrile (ACN), and 
once in ACN. Gel pieces were dried under reduced pressure. 1/50 (w/w) of trypsin in 50 
mM ABC was added to cover all gel pieces with buffer and incubated over night at 37 
°C. Supernatant was collected and peptides were extracted twice with 1:1 50 mM ABC to 
ACN, and twice with 100% ACN. All supernatants were pooled and dried under reduced 
pressure. For LC-MS/MS analysis samples were dissolved in 25 µl 0.1% TFA. 
2.4.14 MS analysis 
LC-MS analysis was performed with a Dionex 3000 nano-HPLC coupled to an LTQ-
Orbitrap ion trap mass spectrometer (ThermoFisher). Peptides were pressure loaded onto 
a home-made 75 μm diameter, 15 cm C18 reverse phase column and separated with a 
gradient running from 95% buffer A (HPLC water with 0.1% formic acid) and 5% buffer 
B (HPLC grade acetonitrile with 0.1% formic acid) to 55% B over 30 min, next ramping 
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to 95% B over 10 min and holding 95% B for 10 min. One full MS scan (300-2000 MW) 
was followed by 3 data dependent scans of the most intense ions with dynamic exclusion 
enabled. The spray voltage was set to 1.94 kV and the flow rate through the column was 
set to 0.25 μL/min. 
2.4.15 Data analysis 
For protein identification all generated .raw files were searched using the SQUEST 
search algorithm under BioWorks 3.3.1 SP1. All searches were performed against a 
concatenated indexed database containing the international protein index (IPI) mouse 
database v3.49, the UniProtKB/Swiss-Prot HAMAP (http://ca.expasy.org/sprot 
/hamap/SALTY.html) database for S. typhimurium LT2/SGSC1412/ATCC700720, as 
well as the most common protein lab contaminants.  The database was indexed in 
BioWorks 3.3.1 with carbamidomethylation as static modification, trypsin as proteolytic 
enzyme, ‘fully enzymatic’ as enzyme limit, 250-5000 as MW range, and 2 missed 
cleavage sites. SEQUEST searches were conducted with monoisotopic precursor and 
fragment masses, 50.00 ppm peptide tolerance, 1.0 AMU fragment ion tolerance, and B 
and Y ion series calculated. Carbamidomethylation was selected as static modification, 
methionine/tryptophan oxidation as well as asparagines/glutamine deamindation was 
selected as variable modification. The generated unified search files .srf were opened in 
Scaffold 2 (Proteome Software) and further analyzed. All searches were filtered in 
Scaffold 2 for 99.9% protein probability, 2 unique peptides, and 95 % peptide 
probability. Data was exported into Excel and further analyzed. All identifications with 
hits in the Met control sample were discarded, as well as all identified contaminations 
(e.g. keratins). 
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3 A phenylalanine-based orthogonal amino acid reporter3 
3.1 Abstract 
Orthogonal amino acid reporters (unnatural amino acids carrying an azide or alkyne 
motif, which can be cell-selectively incorporated) allow the selective labeling of different 
cell types in heterogenous populations through the expression of engineered aminoacyl-
tRNA synthetases. Previously described orthogonal amino acid reporters (AOA and 
ANL, see chapter 2) are limited to proteins that contain at least one methionine. Other 
amino acids are present more frequently and their substitution could allow more 
quantitative proteome labeling. The following chapter discusses the development of a 
phenylalanine-based orthogonal amino acid reporter, which allows labeling of the 
bacterial pathogen S. typhimurium during infection of mammalian cells.  
3.2 Introduction 
Radiolabeled or stable isotope-labeled amino acids, coupled with mass spectrometry, 
allow the differentiation of newly synthesized from pre-existing proteins (Schwanhäusser 
et al. 2011). Nonetheless, it is still challenging to analyze changes in protein expression 
of individual cell types from heterogeneous populations since these labeled amino acids 
are incorporated into all proteomes. The differentiation of individual proteomes could 
significantly aid in the analysis of complex cell mixtures, such as bacterial cells during 
                                                
3 This work was carried out in collaboration with Paul Dossa (The Rockefeller 
Univeristy) and Emma Taylor-Salmon (Bard College). Paul Dossa and Emma Taylor-
Salmon conducted some of the in vitro labeling experiments.  
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host infection. Robust methodologies are thus needed to differentiate the proteomes of 
individual cell types and to separate them from protein contaminations of other cell types.  
Two recently introduced orthogonal amino acid reporters provide a means for cell-
selective labeling of newly synthesized proteins with azide or alkyne reporter groups 
through the expression of mutant methionyl-tRNA synthetases (MetRS*) (Ngo et al. 
2009; Grammel et al. 2010). Expression of MetRS* in S. typhimurium allows the cell-
selective co-translational incorporation of the orthogonal amino acid reporters 
azidonorleucine (ANL, Figure 19a) and 2-amino-7-octynoic acid (AOA, Figure 19a) into 
newly synthesized bacterial proteins in place of methionine (Met) during infection of 
mammalian cells. Since ANL and AOA are not activated by endogenous tRNA 
synthetases, they are excluded from the mammalian proteome. The incorporation of AOA 
permits the subsequent visualization and proteomic analysis of AOA-labeled proteins 
using the Cu(I)-catalyzed alkyne-azide cycloaddition (CuAAC) with an azido-rhodamine 
fluorescence dye and azobenzene-biotin affinity tags, respectively (Y.-Y. Yang, 
Grammel, et al. 2010). Here we describe the use of para-ethynylphenylalanine (PEP, 
Figure 19a) for efficient cell-selective labeling of S. typhimurium during infection of host 
cells (Figure 19b).  
Even though the majority of proteins contain at least one Met (e.g. 96% in S. 
typhimurium LT2), in addition to the initiation Met, other amino acids are present more 
frequently (e.g. 2.8% Met vs. 3.9% phenylalanine) and their replacement could permit 
greater penetration of the bacterial proteomes with a corresponding amino acid reporter. 
We therefore explored the possibility of alternative orthogonal amino acid reporters that 
would replace one of the other proteinogenic amino acids present in higher frequency 
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than Met. Interestingly, an E. coli phenylalanyl-tRNA synthetase (PheRS) mutant 
(A294G, PheRS*) with increased substrate tolerance has been described that activates a 
wide range of para-substituted phenylalanine (Phe) derivatives (Ibba et al. 1994; 
Kirshenbaum et al. 2002). One of these derivatives, PEP, contains an alkyne chemical 
handle for CuAAC and could thus be used as a chemical reporter. 
 
 
Figure 19 A) PEP: para-ethynylphenylalanine, AOA: aminooctynoic acid, ANL: 
azidonorleucine B) Infection of mammalian cells with Salmonella typhimurium 
expressing a mutant phenylalanyl-tRNA synthetase (PheRS*) allows selective metabolic 
labeling of the bacterial proteome with PEP during infection. 
 
3.3 Results 
3.3.1 Development of para-ethynylphenylalanine (PEP) as an orthogonal amino 
acid reporter for the analysis of the S. typhimurium proteome during 
infection  
To achieve incorporation of PEP into S. typhimurium, we expressed the reported mutant 
E. coli alpha chain of PheRS (PheS), containing the A294G mutation (PheSA294G), under 
the control of the constitutively active lac-promoter using the low-copy plasmid pWSK29 
(pWSK29_PheSA294G). Due to the high sequence conservation between the pheS gene in 
E. coli and S. typhimurium (98%), we anticipated that the over-expressed mutant E. coli 
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alpha chain would form a hybrid hetero tetramer with the endogenous copy of the S. 
typhimurium PheRS beta chain (pheT) to generate active mutant PheRS*.  
 
Figure 20 In-gel fluorescence analysis of PEP incorporation into the S. typhimurium 
proteome in M9 minimal medium. a) S. typhimurium or S. typhimurium 
pWSK29_PheSA294G was labeled with PEP in M9 minimal medium. b) S. typhimurium 
pWSK29_PheSA294G was labeled with PEP, S. typhimurium pWSK29_MetGNLL (see 
chapter 2) was labeled with AOA or ANL, in M9 minimal medium. PheRS*: expression 
of PheSA294G, az-rho: azido-rhodamine, alk-rho: alkyne-rhodamine, rho: azido-rhodamine 
or alkyne-rhodamine, CB: coomassie blue. 
 
To assess metabolic incorporation of PEP into the proteome of S. typhimurium, S. 
typhimurium pWSK29_PheSA294G and S. typhimurium pWSK29 was grown in liquid 
culture and incubated with different concentrations of PEP in minimal medium. Cell 
lysates were reacted with an azido-rhodamine fluorescent dye (az-rho) and analyzed by 
in-gel fluorescence scanning. Expression of PheSA294G facilitated incorporation of PEP 
into the S. typhimurium proteome, while wild-type S. typhimurium did not incorporate 
PEP (Figure 20a). Comparison of PEP with the Met-based amino acid reporters AOA and 
ANL showed comparable or even increased incorporation efficiency (Figure 20b), as 
anticipated owing to the higher frequency of phenylalanine in the S. typhimurium 
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proteome. PEP, indeed, serves as a phenylalanine surrogate in S. typhimurium (Figure 
21a) and its incorporation is dependent on active ribosomal protein synthesis, since 
tetracycline inhibition abrogated the observed fluorescence signal (Figure 21b).  
 
Figure 21 Para-enthynylphenylalanine (PEP) serves as a co-translational chemical 
reporter for phenylalanine in S. typhimurium. a) S. typhimurium pWSK29_PheSA294G was 
incubated with PEP and increasing concentrations of phenylalanine (Phe) in M9 minimal 
medium. b) S. typhimurium pWSK29_PheSA294G was incubated with PEP in the presence 
of tetracycline (Tet) in M9 minimal medium. az-rho: azido-rhodamine, CB: coomassie 
blue.  
 
To evaluate the PEP/PheRS* system for cell-selective labeling, we analyzed S. 
typhimurium infections of mammalian cells. Initial PEP labeling experiments in 
RAW264.7 murine macrophages with minimal media revealed low level mammalian 
proteome labeling, but incubation of macrophages with PEP in full medium containing 
10% fetal bovine serum did not lead to any detectable amino acid incorporation (Figure 
22a). These observations suggests that PEP can be utilized by the endogenous 
translational machinery of mammalian cells at low levels, but it is readily competed away 
in the presence of exogenous Phe. We then proceeded with macrophage infection 
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experiments using S. typhimurium pWSK29_PheSA294G. After 16 hours of infection, 
infected macrophages were pulse-labeled with PEP or Phe for 1 hour in full medium. The 
cell lysates were then reacted with az-rho and analyzed for PEP incorporation by in-gel 
fluorescence. Infection of macrophages with S. typhimurium pWSK29_PheSA294G resulted 
in PEP labeling of numerous proteins (Figure 22b), while incubation of uninfected 
macrophages with PEP did not yield any significant incorporation, suggesting selective 
labeling of the bacterial cells inside the infected macrophages. 
 
Figure 22 PEP incorporation into mammalian proteomes can be suppressed. a) In-gel 
fluorescence analysis of para-ethynylphenylalanine (PEP) labeling of RAW264.7 murine 
macrophages. HBSS: Hank’s buffered saline solution, DMEM: Dulbecco’s Modified 
Eagle Medium, FBS: fetal bovine serum. b) In-gel fluorescence analysis of PEP-labeled 
S. typhimurium pWSK29_PheSA294G-infected RAW264.7 murine macrophage cell lysates. 
PEP: para-ethynylphenylalanine, STM-PheRS*: S. typhimurium pWSK29_PheSA294G, az-
rho: azido-rhodamine fluorescence, CB: coomassie blue. 
 
To confirm selective incorporation of PEP into S. typhimurium 
pWSK29_PheSA294G during intracellular infection, we performed fluorescence 
microscopy following CuAAC. In this case, infected RAW264.7 or HeLa cells were 
fixed after pulse labeling with PEP and reacted with az-rho. Rhodamine fluorescence was 
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only observed in the samples pulsed with PEP and was absent from Phe-treated samples 
(Figure 23). The rhodamine signal co-localized well with anti-S. typhimurium antibody 
staining and was absent from the mammalian cytosol, which demonstrates cell-selective 
labeling of bacterial proteomes using the PEP/PheRS* system. While it is possible that 
these amino acid reporters alter protein function or cell viability (Beatty et al. 2005; Ngo 
& Tirrell 2011), in the context of our pulse-labeling experiments we did not observe 




Figure 23 a) Fluorescence microscopy of PEP-labeled S. typhimurium 
pWSK29_PheSA294G-infected RAW264.7 murine macrophages. b) Fluorescence 
microscopy analysis of infected PEP pulse-labeled HeLa cells. HeLa cells were infected 
with S. typhimurium pWSK29_PheSA294G and pulse-labeled with PEP 16 h after infection. 
PEP: para-ethynylphenylalanine, Phe: phenylalanine, az-rho: azido-rhodamine (red), a-
STM Alexa488: anti-S. typhimurium antibody stain visualized with secondary Alexa488 
conjugate (green), DNA TO-PRO-3: DNA stain (blue), scale bar indicates 10 µm. 
 
70 
3.3.2 Double labeling of S. typhimurium with 2-amino-7-octynoic acid (AOA) and 
para-ethynylphenylalanine (PEP) 
PEP and AOA (or ANL) (see chapter 2) can be selectively incorporated into bacterial 
pathogens instead of phenylalanine and methionine, respectively. We have also learned 
that both systems share the intrinsic limitation to the corresponding subproteome, 
containing either phenylalanine or methionine. A combination of the two reporter 
systems might allow wider coverage of the proteome and a higher reporter incorporation 
density per protein. The concomitant expression of PheSA294G and MetRS* (more 
specifically MetGNLL, see chapter 2) in the same bacterium should allow for simultaneous 
incorporation of PEP and AOA (Figure 19a) into the same proteome (Figure 24a). In 
addition, the exclusive nature of azides and alkynes could provide a means of targeting 
individual bacterial population in the same experiment by using PEP (alkyne) in 
combination with ANL (azide) (Figure 19a, Figure 24b). The expression of MetGNLL in 
one population would facilitate the incorporation of ANL, while the expression of 
PheSA294G in a second population would allow the incorporation of PEP. 
 
Figure 24 Double labeling with cell-selective phenylalanine and methionine surrogates a) 
Double expression of MetRS* and PheRS* allows concomitant incorporation of AOA 
and PEP. b) Individually MetRS* and PheRS* expressing strains can be differentiated. 
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To provide concomitant MetRS* and PheRS* activity in the same S. typhimurium 
strain a bicistronic expression construct was generated. PheSA294Gwas amplified by PCR 
and a N-terminal HA-tag as well as a 5’ ribosomal binding site (RBS) was introduced 
with the primers. The generated fragment was cloned into the previously described 
pWSK29_MetGNLL  construct (see chapter 2) to generate the bicistronic dual expression 
construct pWSK29_MetRSNLL_PheRSA294G (Figure 25a). This construct was transformed 
into S. typhimurium and incorporation of PEP and AOA was tested in vitro. Overnight 
cultures of S. typhimurium pWSK29_MetGNLL, S. typhimurium pWSK29_PheSA294G, and 
S. typhimurium pWSK29_MetRSNLL_PheRSA294G were diluted 1:30 into fresh LB medium 
and grown for 3 hours. Aliquots of these cultures were pelleted and resuspended in equal 
volumes of M9 minimal medium with PEP, AOA, or PEP and AOA. The dual bicistronic 
expression construct facilitates PEP and AOA incorporation, even though a diminished 
PEP incorporation can be observed in comparison to the pWSK29_PheSA294G construct 
(Figure 25b). This might be due to a reduced expression level of PheSA294G, since it is the 
second ORF on the bicistronic messanger RNA. Both proteins are expressed (MetGNLL as 
well as PheSA294G), as controlled for by Western blot analysis (Figure 25b). The 
concomitant labeling of the S. typhimurium pWSK29_MetRSNLL_PheRSA294G strain with 
AOA and PEP yields increased labeling in comparison to all mono-labeling combinations 
(Figure 25b). These experiments indicate that the simultaneous labeling with PEP and 
AOA in combination with dual expression of MetGNLL and PheSA294G improves the overall 







Figure 25 Dual labeling with PEP and AOA for improved labeling intensity. a) A 
bicistronic expression construct for dual expression of MetGNLL and PheSA294G 
pWSK29_MetGNLL_PheSA294G. b) In-gel fluorescence analysis of S. typhimurium strains 
labeled with PEP, AOA, or PEP/AOA in minimal medium. aaRS: aminoacyl-tRNA-
synthetase, AA: amino acid, az-rho: azido-rhodamine, CB: coomassie blue, α-Stag: anti-




Figure 26 Dual labeling of infected cells. RAW264.7 In-gel fluorescence analysis of 
cells, infected with S. typhimurium strains and pulse-labeled with AOA, PEP, or 
AOA/PEP 16 hours post-infection. AA: amino acid, STM: S. typhimurium IR715, 
MetG*: pWSK29_MetGNLL, PheS*: pWSK29_PheSA294G, MetG*/PheS*: 
pWSK29_MetGNLL_PheSA294G, az-rho: azido-rhodamine fluorescence, CB: coomassie 
blue.  
 
To investigate the labeling efficiency of the dual labeling system during infection, 
RAW264.7 macrophages were infected with stationary phase S. typhimurium 
pWSK29_MetGNLL, S. typhimurium pWSK29_PheSA294G, or S. typhimurium 
pWSK29_MetGNLL_PheSA294G, at an MOI of 50. 16 hours post-infection, the infected 
macrophages were pulse labeled with 1 mM PEP, 1 mM AOA, or 1 mM PEP/1 mM 
AOA for 1 hour. Analysis of total cell lysates of infected cells, generated by SDS lysis, 
by CuAAC and in-gel fluorescence analysis, revealed that the dual expression construct 
yields almost equal overall labeling intensities as the mono-expression constructs (Figure 
26). Dual labeling with AOA and PEP of S. typhimurium pWSK29_MetGNLL_PheSA294G 
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infected cells seems to provide a slightly elevated overall labeling intensity (Figure 26), 
however this result was not constantly reproducible (data not shown), indicating a large 
degree of variability in the infection setting, potentially due to amino acid uptake, or 
aaRS expression issues.  
In addition to the simultaneous labeling of a single bacterial strain with two 
alkyne reporters (AOA and PEP) for improved proteome coverage, we also explored the 
individual labeling of two different bacterial strains in the same experiment with 
distinguishable reporters (PEP and ANL). The expression of MetRS* in one strain should 
facilitate the exclusive incorporation of ANL while the expression of PheRS* on the 
other strain should exclusively allow the incorporation of PEP. For this purpose 
RAW264.7 macrophages were infected with an equal ratio of S. typhimurium pWSK29 
MetGNLL and S. typhimurium pWSK29_PheSA294G. 16 hours post-infection, the dually 
infected cells were pulse-labeled with a 1:1 mix of 1 mM PEP and 1 mM AOA for 1 
hour. Subsequently the cells were prepared for fluorescence microscopy and successively 
reacted with two orthogonal fluorescent dyes by CuAAC - alk-CyFur (a 2-
dicyanomethylene-3-cyano-2,5-dihydrofuran based dye) (Tsou et al. 2009) and az-rho, 
which allow independent visualization of the tagged species my florescence microscopy. 
Since the visualization of ANL incorporation in S. typhimurium during infection with alk-
CyFur has never been carried out before, singly infected cells with S. typhimurium 
pWSK29_MetGNLL were pulse-labeled with ANL and imaged with alk-CyFur in parallel. 
ANL was selectively incorporated into S. typhimurium pWSK29_MetGNLL inside 
macrophages as was demonstrated by co-localization of the alk-CyFur fluorescence 
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signal with anti-Salmonella antibody staining (Figure 27a). No alk-CyFur fluorescence 
signal could be observed in the methionine labeled control sample. In the double infected,  
 
Figure 27 Visualization of two independent bacterial populations using PEP and ANL. a) 
RAW264.7 cells were infected with S. typhimurium pWSK29_MetGNLL and pulse-labeled 
with ANL. Infected cells were visualized with alk-Cy-Fur (Tsou et al. 2009). Blue: DNA 
Sytox Orange, green: anti-Salmonella antibody stain, red: alk-CyFur.  b) RAW264.7 cells 
were infected with S. typhimurium pWSK29_PheSA294G and S. typhimurium 
pWSK29_MetGNLL and pulse-labeled with PEP and ANL. Cells were visualized with alk-
CyFur and az-rho. Red: alk-CyFur, green: az-rho. (MetG*: pWSK29_MetGNLL, PheS*: 
pWSK29_PheSA294G, az-rho: azido-rhodamine, alk-CyFur: alkyne-cyanofuran based dye.) 
 
76 
PEP and AOA co-labeled macrophages, two distinct populations of bacteria could be 
identified. The fluorescence images clearly showed alk-CyFur positive bacteria, 
indicating ANL incorporation (red, Figure 27b) and therefore pWSK29_MetGNLL 
identity, as well as az-rho positive bacteria (green, Figure 27b), indicating PEP 
incorporation and therefore pWSK29_PheSA294G identity. No bacteria showed co-
localization of both fluorescence dyes, indicating highly selective incorporation of the 
two orthogonal amino acid reporters. Interestingly, most infected mammalian cells 
harbored only one bacterial strain (red or green), only in a few isolated cases both strains 
were present in the same macrophage (Figure 27b, blow-up). Such a scenario could arise 
from a secondary infection over the course of the replication period or from two 
synchronous infections during the infection period.   
3.4 Materials and Methods 
3.4.1 Chemical reagents 
Azido-rhodamine (az-rho), alkyne-rhodamine (alk-rho), alk-CyFur, and TBTA (tris((1-
benzyl-1H-1,2,3-triazol-4-yl)methyl) amine) were generated by the Hang laboratory as 
previously described (Charron et al. 2009; Tsou et al. 2009). PEP, AOA, and ANL were 
generated as previously described ((Kirshenbaum et al. 2002; Grammel et al. 2010). All 
other chemical reagents were purchased from Sigma-Aldrich. 
3.4.2 Plasmids and bacterial strains 
Salmonella typhimurium IR715 was transformed with pWSK29 encoding the A294G 
mutant of the E. coli pheS gene. PheS was amplified from E. Coli K12 by PCR (primer 1 
and primer 2) and sub-cloned into pJET1.2. The resulting fragment contained a mutation 
relative to the reported UniProt sequence (P08312, D258N, GAC to AAC), which was re-
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mutated to the reference sequence together with the introduction of mutation (A294G) by 
use of the QuickChange Multi Site-Directed Mutagenesis Kit (Stratagene, primer 3, 
primer 4). The fragment was excised from pJET1.2 and inserted into pWSK29 with SacI 
and KpnI to generate pWSK29_PheSA294G.  
To generate pWSK29_MetGNLL_PheSA264G, PheSA264G was amplified from 
pWSK29_PheSA264G with the primer 5 and primer 6. The resulting fragment was cloned 
into pWSK29_MetGNLL(Grammel et al. 2010) with SalI and KpnI.  









3.4.3 Bacterial pulse labeling in liquid culture 
Overnight cultures of bacteria were grown in full LB with 100 µg/ml Carbenicillin (Cb). 
These cultures were then diluted 1:30 into fresh LB (Cb) and grown to stationary phase.  
Bacteria were collected by centrifugation (10,000 rpm, 3 min) and resuspended in M9 (1x 
M9 salts, 20 mM glucose, 2 mM MgSO4, 100 µM CaCl2) minimal medium (Cb). Bacteria 
were grown in minimal medium for 15 min and collected by centrifugation. Bacterial 
pellets corresponding to 1 ml of culture volume were resuspended in M9 minimal 
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medium (Cb) containing the chemical reporter. Bacteria were labeled for 1 hour and 
collected by centrifugation, washed once in PBS, and stored at -80 °C. For tetracycline 
(Tet) protein synthesis inhibition, bacteria were grown for 30 min in LB (40 µg/ml Tet) 
before being labeled for 30 min in M9 minimal medium (40 µg/ml Tet).  
3.4.4 Infection of mammalian cells and pulse labeling 
For fluorescence microscopy experiments, 3 x 105 RAW264.7 cells were split into 12 
well plates 24 h before infection on round glass cover slips. For subsequent cell lysis and 
in-gel fluorescence experiments, 1.5 x 106 RAW264.7 cells were split into 6 well plates 
24 h before infection. An LB overnight culture of Salmonella was diluted 1:30 into fresh 
LB with 100 µg/ml carbenicillin and grown to stationary phase (OD600 > 2.0). Bacteria 
were collected by centrifugation and washed once with cold PBS. For a multiplicity of 
infection (MOI) of 100, an appropriate volume of bacteria in PBS was added to DMEM 
(10% FBS) and put on ice for 30 min. Bacteria in DMEM (10% FBS) were added to 
RAW264.7 cells and centrifuged at 1000g for 5 min at 4 °C. The infection was allowed 
to proceed for 25 min at 37 °C at 5% CO2. The wells were then washed 4 times with PBS 
before the cells were covered in DMEM (10% FBS) with 100 µg/ml gentamicin and 
incubated or 90 min at 37 °C at 5% CO2 to kill all extracellular bacteria. Subsequently, 
wells were washed 2 times with PBS and filled with DMEM (10% FBS) with 12.5 µg/ml 
gentamicin. The cells were further incubated for 14.5 h at 37 °C at 5% CO2.   The cells 
were pulse labeled with 1 mM PEP in full medium (DMEM 10% FBS) for 1 h at 37 °C at 
5% CO2. After 1 h the cells were washed 4 times with cold PBS. 
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3.4.5 Cell lysis, click-chemistry, and in-gel fluorescence analysis 
For cell lysis, infected RAW264.7 cells were collected by scraping in ice-cold PBS and 
centrifugation at 1000g for 5 min at 4 °C. Cell pellets were lysed by resuspending them in 
0.1% SDS in PBS with Roche complete protease inhibitor, 1 mM PMSF, and 1 µl 
benzonase/ml (Sigma E1014), and then sonicating them for 30 s in a water bath sonicator, 
followed by 10 min incubation on ice. Samples were filled up with 12% SDS in PBS to a 
final concentration of 4% SDS and sonicated again. Then, remaining debris was removed 
by centrifugation at 20,000g for 10 min at room temperature. Protein concentrations were 
determined by BSA assay (Pierce). For click-chemistry, 50 µg of cell lysate from each 
sample was filled up to the smallest common volume with 4% SDS in PBS. A click 
chemistry master mix was prepared and added to each sample: 100 µM azido-rhodamine 
(az-rho) from a 10 mM stock solution in DMSO, 1 mM TCEP (tris(2-
carboxyethyl)phosphine) from a 50 mM stock solution in water (freshly prepared), 100 
µM TBTA (tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) from a 2 mM stock 
solution in 4:1 n-butanol:DMSO, and 1 mM CuSO4 from a 50 mM stock solution in water 
(freshly prepared). 
The components were added in the order listed above to the master mix and vigorously 
vortexed. Then the master mix was added to each individual protein sample to yield a 
final volume of 50 µl at the final concentrations indicated. The samples were incubated 
for 1 h at room temperature.  
The samples were precipitated after click chemistry to remove small molecules. For this 
purpose, 50 µl of water was added to each sample, followed by 400 µl of methanol, and 
100 µl of chloroform. The samples were vigorously vortexed and 300 µl of water was 
added. The samples were vortexed again and centrifuged at 20,000 g for 5 min at room 
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temperature. The upper phase was removed carefully and 1 ml of ice-cold aetone was 
added. The samples were vortexed and centrifuged at 20,000 g for 15 min at 4 °C.  The 
organic supernatant was discarded and the samples briefly dried on air. Then, the samples 
were resuspended in 30 µl 4% SDS in PBS and briefly sonicated. 10 µl of 4 times 
Laemmli buffer was added to each sample together with 2 µl of beta-mercaptoethanol, 
samples were incubated at 95 °C for 5 min, and run for analysis on a 4-20% Tris-HCl 
Criterion™ Precast Gel (Biorad). Protein gels were rinsed with deionized water and 
incubated for multiple hours in 50% water, 40% methanol, 10% acetic acid at 4 °C. 
Before in-gel fluorescence analysis, protein gels were transferred to deionized water and 
incubated for at least 30 min at room temperature. Protein gels were scanned on an 
Amersham Bioscience Typhoon 9400 variable mode imager (excitation 532 nm, 580 nm 
filter, 30 nm band-pass). All image adjustments were done on the entire depicted image 
for all samples equally in Adobe® Photoshop® CS3. After fluorescence scanning, 
protein gels were stained with GelCode Blue Stain Reagent (Thermo) or Coomassie 
Brilliant Blue (BioRad). Both stains are indicated as coomassie blue (CB) in all figures. 
3.4.6 Sample preparation for fluorescence microscopy 
For fluorescence microscopy, cells were fixed and permeabilized in 3.7% 
paraformaldehyde, 0.2% Triton X-100 in PBS for 15 min at room temperature. The cells 
were then washed at least 4 times for 5 min each with PBS. A click-chemistry master mix 
was prepared from stock solutions listed above to yield the following final concentrations 
in PBS (20 µM az-rho, 1 mM TCEP, 100 µM TBTA, 1 mM CuSO4). The cells were 
covered in click chemistry master mix and incubated for 1 h at room temperature. Then, 
the cells were blocked for 1 h with 2% FBS, 1% Tween 20 in PBS at room temperature. 
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The cells were washed once with PBS and anti-S. typhimurium serum was added (1:250) 
in 0.2% saponin in PBS for 30 min at room temperature. The cells were washed 4 times 
with PBS and subsequently incubated with anti-rabbit Alexa488-conjugated antibody in 
0.2% saponin in PBS for 30 min at room temperature. Cells were washed in PBS and 
finally incubated with TO-PRO-3 DNA stain (1:1000) in 0.2% saponin in PBS. The cells 
were washed once with 0.2% saponin in PBS and 4 times in PBS before mounting on 
microscope slides in ProLong Gold (Invitrogen). The images were taken on an upright 
LSM510 laser scanning confocal microscope (Zeiss) equipped with a Krypton/Argon 
laser with 488 and 568 lines and a HeNe laser with a 633 line, using a 100x oil 
immersion objective.  
For dual labeling experiments, sample preparation was conducted equally with small 
changes. After permeabilization and fixation the first CuAAC with alk-CyFur was carried 
out with 200 µM alk-CyFur for 1 hours at room temperature. The samples were washed 
two times with 20% methanol in PBS for 10 min to remove any un-reacted CuAAC 
reagents. The samples were washed with PBS and the second CuAAC with 20 µM az-rho 
was carried out. Since the emission spectrum of TO-PRO-3 overlaps with the emission 
spectrum of alk-CyFur DNA was visualized with the DNA stain Sytox Orange (1:1000 
dilution of a 5 mM stock).  
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4 Methionine amino acid reporters based on homoserine, homocysteine, and 
cysteine 
4.1 Abstract 
Orthogonal amino acid reporters, such as 2-amino-7-octynoic acid (AOA), 
azidonorleucine (ANL), or para-phenylalanine (PEP) enable the cell-selective labeling of 
bacterial populations in the presence of mammalian cells. Their incorporation is 
dependent on the heterologous expression of mutant E. coli aminoacyl-tRNA-synthetases 
(aaRS), which requires stable transformation with a plasmid encoding the aaRS or stable 
integration of the aaRS gene into the bacterial chromosome. Far from all bacterial species 
are amenable to these genetic manipulations. Therefore it would be highly beneficial for 
the study of bacterial pathogenesis, if amino acid reporters could be developed with 
intrinsic selectivey for the bacterial translational machinery. Here, I present the initial 
progress towards such an intrinsically selective amino acid reporter. 
4.2 Introduction 
Protein expression is a highly dynamic process that is tightly regulated by intrinsic 
cellular signals as well as external environmental cues. In particular, bacterial pathogens 
adapt to environmental changes during the course of a host infection by dramatically 
altering their protein expression. Many pathogens produce the necessary gene products 
for infection (virulence factors) just in time as they encounter different host environments 
(e.g. gut, cell surface, cytosol, intracellular vacuolar compartments). Capturing these 
dynamic changes is indispensable for a complete understanding of the pathogen-host 
interaction and promises to be helpful in combating the incipient downturn of effective 
antimicrobials.  
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To this end selective labeling methods have been developed that can take snap-
shots of the newly synthesized bacterial proteome during infection of mammalian cells. 
Orthogonal amino acid reporters (unnatural amino acids) with alkyne or azide reporter 
groups can be selectively and co-translationally incorporated into the bacterial proteome 
through the over-expression of engineered aminoacyl-tRNA-synthetases (aaRS). These 
reporters allow tagging of newly synthesized proteins with fluorescence dyes for 
visualization or affinity enrichment tags for mass spectrometry-based protein 
identification by the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC).   
Two methionine surrogates, azidonorleucine (ANL) and 2-amino-7-octynoic acid 
(AOA) can be activated by various E. coli methionyl-tRNA-synthetase (MetRS) mutants 
(MetRS*) and selectively incorporated into E. coli or intracellularly replicating S. 
typhimurium in the presence of translationally active host cells. In addition, para-
ethynylphenylalanine (PEP) can also be used as an orthogonal amino acid reporter, since 
its activation is dependent on a mutant E. coli phenylalanyl-tRNA synthetase (PheRS*). 
We have learned that the over-expression of these E. coli aaRS mutants facilitate the 
required enzymatic activity in the distinct, but closely related species, S. typhimurium. 
However, in an evolutionarily more distant species the heterologous E. coli aaRS might 
not recognize the cognate tRNA anymore and therefore would not activate ANL or AOA. 
Furthermore, various bacterial pathogens are not yet genetically tractable and would not 
permit heterologous over-expression of a mutant aaRS. In our studies of alternative 
alkynyl orthogonal amino acid reporters we came across a potential solution for these 




Even tough AOA provides better signal-to-noise than the isosteric azide reporter (ANL) 
in S. typhimurium, the low yield of its synthetic route (<10% of L-AOA) led us to 
investigate alternative reporter scaffolds for methionine. The direct alkylation of 
homocysteine or homoserine with alkynyl electrophiles should provide facile synthetic 
routes for the large-scale synthesis of enantiomerically pure potential amino acid 
reporters for methionine, with a sulfur or oxygen at the same position as in methionine. 
Therefore we synthesized (S)-2-amino-4-(prop-2-yn-1-ylthio)butanoic acid (EME) from a 
N-tert-butoxycarbonyl-protected L-homocysteine thiolactone and (S)-2-amino-4-(prop-2-
yn-1-yloxy)butanoic acid (PHS) from N-tert-butoxycarbonyl-protected L-homoserine. 
EME constitutes an ethynyl-derivative of methionine displaying the sulfur-heteroatom at 
the same position as methionine. PHC, the isoster of EME, has oxygen at the position of 
sulfur. We further wanted to test whether MetRS might still accept more diverse 
derivatives, with a switched sulfur-position, and therefore generated (R)-2-amino-3-(but-
3-yn-1-ylthio)propanoic acid (BCY) from N-acetyl-protected L-cysteine and (R)-2-

















EME PHS BCY PCY  
Figure 28 Potential methionine surrogates. (S)-2-amino-4-(prop-2-yn-1-ylthio)butanoic 
acid (EME), (S)-2-amino-4-(prop-2-yn-1-yloxy)butanoic acid (PHS), (R)-2-amino-3-





Figure 29 PHS and EME are incorporated into the S. typhimurium proteome. a) S. 
typhimurium pWSK29, pWSK29_MetG, pWSK29_MetGL13G, pWSK29_MetGNLL, or 
pWSK29_MetGPLL was incubated with PHS, BCY, PCY, or EME in M9 minimal 
medium, lysed, and analyzed by SDS-PAGE and in-gel fluorescence scanning. az-rho: 
azido-rhodamine, CB: coomassie blue. 
 
Next, we tested incorporation of EME, PHC, BCY, and PCY in S. typhimurium as 
a function of heterologous MetRS activity. EME, PHC, BCY, and PCY was added to S. 
typhimurium, expressing different MetG mutants, grown in M9 minimal medium and 
analyzed the generated cell lysates by CuAAC with azido-rhodamine (az-rho) and in-gel 
fluorescence scanning. This analysis revealed that EME and PHC are incorporated into 
the S. typhimurium proteome upon expression of the MetRS mutants L13G, NLL, and 
PLL (Figure 29). Furthermore the mere over-expression of wild-type MetRS also sufficed 
to incorporate EME or PHC. But most interestingly, EME was even accepted by wild-
type S. typhimurium without the over-expression of any MetRS (Figure 29). EME serves 
as an amino acid reporter for methionine, which is incorporated co-translationally. 
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Provided that mammalian cells do not accept EME, it could therefore serve as an 
intrinsically selective amino acid reporter for wild-type S. typhimurium and potentially 
other bacterial pathogens.  
 
Figure 30 EME serves as an amino acid reporter for wild type S. typhimurium that is co-
translationally incorporated instead of methionine. a) S. typhimurium IR715 was 
incubated with increasing concentrations of methionine (Met) and EME in M9 minimal 
medium. b) S. typhimurium IR715 was incubated with EME in the presence of 
tetracycline (Tet) in M9 minimal medium. az-rho: azido-rhodamine, CB: coomassie blue.  
 
To test this hypothesis we conducted infection experiments with wild-type S. 
typhimurium and RAW264.7 macrophages. Before and 10 hours post-infection we pulse 
labeled with 1 mM Met, 1 mM EME or 1 mM homopropargylglycine (HPG) for 1 hour. 
HPG is an unselective amino acid reporter for methionine that is incorporated into 
mammalian and bacterial proteomes. The infected cells were fixed, reacted with az-rho 
by CuAAC and further prepared for analysis by fluorescence microscopy. EME was 
selectively incorporated into bacterial cells shortly after infection (0 hours) or 10 hours 
post-infection, as was indicated by the co-localization of the az-rho signal with the anti-S. 
typhimurium antibody staining and the absence of az-rho signal from the mammalian 












Figure 31 EME allows selective labeling of wild-type S. typhimurium during 
infection of mammalian cells and visualization by fluorescence microscopy. 
RAW264.7 macrophages were infected with wild-type S. typhimurium and pulse 
labeled with Met, HPG, or EME 0 hours after infection (a) or 10 hours (b) post-
infection. az-rho: azido-rhodamine (red), a-STM: anti-S. typhimurium antibody 













was expected. No az-rho signal was observed in the Met labeled samples. These data 
show that EME possesses intrinsic selectively for incorporation into S. typhimurium and 
exclusion from mammalian proteomes.  
For a more detailed analysis of the labeled proteomes we also investigated EME 
incorporation into S. typhimurium during infection of macrophages by SDS-PAGE and 
in-gel fluorescence scanning. For this purpose macrophages were infected with wild-type 
S. typhimurium 14028 and pulse-labeled with 1 mM EME 16 hours post-infection for 1 
hour. Since we have learned previously that pulse-labeling in full growth medium can 
reduce the incorporation of the orthogonal amino acid reporter into the mammalian 
proteome, we tested EME incorporation in full growth medium as well as Met-depleted 
growth medium. While we could clearly detect EME incorporation in the presence of S. 
typhimurium, we also observed EME labeling of the mammalian proteome, which was 
not diminished by the presence of Met in the growth medium. We attribute the 
discrepancy between the in-gel and the fluorescence microscopy data, to the better 
dynamic range of the in-gel analysis. Even though EME does most likely not provide 
sufficient selectivity for the bacterial proteome for all applications (in particular mass 















Figure 32 Full medium does not reduce EME incorporation into the mammalian 
proteome. RAW264.7 macrophages were infected with wild-type S. typhimurium and 
pulse-labeled with EME 16 hours post-infection. Cells were lysed, reacted with az-rho by 
CuAAC, and analyzed by SDS-PAGE and in-gel fluorescence scanning. az-rho: azido-
rhodamine, CB: coomassie blue, DMEM-Met: Dulbecco’s Modified Eagle Medium 




Figure 33 PHS and EME are incorporated into various bacterial species. S. typhimurium, 
P. aeruginosa, C. violaceum, B. subtilis, and M. smegmatis were pulse-labeled with PHS 
or EME in M9 minimal medium. Cell were lysed, reacted with az-rho by CuAAC, and 
analyzed by SDS-PAGE and in-gel fluorescence scanning. Iden. metG: percentage 
identity between individual metG genes and the metG gene of S. typhimurium. az-rho: 
azido-rhodamine, CB: coomassie blue, AA: amino acid, EME: : (S)-2-amino-4-(prop-2-
yn-1-ylthio)butanoic acid, PHS: (S)-2-amino-4-(prop-2-yn-1-yloxy)butanoic acid. 
 
To assess the general possibility to use these kinds of amino acid reporters in 
other bacterial species, which might benefit more from an intrinsically selective amino 
acid reporter than S. typhimurium, we tested EME and PHS incorporation in a variety of 
other bacterial species: P. aeruginosa, C. violaceum, B. subtilis, and M. smegmatis. All of 
the tested species incorporated EME and PHS, yet none of them as efficiently as S. 
typhimurium. The observed fluorescence intensity (incorporation level) did not scale with 
the percentage identity of the corresponding metG genes with the S. typhimurium metG 
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gene (P. aeruginosa 66 %, C. violaceum 58 %, B. subtilis 29 %, M. smegmatis 26 %). In 
addition to MetRS activity, differences in amino acid reporter uptake and metabolization 
could also cause the observed differences in incorporation levels. These data emphasizes 
the requirement for empiric determination of amino acid reporter acceptance and also the 
possibility to use amino acid reporters like PHS or EME as orthogonal amino acid 
reporters.  
Although EME was not completely excluded from the mammalian proteome we 
wanted to experimentally address the observed differences in EME incorporation 
between S. typhimurium and mammalian cells. We hypothesized that the difference is 
largely due to discrepant MetRS specificities. Over-expression of E. coli MetRS might 
therefore rescue the mammalian EME incorporation deficiency, provided the bacterial 
enzyme is able to properly interact with the mammalian tRNA. Indeed, over-expression 
of E. coli MetRS in 293T cells improved EME incorporation, while HPG incorporation (a 
known mammalian and bacterial amino acid reporter for Met) was not elevated to the 
same extent. Over-expression of E. coli MetRS improved EME labeling almost to the 
same level as the proper mammalian amino acid reporter HPG. From this preliminary 
experiment we concluded that the reduced EME incorporation rate in mammalian cells 
could be most likely attributed to differences in MetRS activity, rather than amino acid 
reporter uptake or metabolization, parameters that should not have been changed by E. 









Figure 34 Over-expression bacterial methionyl-tRNA-synthetase (MetG) facilitates 
increased EME incorporation into the mammalian proteome. 293T cells were transiently 
transfected with a pEGFP-MetG expression construct generating a MetG-GFP protein 
fusion and pulse-labeled with HPG or EME. Cells were lysed, reacted with az-rho by 
CuAAC, and analyzed by SDS-PAGE and in-gel fluorescence scanning. HPG: 
homopropargylglycine, EME: (S)-2-amino-4-(prop-2-yn-1-ylthio)butanoic acid, α-GFP: 





4.4 Materials and methods 























Figure 35 Synthesis of (S)-2-amino-4-(prop-2-yn-1-yloxy)butanoic acid (PHS). 
 
A 100 ml flame dried round bottom flask was charged with 25 ml anhydrous 
dimethylformamide under argon atmosphere. 2-((tert-butoxycarbonyl)amino)-4-
hydroxybutanoic acid (500 mg, 2.28 mmol) was added to the reaction vessel under stirring 
and the reaction mix was cooled to 0 °C. Sodium hydride (137 mg, 5.70 mmol) was added 
to the reaction mix under stirring. After H2 evolution had ceased propargyl bromide (339 
mg, 2.85 mmol) was added under stirring and the reaction was allowed to warm up to room 
temperature and was stirred for 2 h. The reaction was quenched with water and the solvents 
were evaporated under reduced pressure. The resulting material was resuspended in water 
and washed with ethyl acetate and diethylether. The aqueous solution was acidified with 
sodium bisulfate (1 M) and extracted with 3 portions of ethyl acetate. The organic fractions 
were pooled and dried over magnesium sulfate, filtered and evaporated under reduced 
pressure. The resulting material was purified by column chromatography over silica gel 
using 3% methanol in dichloromethane to yield (S)-2-((tert-butoxycarbonyl)amino)-4-
(prop-2-yn-1-yloxy)butanoic acid (43%). 1H NMR (600 MHz, CDCl3): 5.37-5.36 (d, 1H), 
4.31 (s, 1H), 4.08-4.01 (m, 2H), 3.58-3.53 (m, 2H), 2.36 (s, 1H), 2.07-1.95 (m, 2H). 13C 
NMR (600 MHz, CDCl3): 176.45, 155.70, 80.05, 79.3, 74.75, 66.27, 58.17, 51.46, 31.59, 
28.29. Theoretical mass: 257.13, mass observed: [M+Na]+ 280.08, [M+2Na-H]+ 302.08. 
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(S)-2-((tert-butoxycarbonyl)amino)-4-(prop-2-yn-1-yloxy)butanoic acid (271 mg, 1.05 
mmol) was dissolved in3 ml concentrated HCl and stirred for 1.5 hours at room 
temperature. The reaction mix was diluted with 15 ml water and purified over Dowex 
50WX-100 to yield the final product (S)-2-amino-4-(prop-2-yn-1-yloxy)butanoic acid 
(PHS) (75%). 1H NMR (600 MHz, D2O): 4.09 (s, 2H), 3.75-3.73 (m, 1H), 3.67-3.61 (m, 
2H), 2.75 (s, 1H), 2.12-1.96 (m, 2H). 13C NMR (600 MHz, D2O): 173.94, 79.07, 75.76, 
66.82, 57.90, 53.44, 29.65. Theoretical mass: 157.0739, mass observed: [M+H]+ 
158.2096. 





























Figure 36 Synthesis of (S)-2-amino-4-(prop-2-yn-1-ylthio)butanoic acid (EME). 
 
A flame dried 50 ml round bottom flask equipped with a condenser was charged with 10 
ml anhydrous methanol and sodium methoxide (26 mg, 4.83 mmol) was added under 
argon atmosphere and dissolved under stirring at room temperature. (S)-N-tert-
butoxycarbonyl-homocysteine thiolactone (100 mg, 4.6 mmol) was added and the 
reaction mixture was incubated for 10 min at room temperature under stirring. Propargyl 
bromide (66 mg, 5.52 mmol) was added and the reaction mixture was refluxed for 3 h. 
The reaction mixture was cooled to ambient temperature and quenched with water. The 
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solvents were evaporated under reduced pressure. The resulting material was resuspended 
in ethyl acetate and washed with concentrated sodium bicarbonate, 1 M sodium bisulfate 
and brine. The organic fraction was dried over magnesium sulfate, filtered and 
evaporated under reduced pressure. The resulting material was purified by column 
chromatography over silica gel with 15% ethyl acetate in hexanes to yield (S)-methyl 2-
((tert-butoxycarbonyl)amino)-4-(prop-2-yn-1-ylthio)butanoate (63 %). 1H NMR (600 
MHz, CDCl3): 5.10-5.09 (m, 1H), 4.42-4.41 (m, 1H), 3.73 (s, 3H), 3.23 (d, 2H), 2.73-
2.70 (t, 2H) 2.21 (s, 1H), 2.15-2.12 (m, 1H), 1.95-1.91 (m, 1H), 1.42 (s, 9H). 13C NMR 
(600 MHz, CDCl3): 172.71, 155.31, 80.11, 79.57, 71.30, 52.66, 52.49, 32.14, 29.72, 
28.33, 27.21, 19.10. 
 
(S)-methyl 2-((tert-butoxycarbonyl)amino)-4-(prop-2-yn-1-ylthio)butanoate (83 mg) was 
dissolved in 8 ml water and acetonitrile (1:1) and stirred at room temperature. Lithium 
hydroxide (6.92 mg) was dissolved in water and acetonitrile (1:1) and slowly added to the 
stirred reaction mixture. The reaction mixture was stirred at room temperature for 90 min. 
The organic solvent was evaporated under reduced pressure and the remaining aqueous 
phase was acidified with 1 M sodium bisulfate. The aqueous phase was extracted three 
times with ethyl acetate and the organic fractions were pooled, dried over magnesium 
sulfate, filtered and evaporated under reduced pressure. The resulting material was 
purified by column chromatography over silica gel with 5% methanol in dichloromethane 
to 10% methanol in dichloromethane to yield (S)-2-((tert-butoxycarbonyl)amino)-4-
(prop-2-yn-1-ylthio)butanoic acid (59%). 1H NMR (600 MHz, CD3OD): 4.20-4.13 (m, 
1H), 3.28 (m, 2H), 2.76-2.67 (m, 2H), 2.56 (s, 1H), 2.10-1.88 (m, 2H), 1.42 (s, 9H). 13C 
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NMR (600 MHz, CD3OD): 171.62, 156.75, 79.45, 79.11, 70.94, 60.19, 52.76, 31.02, 
27.37, 27.25, 17.96, 13.13. Theoretical mass: 273.10, observed mass: [M+Na]+ 296.08, 
[M+2Na-H]+ 318.08.  
 
(S)-2-((tert-butoxycarbonyl)amino)-4-(prop-2-yn-1-ylthio)butanoic acid was dissolved in 
3 ml concentrated HCl and stirred for 1.5 hours at room temperature. The reaction mix 
was diluted with 15 ml water and purified over Dowex 50WX-100 to yield the final 
product (S)-2-amino-4-(prop-2-yn-1-ylthio)butanoic acid (EME) (45%). 1H NMR (600 
MHz, D2O): 3.76-3.73 (t, 1H, J = 6.24), 3.44-3.37 (m, 2H), 2.87-2.84 (m, 2H), 2.69-2.68 
(m, 1H), 2.32-2.15 (m, 2H). 13C NMR (600 MHz, D2O): 174.06, 80.34, 72.18, 53.82, 
29.84, 26.52, 18.03. Theoretical mass: 173.0510, observed mass: [M+H]+ 174.1730. 






















Figure 37 Synthesis of (R)-2-amino-3-(but-3-yn-1-ylthio)propanoic acid (BCY). 
 
A 50 ml flame dried round bottom flask equipped with a condenser was charged with 12 
ml anhydrous ethanol under argon atmosphere. N-acetyl-cysteine (212 mg, 1.30 mmol) 
was added to the reaction vessel under stirring at room temperature. Sodium ethoxide 
(195 mg, 2.86 mmol) was added to the reaction mix from a 21 wt. % solution of sodium 
ethoxide in ethanol and the reaction mix was stirred for 10 min at room temperature. Iodo 
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butyne (281 mg, 1.56 mmol) was added and the reaction mix was refluxed for 3 h. Since 
the starting material was not completely consumed (TLC) another 0.6 eq. of iodobutyne 
was added and the reaction mix was refluxed for 1h, after which starting material was 
completely consumed (TLC). The reaction was quenched with water and the solvents 
were evaporated under reduced pressure. The resulting material was purified by column 
chromatography over silica with 10% methanol, 0.5% acetic acid in ethyl acetate to yield 
(R)-2-acetamido-3-(but-3-yn-1-ylthio)propanoic acid (60%). 1H NMR (600 MHz, 
CD3OD): 4.61-4.59 (m, 1H), 3.11-3.08 (dd, 1H, 4.8, 13.8), 2.91-2.87 (dd, 1H, 7.8, 13.8), 
2.73-2.71 (t, 2H), 2.48-2.45 (m, 2H), 2.30 (s, 1H), 2.01 (s, 3H). 13C NMR (600 MHz, 
CD3OD): 170.73, 170.36, 80.35, 67.76, 50.74, 50.74, 31.57, 29.30, 19.45, 17.65. 
Theoretical mass: 215.06, observed mass: [M+Na]+ 238.00, [M+2Na-H]+ 260.00. 
 
(R)-2-acetamido-3-(but-3-yn-1-ylthio)propanoic acid (127 mg) was dissolved in 7 ml 
water and the pH was adjusted to 7.8 pH with 1 M NH4OH and 1 M HCl. 1.5 mg of 
acylase I was added and the reaction mix was carefully stirred over night at 37 °C. The 
reaction mix was cooled to ambient temperature and 15 mg activated charcoal was added. 
The reaction mix was filtered through a glasswool, sand, Celite plug, which was rinsed 
with water. The aqueous solution was extracted with ethyl acetate and the observed 
precipitate in the aqueous layer was removed by filtration. The aqueous solvent was 
evaporated at 40 °C under reduced pressure and the resulting material was dissolved in 1 
M HCl and purified over Dowex 50WX-100 to yield the final product (R)-2-amino-3-
(but-3-yn-1-ylthio)propanoic acid (BCY) (84%). 1H NMR (600 MHz, D2O): 3.99-3.97 
(m, 1H), 3.04-3.01 (dd, 1H, 4.2, 15), 2.91-2.88 (dd, 1H, 7.2, 15), 2.56-2.54 (m, 2H), 2.33-
99 
2.31 (m, 2H), 2.17 (s, 1H). 13C NMR (600 MHz, D2O): 171.11, 83.16, 70.43, 52.49, 
31.29, 30.08, 18.66. Theoretical mass: 173.0510, observed mass [M+H]+ 174.2300. 























Figure 38 Synthesis of (R)-2-amino-3-(prop-2-yn-1-ylthio)propanoic acid (PCY). 
 
A 50 ml flame dried round bottom flask was charged with 6 ml anhydrous ethanol under 
argon atmosphere. N-acetyl-cysteine (300 mg, 1 eq.) was added and dissolved and 
sodium ethoxide in ethanol (21%) (273 mg, 2.2 eq.) was added at room temperature. The 
reaction mix was incubated for 10 min at room temperature. Propargyl bromide (262 mg, 
1.2 eq.) was added and the reaction mix was refluxed for 2.5 hours. The reaction mix was 
cooled to ambient temperature and quenched with water. The organic solvent was 
evaporated under reduced pressure and the reaction mix was acidified with 1 M HCl. The 
reaction mix was extracted 3 times with ethyl acetate and the pooled organic fractions 
were dried over magnesium sulfate and evaporated under reduced pressure. The resulting 
material was purified by column chromatography on silica gel with 5% methanol in 
dichloro methane and 0.5% acetic acid to yield the final product (R)-2-acetamido-3-
(prop-2-yn-1-ylthio)propanoic acid (64%). 1H NMR (600 MHz, CD3OD): 6.78-6.71 (m, 
1H), 4.82-4.80 (m, 1H), 3.32-3.29 (m, 1H), 3.26-3.22 (m, 2H), 3.11-3.08 (m, 1H), 2.30 
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(m, 1H), 2.06 (s, 1H). 13C NMR (600 MHz, CD3OD): 172.32, 171.99, 79.04, 71.53, 51.76, 
32.51, 21.10, 18.60. Theoretical mass: 201.05, observed mass: [M+H]+ 202.10. 
 
(R)-2-amino-3-(prop-2-yn-1-ylthio)propanoic acid (PCY) was prepared from (R)-2-
acetamido-3-(prop-2-yn-1-ylthio)propanoic acid in the same way as BCY (44 %). 1H 
NMR (600 MHz, D2O): 3.93-3.91 (dd, J = 4.2, 3.6, 1H), 3.30-3.29 (m, 1H), 2.59 (m, 1H). 
13C NMR (600 MHz, D2O): 172.59, 79.98, 72.62, 53.27, 31.79, 18.76.  
4.4.5 Amino acid reporter labeling of bacteria in liquid culture 
See 2.4.6 
4.4.6 Infection of RAW264.7 macrophages and pulse-labeling with amino acid 
reporter 
See 2.4.5 
4.4.7 Analysis of amino acid reporter labeling by fluorescence microscopy 
See 3.4.6 
4.4.8 Analysis of amino acid reporter labeling by SDS-PAGE and in-gel 
florescence scanning 
See 3.4.5 
4.4.9 Transfection of HEK293T cells with bacterial methionyl-tRNA synthetase 
and pulse-labeling with EME 
E. coli MetG (methionyl-tRNA-synthetase) was cloned into pEGFP-N1 (pEGFP-MetG) 
by amplifying metG from pWSK29_MetG with the primers: GAGCTCATGACTCA 
AGTCGCGAAGAAAATTCTGG and GGTACCAGTTTCACCTGATGACCCGGTTT 
AGC, by PCR and cloning the resulting fragment into pEGFP-N1 with SacI and KpnI. 
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This cloning strategy, however, introduced a frame shift in the GFP protein fusion, which 
was corrected by site-directed mutagenesis using the QuikChange Site-Directed 
Mutagenesis Kit and the primers: CTAAACCGGGTCATCAGGTGAAA 
TGGTACCGCGGGC and GCCCGCGGTACCATTTCACCTGATGACCCGGTTTAG. 
pEGFP-N1 was transfected into 293T cells using the X-tremeGENE (Roche) transfection 
reagent, following the supplied protocol with a ratio of 2:1 between DNA and 
transfection reagent. MetG expression was analyzed by epifluorescence visualization of 
the GFP fluorescence and by Western Blot analysis (Living Colors anti-GFP antibody JL-
8, Clonetech).  
Transfected cells were pulse-labeled with 1 mM EME or 1 mM HPG 24 hours post-
transfection in fresh Dulbecco’s Modified Eagle Medium (DMEM) growth medium 




5 Exploring orthogonal amino acid reporter labeling of S. typhimurium effector 
proteins 
5.1 Abstract 
Intracellular pathogens are able to live and replicate within a mammalian cell without 
clearance of the hosts immune system. A very specialized set of virulence factors enables 
them to survive in this environment and escape from bactericidal mechanisms the host 
cell imposes on them. Various virulence factors are secreted into the host cytosol 
(effector proteins) were they modify host functions and pathways. Both the identification 
of these factors and the analysis of their function are central to the understanding of the 
pathogen-host-interaction. Previous proteomic approaches to detect effector proteins have 
been extremely difficult, due to the complexity of the mixed pathogen host proteome and 
low abundance of secreted bacterial effector proteins. This section discusses our attempts 
to use orthogonal amino acid reporters for the proteomic detection of S. typhimurium 
effector proteins during infection.  
5.2 Introduction 
A highly specialized subset of symbiotic or pathogenic bacteria has evolved to invade 
and replicate within different host cell types. These bacteria are taken up either by 
phagocytic cell populations or actively invade non-phagocytic cells, such as epithelial 
cells. The first step in both processes - adherence to the plasma membrane - is mediated 
by various adherence structures. These structures comprise a plethora of bacterial 
proteins, ranging from rather simple structured adhesins, like fibronectin binding 
proteins, to multimeric complexes such as pili and fimbria (Pizarro-Cerdá & Cossart 
2006). In the second step, the actual invagination takes place, which can be either 
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achieved by interaction with cognate membrane bound host receptors, or by remodeling 
mammalian signaling pathways from within the cell. The latter requires the concerted 
expression, activation, and delivery of effector proteins into the mammalian host cell by 
means of protein secretion systems (Zhou & Galán 2001; DiGiuseppe Champion & J. S. 
Cox 2007; Coburn et al. 2007). Once in the mammalian cytosol, these effector proteins 
can modulate crucial host pathways - often by mimicking mammalian protein activities - 
leading to the uptake of the bacterial cell (Bhavsar et al. 2007). Upon cell entry the 
bacterium finds itself encompassed by vesicular membrane structures, derived from the 
host membranes. Bacteria such as S. typhymurium or M. tuberculosis remain within these 
vesicular structures, replicate, and remodel them to their benefit. Other bacteria however, 
such as L. monocytogenes, egress from these compartments and adopt a cytosolic 
lifestyle. In both cases, the bacterium will adjust to the given environment as well as 
modulate it to guarantee its survival (Bhavsar et al. 2007; Coombes et al. 2004).  
Each step during the above outlined infection process requires the expression and 
activity of specific bacterial proteins - concerted in time and space. Indeed bacterial 
protein expression changes upon superficial contact with mammalian host cells, e.g. in S. 
typhimurium (B B Finlay et al. 1989). The application of microarray technologies to 
dissect changes in gene expression during various stages of the intracellular life cycle 
bears valuable information about necessary virulence factors (Coombes et al. 2004; 
Rohde et al. 2007). However, analysis of gene expression on the transcript level has its 
inherent limitations, especially if taken as a surrogate for protein levels, since protein 
levels and activity – the general effectors of biological function – are determined by 
many other parameters in addition to mRNA levels (J. Cox & Mann 2007). Furthermore 
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the analysis of transcript level does not provide information about protein secretion 
activity. 
Recent data in S. typhimurium emphasizes the role of posttranscriptional 
regulation in bacteria and shows poor correlation of transcript and protein levels (Ansong 
et al. 2009). The advent of modern mass spectrometry based proteomic technologies gave 
biological researcher excess to an immediate representation of proteome composition and 
hence cellular function (Aebersold & Mann 2003). Several studies explored the 
proteomic composition of pathogens under established culture conditions (Rosenkrands 
et al. 2000; C. G. Zhang et al. 2005). While these studies give a general list of bacterial 
proteins, they reveal only limited information about necessary virulence factors and 
dynamic proteome changes. Therefore, several in vivo and in vitro studies aimed at the 
analysis of the bacterial proteome under relevant infection conditions. In traditional in 
vitro experiments bacteria are cultivated under conditions that mimic intracellular 
conditions, such as high pH and low magnesium, which are known to induce the 
expression and secretion of certain virulence factors. This approach has been widely used 
for the identification of secreted effector proteins (Kodama et al. 2008; Yahr et al. 1997). 
Even though these experiments contribute to the understanding of bacterial virulence they 
do not truly reflect the native situation within the host cell. More elaborate experiments 
have tried to measure bacterial protein expression in cell culture infection experiments or 
in vivo. A recent study investigated S. typhimurium proteome changes upon infection of 
murine macrophages either expressing or lacking the host resistance regulator Nramp1 
(natural resistance-associated macrophage protein 1) (Shi et al. 2006). Another study 
used GFP-expressing S. typhimurium to infect mice (Becker et al. 2006). This allowed for 
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flow cytometric sorting of S. typhimurium containing cells isolated from organs of 
infected mice and subsequent proteomic analysis. The overwhelming amount of host 
proteins impedes the analysis of less abundant bacterial proteins (Rodland et al. 2008) 
and none of the above-mentioned studies was able to detect secreted effector proteins in 
the context of the host cell.  
Salmonellae are Gram-negative enterobacteria with a broad host range, in which 
they can cause either systemic disease in the form of enteric (typhoid) fever, or 
gastroenteritis (Ohl & S I Miller 2001). S. typhimurium in particular infects cattle, pigs, 
chickens, and humans. In these hosts it usually causes a self-limiting gastroenteritis. 
However, in certain mouse strains it causes a typhoid fever-like systemic disease, the 
susceptibility to which is greatly determined by Nramp1 (Jones & Falkow 1996; Plant & 
Glynn 1979). This mouse model has been widely used for the analysis of systemic 
Salmonella infection (Ohl & S I Miller 2001; Fields et al. 1986).  
Salmonella spp. possesses a number of virulence factors, such as virulence 
plasmids, toxins, fimbriae, and importantly Salmonella pathogenicity islands (SPI) (van 
Asten & van Dijk 2005). SPIs are thought to be acquired through horizontal gene transfer 
between species, indicated by an anomalous GC content and the presence of fragments of 
transposable elements (Groisman & Ochman 1996). Even though more than five SPIs 
have been described in the literature, the focus has been greatly on SPI-1 and SPI-2 
(Hansen-Wester & M Hensel 2001; Schlumberger & Hardt 2006). Both SPIs encode, 
amongst other proteins, for a type III secretion system (TTSS), which is a multi-
component secretion machinery for the purpose of protein effector delivery into the host 
cell cytosol (Mueller et al. 2008). So far, more than 30 effector proteins have been 
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identified, whose secretion depends on the activity of these two SPI encoded secretion 
systems (McGhie et al. 2009). Conventionally, SPI-1 effectors and SPI-2 effectors are 
associated with very distinct functions. SPI-1 effectors are necessary for the invasion of 
non-phagocytic cells and the establishment of the Salmonella containing vacuole (SCV), 
which is a vesicular structure that harbors S. typhimurium upon cellular invasion. In the 
typhoid fever model SPI-1 TTSS (TTSS1) deficient S. typhimurium show attenuated 
infectivity when administered orally, but not when given intravenously (Ohl & S I Miller 
2001). Furthermore, TTSS1 is implicated in the molecular etiology of S. typhimurium 
induced enteritis. These results indicate the importance of TTSS1 in the interaction and 
penetration of the intestinal epithelium. 
Later during the infection process SPI-2 effectors promote intracellular replication 
and systemic dissemination. It has been shown that SPI-2 TTSS (TTSS2) is necessary for 
systemic infection in the mouse model and for replication in tissue culture. In epithelial 
cells and macrophages, TTSS2 is responsible for the formation of membrane structures 
called Salmonella-induced filaments (Sif) – Sif protrude from SCVs and are possibly 
involved in vesicular trafficking (Haraga et al. 2008). However, contrary to the current 
model, recent data suggest an unappreciated interaction between SPI-1 and SPI-2 
effectors, as classical SPI-1 effectors like SopB have been implicated in late SCV 
positioning functions (Wasylnka et al. 2008). Despite the above-mentioned focus on 
TTSS1/2, other secretion systems have been discovered in S. typhimurium and have been 
implicated in its virulence. One of them is the sci-encoded (Salmonella enterica 
centisome 7 genomic island) type VI secretion system, which when ablated attenuates 
infectivity in various model systems (Filloux et al. 2008). The list of secreted effector 
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proteins is constantly growing and it is likely that more effector proteins are to be 
discovered, especially considering the vast number of non-annotated ORFs. Even tough 
some progress has been made in predicting bacterial effector proteins using 
bioinformatics (Y. Wang et al. 2011; McDermott et al. 2011), it is still desirable to 
develop a robust proteomics strategy that would allow global analysis of effector 
production and secretion in the infected host, since some effectors might always elude the 
bioinformatics prediction and an empiric determination and analysis of the dynamics of 
this concerted process is invaluable for its complete understanding. All previous 
proteomic studies of effector proteins or bacterial infection have failed to achieve this 
goal.  
The orthogonal amino acid reporters presented in the preceding chapters (AOA, 
ANL, PEP) could help to isolate secreted bacterial effector proteins from the mammalian 
cytosol or membrane fraction and therefore could allow the proteomic detection of 
secreted bacterial effector proteins. In the following we present our efforts to use 
orthogonal amino acid reporters for this purpose and describe the current limitations of 
the orthogonal amino acid system.  
5.3 Results 
Initially we wanted to test whether the orthogonal amino acids AOA and ANL 
can be generally incorporated into secreted bacterial effector proteins. To address this 
question we investigated the incorporation of AOA and ANL into secreted bacterial 
effector proteins in liquid culture. S. typhimurium SPI-1 or SPI-2 dependent protein 
secretion can be induced in liquid culture (Ellermeier & Slauch 2003; Yu et al. 2010). S. 
typhimurium pWSK29_MetGPLL IR715 was grown in full LB medium over night and 
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diluted into fresh LB medium. After 2 or 3 hours of growth 1 mM ANL, AOA, or Met 
was added to the growth medium until 4 hours of growth were completed. The culture 
supernatant was separated from the bacteria and the containing proteins were precipitated 
with trichloroacetic acid. The precipitated proteins were reacted with az-rho or alk-rho by 
CuAAC and analyzed by SDS-PAGE and in-gel fluorescence analysis (Figure 39). AOA 
and ANL were incorporated into the secreted effector proteins (identity of these proteins 
was determined under similar conditions by other members of the Hang laboratory). 
Interestingly, earlier addition of the orthogonal amino acid reporter (2 h) impaired protein 
secretion in comparison to the methionine control and the 1 h sample. This speaks for a 
detrimental effect on protein secretion upon longer incubation times with AOA or ANL. 
Both amino acid reporters showed this effect. The smaller effect observed by 
fluorescence could be due to an increased labeling intensity in the 2 h sample compared 
to the 1 h sample, which is able to balance out some of the signal loss due to impaired 
protein secretion. Repeating the same experiment with S. typhimurium 14028 
pWSK29_MetGPLL and S. typhimurium 14028 ΔSPI-1 pWSK29_MetGPLL, a TTSS-1 
inactive mutant, pulse-labeling for 1 hour, confirmed that most of the labeled protein 
species indeed are secreted SPI-1 effector proteins (Figure 40). So, generally AOA or 













Figure 39 AOA and ANL are incorporated into secreted S. typhimurium proteome. SPI-1 
dependent protein secretion of S. typhimurium IR715 pWSK_MetGPLL was induced in full 
LB growth medium. S. typhimurium IR715 pWSK_MetGPLL was pulse-labeled with 
AOA, ANL, or Met and the proteins in the culture supernatant were reacted with az-rho 
or alk-rho by CuAAC and analyzed by SDS-PAGE and in-gel fluorescence. Fluor.: az-
rho or alk-rho fluorescence, CB: coomassie blue, AA: amino acid, az-rho:azido-











Figure 40 AOA and ANL are incorporated into SPI-1 effector proteins. SPI-1 dependent 
protein secretion of S. typhimurium IR715 pWSK_MetGPLL and S. typhimurium IR715 
ΔSPI-1 pWSK_MetGPLL was induced in full LB growth medium. S. typhimurium was 
pulse-labeled with AOA, ANL, or Met and the proteins in the culture supernatant were 
reacted with az-rho or alk-rho by CuAAC and analyzed by SDS-PAGE and in-gel 
fluorescence. Fluor.: az-rho or alk-rho fluorescence, CB: coomassie blue, AA: amino 





For previous proteomics experiments (see chapter 2) we pulse-labeled infected 
macrophages around 16 hours post-infection. Before moving into large-scale proteomics 
experiments for the detection of secreted bacterial effector proteins we wanted to assess 
whether known bacterial effector proteins are actually expressed at this time during 
infection. Eriksson et al published a microarray study profiling S. typhimurium gene 
expression during infection of macrophages and compared it to S. typhimurium grown in 
mammalian growth medium (Eriksson et al. 2003). Their data revealed that the 
transcription of numerous known effector proteins, amongst them SseJ and SifA, is up-
regulated in comparison to the control population 12 hours post-infection (Figure 41).  
 
Figure 41 Relative expression level of selected known effector proteins in S. 
typhimurium during infection of macrophages. Relative expression level: relative 
expression compared to opsonized S. typhimurium in mammalian growth medium. (Data 




SseJ, one of the most strongly up-regulated effector proteins in the microarray 
study by Eriksson and colleagues, is known to take part in the formation of Salmonella-
induced filaments (Sifs) and as a SPI-2 regulated effector proteins plays an important role 
in the establishment of the intracellular infection (Lossi et al. 2008). We analyzed its 
expression dynamics during infection of RAW264.7 macrophages by fluorescence 
microscopy. Macrophages were infected with S. typhimurium IR715 pWSK29_SseJ, 
expressing a HA-tagged SseJ, regulated by the endogenous SseJ promoter. SseJ cannot be 
detected 2 hours post-infection, but can be detected after 7 hours and is most strongly 
expressed at the 20-hour time point.  
 
Figure 42 SseJ is expressed during infection of RAW264.7 macrophages. RAW264.7 
cells were infected with S. typhimurium pWSK29_HASseJ and analyzed by fluorescence 
microscopy. Blue: DNA stain TO-PRO-3, green: anti-Salmonella antibody stain, red: 
anti-HA antibody stain. Bar indicated 10 µm. 
 
As a final step towards establishing orthogonal amino acid incorporation into 
bacterial effector proteins during infection, in preparation of large-scale proteomics 
experiments, we analyzed the incorporation of the amino acid reporter EME (see chapter 
4) into SseJ during infection of macrophages. Macrophages were infected with S. 
typhimurium IR715 pWSK29_SseJ and pulse labeled with EME 16 hours post-infection. 
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SseJ was immunoprecipitated, reacted with az-rho by CuAAC, and analyzed by SDS-
PAGE and in-gel fluorescence scanning. EME was incorporated into SseJ during 
infection of mammalian cells (Figure 43). Based on the mild Brij detergent lysis we 
concluded that the immunoprecipitated SseJ population should be largely of mammalian 
cytosolic origin, hence secreted. These data demonstrate that amino acid reporters can be 
incorporated into SPI-1 and SPI-2 effector proteins in S. typhimurium and that this 
incorporation does not preclude effector secretion. Furthermore, known effector proteins, 
such as SseJ, are expressed between 7 and 20 hours of infection of macrophages, the time 
window we have been conducting our proteomics studies. 
 
Figure 43 SseJ is labeled with the amino acid reporter EME during infection of 
RAW264.7 macrophages. 
 
The identification of secreted effector proteins by mass spectrometry-based 
proteomics requires the separation of intact bacterial cells from the mammalian proteome. 
The mammalian cytosolic, membrane, and even nucleic fraction should contain any 
secreted bacterial effector proteins. It is therefore indispensable to lyse the infected 
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mammalian cell without also lysing the containing bacterial cell bodies since any 
contamination of the mammalian fraction with non-secreted bacterial proteins impedes 
the assignment of an identified bacterial protein to the secreted proteome fraction.  
The literature is filled with a wide range of different selective lysis conditions that 
have been used for the analysis of secreted effector proteins. Initially we tested a standard 
fraction fractionation procedure based on an initial lysis with 0.2% saponin, followed by 
a 0.1% Triton X-100 lysis (Kuhle & Michael Hensel 2002). RAW264.7 cells were 
infected with S. typhimurium pWSK29_MetGPLL and pulse-labeled with AOA 16 hours 
post-infection for 1, 2, or 3 hours. Subsequently the infected cells were fractionated with 
0.2% saponin and 0.1% Triton X-100 into a cytosolic (0.2% saponin), a membrane (0.1% 
Triton X-100), and a pellet fraction, which should contain the nucleus and the intact 
bacteria. The resulting proteome fractions were reacted with az-rho by CuAAC and 
analyzed by SDS-PAGE, in-gel fluorescence scanning, and Western blot. The S-tag 
epitope tag of MetGPLL expressed only in the bacterial cells served as a bacterial cytosolic 
marker. Fluorescence signal was detected in all three fractions. The mammalian cytosolic 
fraction differed qualitatively from the membrane and the pellet fraction, while the latter 
two were highly similar. MetGPLL was detected in all three fractions, indicating that a 
major portion of bacterial cells is lysed during cell lyses or prior to that, during infection. 
This data indicated that these lysis conditions were not selective enough and resulted in 
bacterial contaminations in the mammalian cytosol, provided post-labeling cell lysis was 
the reason for the contamination.  
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Figure 44 AOA can be detected in various proteome fractions. RAW264.7 cells were 
infected with S. typhimurium pWSK29_MetGPLL and pulse-labeled with 1 mM AOA 
for different times 16 hours post-infection. Cells were fractionated with 0.2% saponin 
(cytosol) and 0.1% Triton X-100 (membrane). az-rho: azido-rhodamine, CB: coomassie 
blue,  
 
Due to the high background lysis observed in the first fractionation experiment 
(Figure 44), we investigated various lysis procedures for their selectivity for mammalian 
cells. Blotting for MetG in the isolated mammalian proteome fraction served as the read-
out for bacterial co-lysis. Infected RAW264.7 cell were infected with S. typhimurium 
pWSK29_MetGPLL and lysed by different procedures 16 hours post-infection. Cells were 
either lysed by mechanical disruption in sucrose and imidazole (N1) or triethanolamine 
(N2) or by detergents (Triton X-100, saponin). Western blot analysis of MetGPLL as a 
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marker for bacterial integrity revealed the mechanical lysis (N1) as the most selective, 
while the traditional 0.1% Triton X-100 lysis seemed to be the least selective (Figure 45).  
 
Figure 45 Analysis if differential lysis procedures. N1: mechanical lysis in sucrose and 
imidazol, N2: mechanical lysis in triethanolamine, 0.1TX: 0.1% Triton X-100, 0.01TX: 
0.01% Triton X-100, 0.2Sp: 0.2% saponin, 0.02Sp: 0.02% saponin, α-S-tag: anti-S-tag 
(MetGPLL) Western blot analysis.  
 
Based on these results we conducted an infection and fractionation experiment. 
RAW264.7 cells were infected with S. typhimurium pWSK29_MetGPLL and pulse-labeled 
with AOA 16 hours post-infection for 2 hours. Subsequently the cells were lyzed by 
method N1, 0.01% Triton X-100, or 0.02% saponin. The resulting fractions were 
analyzed by CuAAC with az-rho, SDS-PAGE, and in-gel-fluorescence scanning as well 
as Western blot. Compared to the precious experiment (Figure 44) the improved selective 
fractionation conditions caused less bacterial lysis, since no MetGPLL signal was detected 
in the supernatant fractions (mammalian cytosol). In addition, the total fluorescence 
intensity in the supernatant fraction seemed to be reduced, indicating reduced levels of 




Figure 46 Improved fractionation conditions. RAW264.7 cells were infected with S. 
typhimurium pWSK29_MetGPLL and pulse-labeled with AOA for 2 hours 16 hours 
post-infection. N1: mechanical lysis in sucrose and imidazol, 0.01TX: 0.01% Triton X-
100, 0.02Sp: 0.02 % saponin, az-rho: azido-rhodamine, CB: coomassie blue.  
 
With these fractionation conditions in hand we decided to approach the first large-
scale proteomics experiment. For the initial experiment we decided for the most selective 
fractionation condition N1, even tough this condition also provides the least fluorescence 
signal, which suggested very little protein retrieval by affinity enrichment of AOA-
labeled proteins. Since the expected protein amount was very small we choose to use an 
in-solution digest protocol to minimize protein loss during the sample preparation for 
mass spectrometry (Wiśniewski et al. 2009). RAW264.7 cells were infected with S. 
typhimurium pWSK29_MetGPLL and pulse-labeled with AOA 16 hours post-infection for 
2 hours. Cells were washed, harvested, and frozen in liquid nitrogen. Cells were lysed 
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and fractionated by the N1 procedure and the resulting protein fractions were precipitated 
by methanol/chloroform precipitation and resuspended in SDS buffer for CuAAC with 
azide-azo-biotin. Clicked protein samples were precipitated again and bound to 
streptavidin beads. The protein bound beads were washed and finally the selectively 
bound proteins were eluted with sodium dithionite. Protein reduction, alkylation, and 
digestion with Lys-C and trypsin was carried out on Microcon YM-10 filters (Wiśniewski 
et al. 2009). Resulting peptides were purified on StageTips and analyzed by LC-MS/MS.  
 
Table 2 Identified proteins in the N1 supernatant fraction by Filter Aided Sample 
Preparation (FASP). 
#	   Identified	  Protein	   Accession	  Number	  
1	   mouse	   IPI:IPI00319992.1	  
2	   mouse	   IPI:IPI00407130.4	  
3	   mouse	   IPI:IPI00886297.1	  
4	   60	  kDa	  chaperonin	   P0A1D3|CH60_SALTY	  
5	   Elongation	  factor	  G	   P0A1H3|EFG_SALTY	  
6	   Elongation	  factor	  Tu	   P0A1H5|EFTU_SALTY	  
7	   Spermidine/putrescine-­‐binding	  periplasmic	  prot	   P0A2C7|POTD_SALTY	  
8	   Chaperone	  protein	  htpG	   P58480|HTPG_SALTY	  
9	   Enolase	   P64076|ENO_SALTY	  
10	   Chaperone	  protein	  dnaK	   Q56073|DNAK_SALTY	  
11	   Chaperone	  protein	  clpB	   Q7CQ01|CLPB_SALTY	  
12	   30S	  ribosomal	  subunit	  protein	  S1	   Q7CQT9|Q7CQT9_SALTY	  
13	   Pyruvate	  formate	  lyase	  I,	  induced	  anaerobicall	  	   Q7CQU1|Q7CQU1_SALTY	  
 
Not surprisingly, given the low fluorescence intensity in the N1 supernatant 
fraction (Figure 46), the total number of proteins was very low (Table 2). Three proteins 
were mouse proteins, the remaining ten were S. typhimurium proteins, presenting an 
overall enrichment of S. typhimurium proteins similar what was observed in previous 
AOA labeling studies (Grammel et al. 2010). The identified S. typhimurium proteins did 
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not contain any known or previously described potential effector proteins and almost all 
of them were previously identified from intact bacteria infecting RAW264.7 
macrophages (see chapter 1). We concluded that none of these proteins are in fact 
effector proteins.  
Due to the low overall protein retrieval from the N1 supernatant fraction we 
turned to the Triton X-100 fractionation method, resulting in an increased fluorescence 
signal in the supernatant fraction (Figure 46). The RAW264.7 cell infection experiment 
was carried out as before, however cells were lysed in 0.1% Triton X-100. The resulting 
fractions were precipitated by methanol/chloroform precipitation and reacted with azido-
azo-biotin for affinity enrichment. Since we expected higher protein recovery upon Triton 
X-100 lysis, compared to the N1 lysis, samples for LC-MS/MS analysis were prepared by 
in-gel digestion, providing a means of sample complexity reduction. Captured proteins 
were selectively eluted by sodium dithionite and separated by SDS-PAGE (Figure 47). 
SDS-PAGE analysis already indicated that the major protein components retrieved from 
the supernatant and the pellet fraction could be identical. LC-MS/MS and data analysis 
was carried out as previously (Grammel et al. 2010). 55 S. typhimurium proteins were 
identified in the supernatant fraction (Table 5), all of which were also detected in the 
bacterial pellet fraction, which comprised 140 identified S. typhimurium (Table 6). None 
of the identified proteins in the supernatant or pellet fraction was a known and 
characterized effector proteins (e.g. SifA, SseJ), which should be expressed 16 hours 
post-infection (Figure 41, Figure 42, Figure 43). In addition, non of the recently predicted 
putative effector proteins were among the identified proteins (Samudrala et al. 2009; 
Arnold et al. 2009). In conclusion, neither the highly selective N1 mechanical lysis nor 
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the harsher Triton X-100 lysis resulted in the proteomic identification of a known or 
putative effector protein. The reduction in general fluorescence recovery in the 
supernatant fraction only was accompanied by a reduction in dynamic range of bacterial 
protein detection, since the top protein hits in both, the N1 and the Triton X-100, lysis are 
the same. These proteins are highly abundant chaperones and translational components. 
 
 
Figure 47 In-gel sample preparation enriched bacterial proteins from infected RAW264.7 
cells, fractionated by 0.1% Triton X-100 lysis.  
 
5.4 Materials and Methods 
5.4.1 Labeling effector proteins in liquid culture with AOA or ANL 
An overnight culture of S. typhimurium IR715 pWSK29_MetGPLL , S. typhimurium 14028 
pWSK29_MetGPLL, or S. typhimurium 14028 ΔSPI-1 pWSK29_MetGPLL was centrifuged 
and resuspended in fresh LB medium with 100 µg/ml carbenicillin. For secretion assays 
the cultures were grown in 15 ml plastic culture tubes at 37 °C with aeration (2 ml culture 
volume). For amino acid labeling, 2 mM AOA, ANL, or Met was added either 2 or 3 
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hours afterwards. Bacteria were harvested by centrifugations, twice. To the culture 
supernatant trichloroacetic acid was added to a final concentration of 10% an the sample 
was incubated over night at 4 °C. The sample was centrifuged for 30 min at 20,000g at 4 
°C. The resulting pellet was carefully rinsed with ice-cold acetone three times. The 
resulting pellets were resuspended in 20 µl 4% SDS, 50 mM TEA, 150 mM NaCl. To this 
solution 5 µl click-chemistry master mix was added (see 3.4.5). The samples were 
precipitated by methanol/chloroform precipitation after CuACC to remove all small 
molecules and finally completely loaded on a SDS-PAGE for separation and in-gel 
fluorescence scanning.  
5.4.2 Cloning of SseJ into pWSK29 
Initially a pWSK29_HA plasmid was generated by annealing two primers 
(TCGAGTTATGCATAATCAGGAACATCATAAGGATAG and 
AATTCTATCCTTATGATGTTCCTGATTATGCATAAC), digesting them with EcoRI 
and XhoI, and ligating them in pWSK29, also cut with EcoRI and XhoI. SseJ was 
amplified from S. typhimurium IR715 by PCR 
(GAATTCTTCAGTGGAATAATGATGAGCTATAAAAC and 
TCTAGAGATAGCAGTCAGATAATATGTACCAGGC). The resulting PCR product 
was digested with EcoRI and XbaI and ligated into pWSK29_HA, also cut with EcoRI 
ans XbaI.  
5.4.3 Imaging of SseJ during infection by fluorescence microscopy 
For infection see 3.4.4, for fluorescence microscopy see 3.4.6. 
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5.4.4 Pulse-labeling with EME and immunoprecipitation of SseJ during infection 
Confluent 6 well dishes of RAW264.7 cells were infected with S. typhimurium IR715 
pWSK29_HASseJ grown in LB medium to stationary phase at an MOI of 10 (see 3.4.4). 
16 hours post-infection cells were washed with PBS and incubated with methionine free 
DMEM and 1 mM EME or 1 mM Met for 1 hour. Cells were washed with PBD and lysed 
in Brij-97 buffer (M. M. Zhang et al. 2010). Immunoprecipitation, CuAAC on beads, and 
analysis was carried out as reported previously (M. M. Zhang et al. 2010). 
5.4.5 Fractionation of infected RAW264.7 macrophages 
For detergent based lysis, infected cells were resuspended in ice-cold 50 mM TEA buffer 
pH 7.4 containing 1 mM PMSF, 1 RocheComplete protease inhibitor tablet per 25 ml, 
and different concentrations of detergent (0.1% Triton X-100, 0.01% Triton X-100, 0.2% 
saponin, or 0.02% saponin). Cells were lysed on ice for 10 min and centrifuged at 20,000 
g for 5min at 4°C to yield the supernatant and pellet fraction.  
For mechanical lysis, cells were resuspended in either 250 mM sucrose, 3 mM imidazole, 
0.5 mM EDTA, 1 mM PMSF, and 1 RocheComplete protease inhibitor tablet per 25 ml 
(N1) or 50 mM TEA pH 7.4, 1 mM PMSF, and 1 RocheComplete protease inhibitor 
tablet per 25 ml (N2). Cells were pushed trough a 21.5 gauge needle 20 times. Lysates 
were centrifuged at 20,000 g for 5min at 4 °C to yield the supernatant and pellet fraction.  
5.4.6 Sample preparation for LC-MS/MS analysis 
Sample preparation by in-gel digestion, LC-MS/MS and data analysis was carried out as 
in 2.4.11, 2.4.12, 2.4.13, 2.4.14, and 2.4.15. 
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5.4.7 Filter aided sample preparation (FASP) 
Sample preparation by filter aided sample preparation (FASP) was strictly carried out as 
published previously (Wiśniewski et al. 2009). 
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6 A chemical reporter for protein AMPylation4 
6.1 Abstract 
Protein AMPylation is an emerging posttranslational modification, which plays key roles 
in bacterial pathogenesis and cell biology. Enzymes with AMPylation activity, referred to 
as AMPylators, have been identified in several bacterial pathogens and eukaryotes. To 
facilitate the study of this unique modification, we developed an alkynyl chemical 
reporter for detection and identification of protein AMPylation substrates. Covalent 
functionalization of AMPylation substrates with the alkynyl reporter in lieu of adenylyl 
5’-monophosphate (AMP) allows their subsequent bioorthogonal labeling with azide-
fluorescent dyes or affinity enrichment tags. We show that this chemical reporter is 
transferred by a range of AMPylators onto their cognate protein substrates and allows 
rapid detection and identification of AMPylated substrates. 
6.2 Introduction 
Protein AMPylation refers to the covalent modification of protein side chain hydroxyl 
groups with adenylyl 5’-monophosphate (AMP) through a phosphodiester bond. This 
posttranslational modification is installed by the enzymatic transfer of AMP from 
adenosine-5’-triphosphate (ATP) to the substrate hydroxyl group. This catalytic activity 
was initially described for E. coli glutamine synthetase (GS) adenylyl transferase, which 
tightly regulates GS activity (Kingdon et al. 1967; Shapiro & Stadtman 1970). Additional 
proteins with AMPylation activity (AMPylators) have been identified that contain either 
                                                
4 This work was carried out in collaboration with Phi Luong (UT Southwestern) and Kim 
Orth (UT Southwestern). Phi Luong conducted all cloning and expression experiments. 
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the filamentation induced by cAMP (fic) domain or the adenylyl transferase (ATase) 
domain, which confer AMPylation activity (Woolery et al. 2010; Lisa N Kinch et al. 
2009). Many of these characterized AMPylators serve as bacterial virulence factors that 
are secreted into the mammalian host cell during infection. There, they AMPylate 
mammalian host proteins to alter their function for the benefit of the pathogen. In 
particular, secreted bacterial AMPylators, such as VopS (Vibrio parahaemolyticus), IbpA 
(Legionella pneumophila), and DrrA (Legionella pneumophila) have been shown to 
target mammalian small GTPases, like RhoA, Rac1, Cdc42, and Rab1 (Melanie L 
Yarbrough, Yan Li, et al. 2009; Worby et al. 2009; Müller et al. 2010). Another bacterial 
effector protein has been identified that selectively deAMPylates a GTPase, indicating 
the dynamic nature of this modification (Tan & Luo 2011; Neunuebel et al. 2011). The 
AMPylation of small GTPases, on threonine or tyrosine residues, interferes with their 
proper function, either by sterically blocking the interaction with downstream signaling 
components or GTPase activating proteins (GAPs). Interestingly, fic and ATase domains 
are not limited to bacterial effector proteins, but have been identified in archaea and 
eukaryotes as well. Most eukaryotic genomes appear to contain a fic domain protein. 
AMPylation activity has been observed for the human protein HYPE and the Drosophila 
protein dFic (Lisa N Kinch et al. 2009; Worby et al. 2009). The widespread presence of 
these domains suggests a ubiquitous role for protein AMPylation as a regulated and 
reversible posttranslational modification. While radioactive ATP, targeted mass 
spectrometry, and specific antibodies, can be used to detect AMPylated substrates, more 
general and efficient analytical tools are still needed for the unbiased identification of 
new AMPylated substrates and the analysis of their regulation. We therefore developed 
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an alkynyl chemical reporter for bioorthogonal detection, enrichment and identification 
of AMPylated proteins (Figure 48). 
 
Figure 48 N6pATP – N6-propargyl adenosine-5’-triphosphate; N6pAMP – N6-propargyl 
adenosine-5’-monophosphat; PPi – pyrophosphate; CuAAC – Cu(I)-catalyzed azide-
alkyne cycloaddition; Tag – rhodamine fluorescence dye or cleavable biotin enrichment 
tag .  
 
6.3 Results 
Alkynyl chemical reporters allow Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) 
of labeled substrates with azide-functionalized detection and enrichment reagents. This 
technology has facilitated the analysis of various posttranslational modifications and 
nucleic acid biogenesis (Sletten & Bertozzi 2009). Recent structural studies of 
AMPylators and previous studies of fluorescent AMP analogs, suggested that a 
modification of the N6 position of the adenine ring could be tolerated (Chock et al. 1973; 
Rhee et al. 1981; Xiao et al. 2010; Luong et al. 2010a; Palanivelu et al. 2011). Thus, we 
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synthesized the ATP analog N6-propargyl adenosine-5’-triphosphate (N6pATP) as a 
potential chemical reporter for AMPylation.  
To assess the activity of N6pATP as a possible chemical reporter for AMPylation, 
we used a well-established in vitro system, based on the recently identified AMPylator 
VopS and its cognate mammalian target Cdc42 (M. L. Yarbrough, Y. Li, L. N. Kinch, et 
al. 2009). Cdc42(Q61L), subsequently referred to as Cdc42, was incubated with VopS in 
the presence of increasing concentrations of N6pATP under previously reported in vitro 
AMPylation conditions (Luong et al. 2010b). N6pAMP transfer was analyzed by CuAAC 
with azido-rhodamine (az-rho) dye and in-gel fluorescence scanning (Charron et al. 
2009). Increasing concentrations of N6pATP yielded dose-dependent increase in 
fluorescence labeling of Cdc42 (Figure 49). The chemical reporter proved to be 
transferred only in the presence of VopS and appeared to be highly selective for the 
native substrate Cdc42, as judged by the lack of concomitant BSA labeling (Figure 49).  
 
Figure 49 VopS labeled its native substrate with the chemical reporter N6pATP. Cdc42 
(0.5 µg) was incubated with VopS (1 ng) with increasing concentrations of N6pATP for 1 
hour at 30°C in reaction buffer and analyzed by CuAAC and in-gel fluorescence. az-rho: 
azido-rhodamine, CB: coomassie blue.  
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To investigate the selectivity of N6pATP, we made use of substrate and 
AMPylator mutants. When VopS was incubated with the T35A mutant of Cdc42, in 
which the target threonine residue of VopS was mutated to an alanine, no transfer was 
observed (Figure 50b) (M. L. Yarbrough, Y. Li, L. N. Kinch, et al. 2009). In addition, a 
catalytic inactive mutant of VopS, H348A, failed to transfer the chemical reporter (Figure 
50b) (M. L. Yarbrough, Y. Li, L. N. Kinch, et al. 2009). The dependence on this 
previously described catalytic histidine suggests that N6pAMP is transferred by the same 
catalytic mechanism as the native AMP group. These data emphasize the distinct 
selectivity of N6pATP, which was further demonstrated by competitive inhibition with 
ATP (Figure 50c). N6pATP appears to be a general cofactor for AMPylation, since it was 
also utilized by VopS to modify its alternative substrates RhoA and Rac1 (Figure 50d). It 
should be noted that labeling of Cdc42(T35S) by VopS was also observed (Figure 50e), 
supporting the notion that AMPylation may occur on serine residues. Moreover, it served 
as a chemical reporter for another fic domain AMPylator, IbpA (Fic2, Figure 51a). Like 
VopS, Fic2 modifies Cdc42, however, it transfers AMP onto tyrosine residue Y32 
(Worby et al. 2009) (Figure 51b). We also tested the ATase domain AMPylator DrrA for 
its ability to utilize N6pATP. Indeed, DrrA accepted N6pATP as cofactor and labeled the 
reported protein substrate Rab1 (Figure 51c) (Worby et al. 2009). These experiments 
demonstrate the versatile nature of N6pATP as a chemical reporter for all known 
AMPylator families, namely fic domain and ATase domain AMPylators. N6pATP 
labeling appears to be independent of the target protein substrate and could also allow the 






Figure 50 In vitro analysis of VopS activity, using N6-propargyl adenosine-5’-
triphosphate (N6pATP) as a chemical reporter, by click-chemistry and in-gel fluorescence 
scanning. All AMPylation reactions were carried out in 15 µl total volume for 1 h at 30°C 
. A) Cdc42 (0.5 µg) was incubated with VopS (1 ng) and increasing concentrations of 
N6pATP. B) Cdc42 (0.5 µg) or Cdc42(T35A) (0.5 µg) was incubated with VopS (1 ng) or 
VopS(H348A) (1 ng) and N6pATP. C) Analysis of Cdc42 labeling by VopS, using N6-
propargyl-adenosine-5’-triphosphate (N6pATP) as a chemical reporter, with increasing 
concentrations of adenosine-5’-triphosphate, by click-chemistry and in-gel fluorescence 
scanning. VopS (1 ng) was incubated with Cdc42 (0.5 µg), N6pATP (100 µM) and 
increasing concentrations of ATP in a total volume of 15 µl for 1 h at 30°C. D) RhoA 
(0.5 µg) was incubated with VopS (10 ng). Rac1 (0.5 µg) was incubated with VopS (10 
ng) in the presence of N6pATP (100 µM) in a total volume of 15 µl for 1 h at 30°C. E) 
Cdc42(T35S) (0.5 µg) was incubated with VopS (10 ng). az-rho: azido-rhodamine 












Figure 51 N6pATP is used by all known AMPylation enzyme families. a) Cdc42 (0.5 µg) 
was incubated with increasing amounts of Fic2 (IbpA) in the presence of N6pATP in 
reaction buffer. b) Cdc42 (0.5 μg) or Cdc42(Y32A) (0.5 μg) was incubated with Fic2 (10 
ng) or Fic2(H3717A) (10 ng) and N6pATP in a total volume of 15 μl for 1 h at 30°C. c) 
Increasing amounts of DrrA were incubated with Rab1a (0.5 μg) and N6pATP (100 μM) 









We next analyzed the ability of VopS, Fic2, and DrrA to modify their substrates 
with N6pATP in mammalian cell lysates. It has been reported that addition of purified 
VopS or Fic2 to HeLa cell lysates in the presence of 32P-a-ATP results in the labeling of 
one distinct band in the molecular weight range of small GTPases, as assessed by 
autoradiography (Melanie L Yarbrough et al. 2009; Worby et al. 2009). We incubated 
purified VopS, Fic2, and DrrA with Triton X-100 lysed HeLa cell lysates and N6pATP 
(100 µM). As previously observed for 32P-a-ATP labeled cell lysates, VopS and Fic2 
labeled one distinct protein or protein population at the corresponding molecular weight 
of small GTPases (Figure 52a, b). Addition of DrrA also resulted in the modification of 
one distinct protein or protein population at ~21 kDa (Figure 52c), although more 
recombinant DrrA was needed to observe similar levels of labeling. In the absence of 
recombinant enzyme, the reporter did not significantly label the cell lysate. All three 
enzymes displayed auto-AMPylation activity as evidenced by a specific fluorescent 
signal at the corresponding molecular weight (Figure 52a, b, c). These results corroborate 
previous findings, underscoring the distinctive selectivity of these effector proteins for 















Figure 52 Detection of endogenous AMPylation substrates in cell lysates. AMPylation 
reactions (a-c) were carried out in 15 µl for 1 h at 30°C. a) VopS (100 ng) was added to 
HeLa cell lysate (10 mg) in the presence of N6pATP (100 µM). b) Fic2 (300 ng) was 
added to HeLa cell lysate (10 mg) in the presence of N6pATP (100 µM). c) DrrA (4 µg) 









To explore the utility of N6pATP for the unbiased identification of AMPylated 
substrates, we incubated HeLa cell lysate (1 mg) with N6pATP (100 µM) in the presence 
or absence of VopS (88µg). The bulk of the samples was then reacted with a cleavable 
biotin enrichment tag (ortho-hydroxy-azidoethoxy-azo-biotin) and incubated with 
Streptavidin beads for affinity capture of labeled proteins (Y.-Y. Yang et al. 2010). 
Captured proteins were digested on beads and the resulting peptides were collected and 
subjected to protein identification by tandem mass spectrometry. For data analysis, all 
protein hits of the negative control were subtracted from the VopS containing sample, 
which revealed two final protein identifications: VopS and Cdc42, with VopS peptides 
representing the majority of the identified peptides (Figure 53b, c). The dominant VopS 
fraction correlates well with the observed fluorescence profiling of the same samples 
(Figure 53a). This data demonstrates that N6pATP can be used to identify substrates of 
individual AMPylators in complex cellular protein samples and confirms Cdc42 as an 

















Figure 53 Proteomic analysis of endogenous VopS substrates in Hela cell lysates 
confirms Cdc42. a) 1 mg HeLa cell lysates was incubated with VopS (88 µg) and 
N6pATP (100 µM). b) Proteomic analysis of VopS substrates in HeLa cell lysate 
identified two proteins above background, VopS and Cdc42. c) Identified Cdc42 
peptides. # TS – number of total spectra, # UP – number of unique peptides, XCorr – 
SEQUEST Xcorr score, DCn – SEQUEST DCn score, az-rho - azido-rhodamine 








6.4 Materials and Methods 
6.4.1 General methods and materials 
All chemical reagents were purchased from Sigma-Aldrich. Analytical and preparative 
HPLC was conducted on a Waters 1525 Binary HPLC Pump system with a XBridge Prep 
C18 5 µm OBD, 19 x 150 mm, column or a Xbridge C18 5µm, 4.6 x 150 mm, analytical 
column. Compounds were eluted with a linear gradient of 100% acetonitrile and 20 mM 
triethylammonium bicarbonate, 2% acetonitrile, adjusted to pH 7.4 with acetic acid. 31P 
NMR analysis was done on a Bruker Avance DPX400 and 1H analysis on a Bruker 
Avance DMX600 system. HRMS analysis was conducted by the Proteomics Resource 
Center of The Rockefeller University on a LTQ-Orbitrap (Thermo Scientific). Azido-
rhodamine (az-rho) and TBTA (tris((1-benzyl-1H-1,2,3-triazol-4-yl)methyl) amine) was 
generated by the Hang laboratory as previously described (Charron et al. 2009). 
6.4.2 Chemical synthesis 
6.4.2.1 6-propargyl-adenosine 
6-propargyl-adenosine was synthesized as previously reported (Jiang et al. 2009). Briefly, 
6-Choropurine nucleoside (1 eq.), calcium carbonate (2 eq.) and propargylamine (5 eq.) 
were added to absolute ethanol and refluxed under argon for 12 hours. The reaction 
mixture was filtered and the filtrate was kept at -20 °C over night. The white precipitate 
was collected by filtration, washed with ether and dried under vacuum to afford the pure 
product. 1H NMR (DMSO): δ 8.36 (s, 1H), 8.24 (s, 1H), 8.20 (br, 1H), 5.86 (d, 1H, J = 
6.1 Hz), 5.4 (d, 1H, J = 6.2 Hz), 5.28 (dd, 1H, J = 4.7, 2.3 Hz), 5.14 (d, 1H, J = 4.7 Hz), 
4.56 (dd, 1H, J = 6.0, 5.2 Hz), 4.21 (br, 2H), 4.11 (dd, 1H, J = 4.7, 3.3 Hz), 3.92 (dd, 1H, 
J = 3.5, 3.4 Hz), 3.63 (m, 1H), 3.51 (m, 1H). 
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6.4.2.2 N6-propargyl-adenosine-5’-triphosphate 
N6-propargyl-adenosine-5’-triphosphate was synthesized using the Yoshikawa 
(Yoshikawa et al. 1967) reaction for selective phosphorylation of the 5’-hydroxyl group, 
generally following the method of Ludwig (Ludwig 1981). Trimethyl phosphate was 
dried for 18 h over molecular sieves (3A) and under argon atmosphere. 0.5 ml trimethyl 
phosphate was transferred into a flame dried round bottom flask and 6-propargyl-
adenosine (61 mg, 0.2 mmol) was added. Phosphoryl chloride (39.8 mg, 0.26 mmol) was 
added to the stirred suspension with a syringe and the reaction mix was stirred for 1.5 h at 
0 °C until it cleared. To this solution tributylammonium pyrophosphate (549 mg, 1 
mmol), in 2 ml anhydrous dimethylformamide, was added and stirred for 20 min at 0 °C. 
The reaction mix was further stirred for 5 min at room temperature, before 2 ml of 
triethylammonium bicarbonate (1M) was added. Solvent was evaporated under reduced 
pressure and half of the resulting material was purified by reverse phase HPLC using a 
gradient of 20 mM triethylammonium bicarbonate (pH 7.4, acetic acid, 2% acetonitrile) 
and 100 % acetonitrile. Fractions that contained the desired product were lyophilized to 
afford 54 mg of N6-propargyl-adenosine-5’-triphosphate as a triethylammonium salt 
(54% extrapolated yield). 31P NMR (D2O): 1.74 (s), -9.63 (m), -10.27 (m); 1H NMR 
(D2O): δ 8.55 (m, 1H), 8.34 (m, 1H), 6.16 (m, 1H), 4.56 (m, 1H), 4.40 (m, 3H), 4.30 (m, 
1H), 4.22 (m, 1H), 4.07 (m, 1H), 2.63 (s, 1H). HRMS calcd. for C13H18N5O13P3 [(M+H)+] 
546.0187, obsd. 546.0247. 
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6.4.3 Cloning and expression 
VopS (31-387) pGEXTEV and His6-Cdc42-(1-179)-(Q61L) pPROEXHTa were 
expressed and purified as described previously (Luong et al. 2010). GST-Fic2 
pGEXTEV, GST-Fic2-(H3717A) pGEXTEV, Rab1a (Canis) pet28a, DrrA (1-339) 
pet28a, RacV12 pet28a, RhoApGEX-KG, His6-Cdc42-(1-179)-(Q61L, T35S) 
pPROEXHTa, His6-Cdc42-(1-179)-(Q61L, T35A) pPROEXHTa and His6-Cdc42-(1-179)-
(Q61L, Y32A) pPROEXHTa were expressed and transformed in BL21 (DE3) cells. 
Protein expression was performed overnight at room temperature with 0.4 mM IPTG. 
Protein pellets were purified using glutathione-agarose (Sigma) or immobilized metal ion 
affinity chromatography (Sigma). Proteins were buffer exchanged in 20 mM Tris pH 8.0, 
100 mM NaCl, 10% glycerol, 1 mM DTT with an Amicon 10K concentrator and stored 
at -80 °C. Protein concentrations were assayed by the Bradford method (Bio-Rad) and 
purity by SDS-PAGE analysis.  
6.4.4 AMPylation reactions 
In vitro AMPylation reactions were carried out at 30 °C for 1 hour, if not indicated 
otherwise, in a total volume of 15 µl. For in vitro AMPylation reactions with purified 
substrates, protein substrates (0.5 µg) and AMPylation enzymes (VopS 1-10 ng, Fic2 1-
100 ng, DrrA 1-1000 ng) were incubated with N6pATP (100 µM, unless indicated 
otherwise) in 20 mM Hepes pH 7.4, 100 mM NaCl, 5 mM MgCl2, 0.1 mg/ml BSA and 
1mM DTT. For the ATP competition experiment, increasing concentrations of ATP from 
a dilution series was added to the assay mix. 
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For in vitro AMPylation reactions with cell lysates, AMPylation enzymes (100 ng VopS, 
300 ng Fic2, 4 µg DrrA) were incubated with 10 µg cell lysate in 20 mM Hepes pH 7.4, 
100 mM NaCl, 5 mM MgCl2, and 1mM DTT.  
HeLa cells were grown in DMEM medium supplemented with 10% fetal bovine serum. 
HeLa cell lysates were generated from 1 P15 dish of 80% confluent HeLa cells. Cells 
were harvested by trypsinization, collected by centrifugation, and washed once in PBS. 
The cell pellet was lysed with 1 ml 20 mM Tris, pH 8.0, 150 mM NaCl, 0.5% Triton X-
100, 1 mM EDTA and Roche complete EDTA-free protease inhibitors (1 tablet/25 ml) 
for 20 min on ice. Cell lysate was cleared by centrifugation at 23,000 g, 4 °C, for 15 min. 
Protein concentration was determined using the BCA assay. The resulting protein 
concentration was 5 µg/µl. 
6.4.5 Click-chemistry and in-gel fluorescence analysis 
The AMPylation reaction was stopped by methanol/chloroform precipitation. To 15 µl 
assay volume, 85 µl water, 400 µl methanol and 100 µl chloroform was added and 
samples were vortexed; 300 µl water was added, samples were vortexed again and 
centrifuged at 23,000 g, at room temperature, for 5 min. The upper phase was carefully 
discarded and 1 ml ice-cold acetone was added. Samples were vortexed and centrifuged 
at 23,000g, at 4 °C, for 10 min. The supernatant was discarded and pellets were dried for 
5 min. Subsequently, pellets were dissolved in 15 µl 4% SDS, 150 mM NaCl, 50 mM 
triethanolamine, pH 7.5 (4ST).  
For in-gel fluorescence detection of N6pATP modified substrate proteins, resolubilized 
protein pellets from AMPylation reactions were reacted with azido-rhodamine (az-rho). 
For this purpose a click-chemistry master mix was prepared with 7.5 µl 4ST, 0.25 µl 10 
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mM az-rho, 0.5 µl 50 mM TCEP (tris(2-carboxyethyl)phosphine), 1.25 µl 2 mM TBTA 
(tris((1-benzyl-1H-1,2,3-triazol-4-yl)methyl) amine) in 1:4 DMSO:n-butanol  and 0.5 µl 
CuSO4 per individual sample. 10 µl click-chemistry master mix was added to each 
individual protein sample to yield a total volume of 25 µl with 0.1 mM az-rho, 1 mM 
TCEP, 0.1 mM TBTA and 1 mM CuSO4. Click-chemistry was carried out for 1 hour at 
room temperature. Click-chemistry was stopped by addition of 8.3 µl 4x Laemmli buffer 
and 1.6 µl 2-mercaptoethanol. Samples were incubated at 95 °C for 5 min and run for 
analysis on a 4-20% Tris-HCl Criterion™ Precast Gel (Biorad). 
Protein gels were rinsed with deionized water and incubated for multiple hours in 50% 
water, 40% methanol, 10% acetic acid at 4 °C. Before in-gel fluorescence analysis 
protein gels were transferred to deionized water and incubated for at least 30 min at room 
temperature. Protein gels were scanned on a Amersham Bioscience Typhoon 9400 
variable mode imager (excitation 532 nm, 580 nm filter, 30 nm band-pass). All image 
adjustments were done on the entire depicted image for all samples equally in Adobe® 
Photoshop® CS3. Subsequent to fluorescence scanning, protein gels were stained with 
GelCode Blue Stain Reagent (Thermo) or Coomassie Brilliant Blue (BioRad). Both stains 
are indicated as coomassie blue (CB) in all figures. 
6.4.6 AMPylation reaction and sample preparation for proteomic analysis 
For large-scale proteomic analysis, 1 mg of HeLa cell lysate (preparation see above) was 
incubated with 100 µM N6pATP in the presence or absence of VopS (88 µg) for 1.5 h at 
30 °C in a total volume of 1.5 ml of 20 mM Hepes pH 7.4, 100 mM NaCl, 5 mM MgCl2, 
and 1mM DTT. The reaction mix was precipitated by methanol chloroform precipitation, 
adding 6 ml methanol, 1.5 ml chloroform, and 4.5 ml water in a 15 ml falcon tube. 
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Samples was vigorously vortexed and centrifuged for 30 min at 5200g at 4 °C. The upper 
phase was discarded and 10ml ice-cold acetone was added and mixed. Samples were 
centrifuged for 30 min at 5200g at 4 °C and the supernatant was discarded and the pellets 
were dried on air.  
Protein pellets were resuspended in 400 µl 4 % SDS in PBS. A click-chemistry master 
mix was prepared with 21 µl of a 10 mM solution of ortho-hydroxy-azidoethoxy-azo-
biotin (compound 5 in Yang et al. 2010), 42 µl of a 50 mM TCEP (tris(2-
carboxyethyl)posphine; freshly prepared in water) solution, 105 µl of a 2 mM TBTA 
(tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine; in 4:1 n-butanol and DMSO) 
solution, 42 µl of a 50 mM CuSO4 solution, and 1050 µl of 4 % SDS in PBS. 600 µl of 
the master mix was added to each sample and each sample was incubated for 1.5 h at 
room temperature. Click-chemistry was ended by methanol/chloroform precipitation (4 
ml methanol, 1 ml chloroform, 3 ml water). The resulting pellet was rinsed 3 times with 
ice-cold methanol and vigorously vortexed each time. The pellets were dried on air. The 
resulting protein pellets were dissolved in 1 ml 6M urea/2M thiourea in 10 mM Hepes pH 
8.0. Proteins were reduced by addition of DTT to 1mM (from 500 mM DTT stock) for 45 
min at room temperature. Then, proteins were alkylated by addition of iodoacetamide to 
5.5 mM from a 500 mM stock. Samples were incubated for 30 min at room temperature 
in the dark. High-capacity streptavidin beads (Thermo) were equilibrated with 6M 
urea/2M thiourea in 10 mM Hepes pH 8.0. The reduced and alkylated protein samples 
were directly loaded onto the equilibrated beads and incubated on a nutator mixer for 1.5 
h at room temperature. The beads were washed 3 times with 6M urea/2M thiourea in 10 
mM Hepes pH 8.0, 3 times with 0.2% SDS in PBS, 3 times with PBS, and 1 time in 4.5 
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M urea/1.5 M thiourea in 10 mM Hepes pH 8.0. Beads were drained and 200 µl 4.5 M 
urea/1.5 M thiourea in 10 mM Hepes pH 8.0 was added with 2 µg Lys-C. Samples were 
incubated in shaker (1000 rpm) for 4 h at room temperature. Samples were diluted by 
addition of 600 µl 10 mM Hepes pH 8.0 and 2 µl trypsin was added to each sample (2 
µl/5 µl in 50 mM acetic acid stock). Samples were incubated over night at 1000 rpm at 
room temperature. Beads were spun down (2000g for 1 min) and the supernatant was 
collected for mass spectrometry analysis. The supernatant was then purified by Zip-Tip 
Pipette tips (Millipore).  
6.4.7 Mass spectrometry  
LC-MS analysis was performed at the Rockefeller Proteomics Resource Center, with a 
Dionex 3000 nano-HPLC coupled to an LTQ-Orbitrap ion trap mass spectrometer 
(ThermoFisher). Peptides were pressure loaded onto a home-made 75 μm diameter, 15 
cm C18 reverse phase column and separated with a gradient running from 95% buffer A 
(HPLC water with 0.1% formic acid) and 5% buffer B (HPLC grade acetonitrile with 
0.1% formic acid) to 55% B over 30 min, next ramping to 95% B over 10 min and 
holding 95% B for 10 min. One full MS scan (300-2000 MW) was followed by 3 data 
dependent scans of the most intense ions with dynamic exclusion enabled. The spray 
voltage was set to 1.94 kV and the flow rate through the column was set to 0.25 μL/min. 
6.4.8 Data analysis 
For protein identification all generated .raw files were searched using the SQUEST 
search algorithm under BioWorks 3.3.1 SP1. All searches were performed against a 
indexed database containing the international protein index (IPI) human database v3.86, 
the sequence of VopS, and the sequence of streptavidin. The database was indexed in 
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BioWorks 3.3.1 with carbamidomethylation as static modification, trypsin as proteolytic 
enzyme, ‘fully enzymatic’ as enzyme limit, 250-7000 as MW range, and 2 missed 
cleavage sites.  SEQUEST searches were conducted with monoisotopic precursor and 
fragment masses, 50.00 ppm peptide tolerance, 1.0 AMU fragment ion tolerance, and B 
and Y ion series calculated. Carbamidomethylation was selected as static modification, 
methionine/tryptophan oxidation as well as asparagine/glutamine deamindation was 
selected as variable modification. The generated unified search files .srf were opened in 
Scaffold 3 (Proteome Software) and further analyzed. All searches were filtered in 
Scaffold 2 for 99.9% protein probability, 2 unique peptides, and 95% peptide probability. 
Data was exported into Excel and further analyzed. All identifications with hits in the 
control sample were discarded, as well as all identified contaminations (e.g. keratins). 
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7 Chemical reporters for RNA synthesis and mRNA polyadenylation5 
7.1 Abstract 
Modern array and sequencing technologies have tremendously improved our capabilities 
for transcriptome analysis. In parallel metabolic labeling approaches have been taken to 
label newly synthesized mRNAs with chemical reporters, which allow analysis of mRNA 
synthesis and degradation. In this chapter we present a new adenosine based chemical 
reporter for RNA synthesis that is incorporated into newly transcribed mRNA and into 
mRNA polyadenylation tails.  
7.2 Introduction 
Understanding the mechanisms of gene expression requires a thorough knowledge of the 
balance between the biogenesis of an mRNA and its degradation. While advances in 
transcriptome profiling methods have enabled the large-scale analysis of RNA steady-
state levels, monitoring the synthesis, processing and decay rates of specific transcripts 
remains technically challenging. The application of nucleoside analogs such as 4-
thiouridine (4-sU) has recently enabled metabolic labeling and enrichment of nascent 
transcripts to monitor RNA dynamics in mammalian cells (Rabani et al. 2011). Thiol-
selective labeling allows the capture and enrichment of RNA but is incompatible with 
cellular imaging due to competing free thiols in cells. Alternatively, metabolic labeling 
with 5-ethynyluridine (EU) is compatible with fluorescence imaging of nascent 
                                                
5 This work was carried out in collaboration with Nicholas K. Conrad (UT Southwestern). 
Nicholas K. Conrad conducted all experiments pertaining to Figure 55, Figure 56, and 
Figure 57. 
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transcripts in cells, tissues and model organisms following copper (I)-catalyzed azide-
alkyne cycloaddition (CuAAC or “click chemistry”) with azide-functionalized 
fluorescent dyes (Jao & Salic 2008). Here we report N6-propargyl adenosine (N6pA; 
Figure 54a) is efficiently incorporated into RNA in mammalian cells and can be used for 
CuAAC-mediated fluorescence imaging and affinity enrichment of nascent transcripts. 
We also demonstrate how “clickable” nucleosides can be employed to monitor 
polyadenylate [poly(A)] tail dynamics in cells.  
7.3 Results 
To determine whether N6pA labels cellular RNA, we analyzed metabolic incorporation of 
N6pA into mammalian cells by fluorescence microscopy. HeLa cells were incubated in 
complete medium containing a range of N6pA concentrations (1.0 µM - 1 mM). After 12 
hours, the cells were washed, permeabilized, fixed, reacted with azido-rhodamine via 
CuAAC and visualized by fluorescence microscopy (Figure 54b). The majority of N6pA-
specific fluorescence signal localized to distinct substructures of the nucleus, most likely 
nucleoli, in accordance with the dominant transcriptional activity of RNA polymerase I 
(pol I). Incorporation of N6pA was observed with as little as 10 µM of N6pA and 
appeared to reach its maximum between 10 µM and 100 µM. To distinguish between 
DNA and RNA labeling, we examined N6pA incorporation in the presence of 
hydroxyurea, a ribonucleotide reductase inhibitor, or actinomycin D, a transcription 
inhibitor (Figure 54c). While the addition of hydroxyurea had no effect, actinomycin D 
completely abolished fluorescence, demonstrating that N6pA is incorporated into RNA, 
but not DNA. We conclude that, similar to EU, N6pA is efficiently incorporated into 
rRNA by pol I in cells.  
145 
 
Figure 54 N6pA is incorporated by pol I in cells. a) Structure of N6pA and N6pATP. b) 
Cells were incubated for 12 hours in media containing the indicated concentrations of 
N6pA. After fixation and permeabilization, rhodoamine-azide was conjugated via click 
chemistry. Top panels are rhodamine signal and the bottom panels are nuclei 
counterstained with TO-PRO-3. c) Cells were incubated with 1 mM N6pA in the presence 





In contrast to EU, N6pA is a potential substrate for incorporation into poly(A) tails by 
cellular poly(A) polymerases. To test this, we performed in vitro polyadenylation 
reactions with HeLa nuclear extracts, a uniformly 32P-labeled RNA substrate and N6-
propargyl adenosine-5´-triphosphate (N6pATP; Figure 54a) (Grammel et al. 2011). 
Incubation of the substrate in nuclear extract under polyadenylation conditions leads to 
the addition of a poly(A) tail of ~150-250 nt, as previously observed (Wilusz & Shenk 
1988) (Figure 55a, lanes 1 and 2). Inclusion of N6pATP in the reaction at various 
concentrations (Figure 55a, lanes 3-5) had no apparent effect on polyadenylation 
efficiency, as judged by the intensity and lengths of the polyadenylated products (Figure 
55a, lanes 2-5). However, when ATP was replaced completely with N6pATP, no poly(A) 
extension was observed (Figure 55a, lane 6). To show incorporation of N6pA into 
poly(A) tails, polyadenylation products were biotinylated using CuAAC with biotin-azide 
and captured on streptavidin beads. Polyadenylated RNAs generated in the presence of 
N6pATP were retained by streptavidin beads, whereas those generated in its absence were 
not (Figure 55a, compare lanes 9-11 to lane 8). In principle, incorporation of only one 
N6pATP and its subsequent biotinylation should be sufficient for binding. However, the 
recovery of the polyadenylated substrates correlated with higher N6pATP:ATP ratios. 
This may indicate that N6pATP is not utilized by poly(A) polymerase as efficiently as 
ATP or that any one of the downstream steps (i.e. biotinylation, binding or retention on 
the column) requires more than one modified residue for maximal recovery. Interestingly, 
while N6pATP alone did not support processive polyadenylation, this substrate was 
recovered more efficiently than the control (Figure 55a, lane 12 versus lane 7). It is 
therefore likely that a few N6pATP molecules were incorporated into the substrate, but 
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the tail could not be further extended. Perhaps natural adenosines in the poly(A) tail are 
required to promote processive polyadenylation or ATP may be necessary for the activity 
of putative ATP-dependent enzymes (e.g. helicases) involved in polyadenylation in 
extract. In either case, these data clearly show that N6pA is utilized by a poly(A) 
polymerase in vitro. 
 
Figure 55 N6pA is incorporated into poly(A) tails in vitro and in vivo. a) In vitro 
polyadenylation assays with a 32P-labeled “pre-cleaved” substrate in HeLa nuclear extract 
(Wilusz & Shenk 1988). The substrate is a 247-nt in vitro transcribed RNA derived from 
the 3´ end of PANΔ79 RNA (Conrad et al. 2007) that contains the AAUAAA 
polyadenylation signal and terminates at the natural cleavage site. As a result, 
polyadenylation is uncoupled from the endonucleolytic cleavage step of 3´-end 
formation. The concentrations of N6pATP and ATP in the reaction are shown above each 
lane. Lanes 1-6 contain the products of the polyadenylation reaction (20% of the total 
reaction), while lanes 7-12 are the streptavidin-bound transcripts. b) N6pA is incorporated 
into poly(A) tails in vivo. 10% of the RNase T1-treated RNA (Input) or 100% of the 
streptavidin-bound RNA was analyzed by northern blot using an oligo dT probe to detect 
poly(A) tails. The experimental flow is shown to the right. 
 
Next we tested whether N6pA is incorporated into poly(A) tails in mammalian 
cells. To do this, we labeled HEK293 cells with 200 µM EU or N6pA for 12 hr, harvested 
cells, and extracted RNA. To degrade total RNA but leave poly(A) tails intact, we treated 
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the RNA with RNase T1, a G-specific endonuclease, prior to biotinylation and selection. 
Heterogeneous poly(A) tails are observed in each of the input samples (Figure 55b). 
However, only the poly(A) tails from cells labeled with N6pA bound the streptavidin 
column (Figure 55b), while the EU-treated or control (DMSO) poly(A) tails did not. 
These results demonstrate that N6pA is incorporated into poly(A) tails by at least one 
poly(A) polymerase in cells. While several poly(A) polymerases are expressed in cells, 
our results are consistent with the conclusion that we are monitoring incorporation by the 
“canonical” poly(A) polymerase, PAPα (PAPOLA) (Eckmann et al. 2011). PAPα is 
responsible for the polyadenylation of cellular mRNAs that contain a typical AAUAAA 
poly(A) signal. Both our in vitro substrate (Figure 55a) and the majority of the “bulk” 
poly(A) tails (Figure 55b) fall into this category, so it seems likely that this is the poly(A) 
polymerase responsible for the activity we are monitoring. Further studies are necessary 
to determine whether the “noncanonical” poly(A) polymerases involved in a variety of 
alternative polyadenylation pathways (Schmidt & Norbury 2010) can also utilize N6pA.  
We next examined whether pol II and pol III utilize N6pA. For pol II, we needed 
to experimentally distinguish between pol II and PAPα activity in cells. To do so, we 
tested whether the histone mRNAs, which are non-polyadenylated pol II transcripts 
(Marzluff et al. 2008), were labeled with N6pA. Total RNA from N6pA-treated cells was 
biotinylated, selected, and recovered transcripts were analyzed by semi-quantitative RT-
PCR (Figure 56, top). H2A mRNA was efficiently recovered from N6pA-treated cells as 
well as from positive control (EU) cells. In contrast, minimal H2A mRNA was observed 
in the negative control (DMSO). Similar results were obtained for histone HIST3H2BB 
mRNA (data not shown). Additionally, the pol III-transcribed 7SK RNA was detected 
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among the selected transcripts from EU and N6pA-treated cells (Figure 56, bottom). From 
these results and those presented above, we conclude that N6pA is incorporated into RNA 
by pol I, II, III and PAPα. 
 
Figure 56 N6pA is incorporated into pol II and pol III transcripts in vivo. RNA harvested 
from cells treated with DMSO, 200 μM EU, or 200 μM N6pA for 12 hr was subject to 
click chemistry with biotin-azide and selected on a streptavidin column. 10% of the input 
and 100% of the bound RNA was analyzed by semi-quantitative RT-PCR using primers 
specific for the histone H2A mRNA or the 7SK small noncoding RNA. Negative controls 
lacking reverse transcriptase are also shown (-RT). 
 
The general pathway for destruction of cytoplasmic mRNAs begins with a slow 
distributive deadenylation of the transcript, which is followed by nearly coincident 
decapping, processive deadenylation, and transcript decay (Parker & Song 2004; 
Yamashita et al. 2005). In most cases, distributive deadenylation has been observed using 
specific reporter transcripts driven from inducible promoters, but has not been 
demonstrated at the bulk level. Changes in bulk poly(A) lengths have been limited to 
steady-state observations primarily due to the lack of simple approaches for global pulse-
chase analysis of poly(A) tail lengths. While steady-state analysis can be informative 
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(Apponi et al. 2010), interpreting poly(A) tail length differences in a pool of transcripts 
that contains both newly synthesized transcripts and older transcripts can be difficult. We 
therefore developed a pulse-chase strategy using EU or N6pA to study bulk poly(A) tail 
dynamics in cells. HEK293 cells were pulse-labeled with 200 µM EU or N6pA for 2 hr, 
washed, and chased with media lacking modified nucleoside. Cytoplasmic RNA was 
extracted from cells at given time intervals following the chase. Metabolically labeled 
transcripts were biotinylated by CuAAC, captured on streptavidin columns, and digested 
with RNase T1. Northern blot analysis of the resulting poly(A) tails showed that after a 2-
hr pulse (t=0), the cytoplasmic poly(A) tails were ~150-200 nt long (Figure 57). 
Importantly, the tails shortened over time and decreased in their abundance, consistent 
with the model that most cytoplasmic mRNAs are gradually deadenylated prior to their 
destruction. This assay has the advantage of observing RNAs transcribed from 
endogenous promoters in the absence of general transcription inhibitors, which often 
have pleiotropic effects (Loflin et al. 1999). The ability to detect bulk poly(A) tails after a 
short labeling pulse allows us to examine poly(A) dynamics of transcripts that were 
synthesized within a 2-hr window, thereby limiting the heterogeneity of poly(A) tail 
length that arises over time. We conclude that alkyne-nucleosides and click chemistry can 
be employed to examine poly(A) tail dynamics in cells. In principle, this approach could 
be extended to examine poly(A) tail dynamics of specific cellular mRNAs using 
previously described RT-PCR techniques to detect poly(A) tail length (Sallés et al. 1999).  
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Figure 57 Pulse-chase assay to analyze poly(A) tail dynamics. a) Experimental flow. 
Cells were labeled for two hours with EU or N6pA and chased for 2, 4, or 6 hr prior to 
cytoplasmic RNA extraction. Poly(A) tails of captured transcripts were then analyzed by 
northern blot using an oligo dT probe. b) Data from an in vivo poly(A) tail dynamics 
assay. 
 
In summary, we report N6pA is incorporated by all three cellular RNA polymerases 
(pol I, pol II, pol III) in mammalian cells. Moreover, N6pA is added to poly(A) tails in 
vitro and in vivo, demonstrating that this chemical reporter is utilized by poly(A) 
polymerase. Furthermore, we showed that clickable nucleosides can be employed to 
monitor cellular poly(A) tail dynamics. These alkyne-adenosine reporters should provide 
new tools to monitor RNA metabolism in vitro and in vivo using bioorthogonal chemistry 
(Boyce & Bertozzi 2011) and Raman microscopy (Yamakoshi et al. 2011). 
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7.4 Materials and methods 
7.4.1 Metabolic labeling of HeLa cells and visualization by fluorescence 
microscopy 
For metabolic labeling experiments in mammalian cell culture, 5 x 104 HeLa cells were 
split into 12 well plates on glass cover slips 24 hours before the experiment. HeLa cells 
were cultured in Dulbecco’s Modified Eagle Medium (DMEM) with 10 % fetal bovine 
serum (FBS). Cells were washed once with phosphate-buffered saline (PBS) and then 
incubated with N6pA in culture media for 12 hours at 37 °C at 5% CO2. Actinomycin D 
(Sigma Aldrich) or hydroxyurea (Fisher Scientific) was added to the growth medium 
together with N6pA at 2 µM or 10 mM, respectively. 
 
After metabolic labeling, the cells were washed three times with PBS and subsequently 
fixed and permeabilized with 3.7% formaldehyde in PBS with 0.2% Triton X-100 for 30 
min at room temperature. Then, cells were washed three times for 5 min each with PBS.  
 
To detect incorporation of N6pA, fixed cells were reacted with an azide-rhodamine (az-
rho) fluorescence dye. For this purpose, click chemistry master mix (300 µl) was added 
to each well for a 1 h incubation period at room temperature. The master mix was 
prepared in PBS by addition of azido-rhodamine (Charron et al. 2009) (N-(9-(2-(4-(6-
azidohexanoyl)piperazine-1-carbonyl)phenyl)-6-(diethylamino)-3H-xanthen-3-ylidene)-
N-ethylethanaminium chloride, from a 10 mM stock solution in DMSO) to a final 
concentration of 20 µM, TCEP (tris(2-carboxyethyl)phosphine, from a 50 mM freshly 
prepared aqueous solution) to a final concentration of 1 mM, TBTA (tris[(1-benzyl-1H-
1,2,3-triazol-4-yl)methyl]amine, from a 2 mM solution in 4:1 n-butanol:DMSO) to a final 
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concentration of 100 µM, and CuSO4 (from a 50 mM freshly prepared aqueous solution) 
to a final concentration of 1 mM. The components were added in the order listed and the 
mix was vigorously vortexed after the addition of each component. After click chemistry, 
the cells were washed three times for 5 min each. Cells were incubated with TO-PRO-3 
DNA dye (1:1000 in PBS) for 30 min at room temperature. Cells were washed three 
times for 5 min each. Cover slips were mounted on glass slides in ProLong Gold 
Mounting medium (Invitrogen). The images were taken on an upright LSM510 laser 
scanning confocal microscope (Zeiss) equipped with a Krypton/Argon laser with 488 and 
568 lines and a HeNe laser with a 633 line, using a 100x oil immersion objective. 
7.4.2 CuAAC reaction and streptavidin selection of alkyne-modified RNA 
Modified transcripts were selected using the Click-iT Nascent RNA Capture Kit 
(Invitrogen) with several alterations to the manufacturer’s protocol. Primarily, we scaled 
down the procedure to cost-effectively accommodate the number of samples required for 
pulse-chase analyses. Additionally, the elution and detection schemes were experiment-
specific. A typical click reaction contained from 100 ng - 3 µg RNA, 10 µl of Click-iT 
EU Buffer, 2 mM CuSO4, 250 nM biotin-azide, 0.5 µl of Click-iT reaction additive 1, and 
0.5 µl of Click-iT reaction additive 2 in a total volume of 20 µl. As per the 
manufacturer’s instructions, the Click-iT reaction additives were added last; additive 2 
was added 3 min after additive 1. Generally, we used the higher range of RNA 
concentrations (~1-3 µg) from cells treated for shorter times with ethynyluridine (EU, 
Invitrogen) or N6pA. The reaction proceeded for 30 min, and was mixed tapping the tube 
every ~10 min.  Subsequently, 20 µl of 10M NH4OAc, 15 µg of GlycoBlue (Ambion), 
and 350 µl of ethanol were added and the RNA was precipitated overnight at -20 °C. 
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Dynabeads streptavidin beads were washed three times in an equal volume of Wash 
Buffer 2; 10 µl of slurry was used per click reaction. After the final wash, the beads were 
resuspended in 20 µl of Wash Buffer 2. Precipitated RNA from the click reaction was 
washed with 70% ethanol and resuspended in 5 µl H2O. 25 µl of 2X binding buffer 
supplemented with 10 U RNase inhibitor (Promega) was mixed with the RNA suspension 
and heated to 65 °C for 5 min prior to the addition of 20 µl bead suspension. The 
resulting 50 µl binding reactions were incubated at room temperature for 60 min with 
gentle vortexing every ~10 min to keep beads from settling. The beads were subsequently 
washed three times with 100 µl of Click-iT reaction wash buffer 1 and then three times 
with 100 µl of Click-iT reaction wash buffer 2. Selected RNAs were eluted in an 
experiment-specific manner. 
7.4.3 In vitro polyadenylation 
In vitro polyadenylation reactions were performed using pre-cleaved substrates based on 
previously described protocols (Wilusz & Shenk 1988). The gel-purified, uniformly 32P-
labeled substrate contains the 3´-most 247 nt of PANΔ79 RNA (Conrad et al. 2007) 
including the AAUAAA hexamer and ends at the natural poly(A) addition site. Substrates 
were generated by in vitro transcription with bacteriophage T7 RNA polymerase using 
general laboratory protocols. The template was made by PCR amplification of PANΔ79 
with primers NC137 (5´-cgtaatacgactcactatagggcagctgggagcgctctttcaatg-3´) and NC138 
(5´-tatggattaaacattgacctttatttatgttgtaagttgc-3´). Excluding contributions from nuclear 
extract, each 25 µl polyadenylation reaction contained ~25 fmol of substrate, 20 mM 
creatine phosphate, 1 mM DTT, 2% (v/v) polyvinyl alcohol, 1 mM MgCl2, 20 µg/ml 
tRNA, 20 U RNase Inhibitor, and 45% HeLa nuclear extract. The nuclear extract 
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contained 20 mM HEPES (pH 7.9), 20% glycerol, 50 mM KCl, 0.2 mM EDTA, and 0.5 
mM DTT (Dignam et al. 1983). ATP and N6pATP was added as indicated in Figure 2. 
After 60 min at 30 °C, reactions were stopped by the addition of 200 µl of 0.1 mg/ml 
proteinase K, 0.1% (v/v) SDS, 15 µg GlycoBlue, 20 µg torula yeast RNA (Sigma), and 
incubated for an additional 30 min at 37 °C. RNAs were phenol-chloroform extracted and 
ethanol precipitated using standard laboratory techniques.  
 
After precipitation, the entire reaction was subjected to click chemistry and streptavidin 
selection as described above. After washing, the bound transcripts were eluted in two 
steps. First, the beads were heated to 90 °C in 50 µl of a solution of 98% formamide and 
10 mM EDTA. Second, after removal of the eluted formamide solution, the beads were 
stripped by incubation for 60 min at 50 °C in 250 µl of a solution containing 0.1% SDS, 
0.1 mg/ml proteinase K, 20 mM Tris-HCl (pH 6.8), and 22.5 µg of GlycoBlue. The 
formamide and proteinase K elutions were combined, 30 µl of 3M NaOAc was added, 
and the samples were phenol-chloroform extracted and ethanol precipitated using 
standard laboratory techniques. Input and eluted RNAs were run on 6% urea-PAGE, the 
gel was dried, and substrate was detected by Phosphorimager (Molecular Dynamics).  
7.4.4 Metabolic labeling of poly(A) tails in vivo 
To determine whether N6pA was incorporated into poly(A) tails in vivo, HEK293 were 
grown in DMEM supplemented with 10% fetal bovine serum, 1X penicillin-streptomycin 
(Sigma), 2 mM L-glutamate, and 200 µM of EU, N6pA, or DMSO as a control. After 
overnight incubation, a slightly lower confluence of cells treated with N6pA was 
observed, suggesting a minor growth defect compared to the DMSO control. Total RNA 
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was extracted using Tri-Reagent (Molecular Research Center) following the 
manufacturers protocol and treated with RQ1 DNase (Promega). One µg total RNA was 
digested in 10 µl reactions containing 10 mM Tris-HCl (pH 7.5), 200 U RNase T1 
(Ambion), 20 U RNase Inhibitor for 30 min at 37 °C. This treatment is sufficient to 
completely digest the RNA as a 5-fold range of RNase T1 concentrations yielded similar 
digestion products (data not shown). After digestion, the reaction was stopped by the 
addition of 190 µl of 300 mM NaOAc, 0.1 mg/ml proteinase K, 0.25% SDS, 2 mM 
EDTA, 20 mM Tris-HCl (pH 7.0) for 30 min at 37 °C. The RNA was then phenol-
chloroform extracted and ethanol precipitated using standard lab techniques. 10% of the 
RNA was set aside as “Input” samples and the remaining RNA was selected using click 
chemistry and streptavidin as described above. Elution protocol was the same as used for 
the in vitro poly(A) selection.  
7.4.5 Metabolic labeling and detection of histone mRNAs and 7SK RNA 
Labeling and extraction of RNA was performed as described for the in vivo poly(A) 
labeling assay. One µg of total RNA was used for click chemistry and streptavidin 
selection as described above. After selection and washing, the selected RNA was reverse 
transcribed on the beads. To the washed pellets, we added 25 µl of a solution containing 
100 ng random hexamers (Sigma) and 10 mM solution of all four dNTPs. The mix was 
heated for 5 min at 65 °C, briefly chilled on ice. To this solution, 8 µl of 5X first strand 
buffer (Invitrogen), 4 µl of 100 mM DTT and 40 U RNase Inhibitor were added for a 
total of 38 µl. Half of this mix was added to 1 µl (200 U) of M-MuLV reverse 
transcriptase (New England Biolabs) while the other half was mixed with 1 µl H2O as a 
“no-RT” control. Reverse transcription proceeded at 25 °C for 15 min and then at 42 °C 
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for 1 hr. After the reverse transcription, 1 U of RNase H (Promega) and 5 ng RNase A 
(Sigma) was added to the reaction for 30 min at 37 °C. The reaction was stopped by the 
addition of 180 µl of a solution containing 300 mM NaOAc, 0.25% SDS, 2 mM EDTA, 
20 mM Tris-HCl (pH 7.0) and 15 µg GlycoBlue. The cDNA was then phenol-chloroform 
extracted and ethanol precipitated using standard lab techniques. PCR was performed 
using 1/100th of the cDNA as template in a standard 20 µl PCR reaction with primers: 
NC996 (5´ gtctggtcgtggcaaacaag-3´) and NC997 (5´-tgcgcgtcttcttgttgtcc-3´) for histone 
H2A, NC998 (5´ atgccagacccgtccaaatc-3´) and NC999 (5´-tggtggagcgcttgttgtag-3´) for 
histone HIST3H2BB and ID15 (5´- taagagctcggatgtgagggcgatctg -3´) and ID16 (5´- 
cgaattcggagcggtgagggaggaag -3´) for 7SK RNA.  
7.4.6 In vivo poly(A) tail dynamics assay 
HEK293 cells were grown to ~80% confluency in 6-well plates and 200 µM EU, 200 µM 
N6pA, or DMSO was added directly to the media. After 2 hr, the cells were washed twice 
with PBS containing calcium and magnesium (Sigma); cells were harvested at time 
intervals shown in Figure 4. To collect cytoplasmic RNA, cells were resuspended in 
Buffer I (0.32 M sucrose, 3mM CaCl2, 2 mM MgCl2, 0.1 mM EDTA, 10 mM Tris-HCl 
(pH 8.0), 1 mM DTT, 0.04 U/µl RNase Inhibitor, 0.5% Triton X-100), incubated on ice 
for 5 min, centrifuged at 500 x g for 3 min at 4 °C, and RNA in the supernatant was 
extracted using TriReagent followed by an additional phenol-chloroform extraction. One 
µg of cytoplasmic RNA was used for click chemistry and streptavidin selection as 
described above. After binding and washing, the beads were treated with 30 µl RNase T1 
solution (20 mM Tris-HCl (pH 6.8), 8U RNase Inhibitor, 150 U RNase T1) for 15 min at 
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37°. Subsequently, RNA was eluted as for the in vitro poly(A) selection assay and 
poly(A) tails were detected by northern blotting. 
7.4.7 Northern blot analysis 
To examine bulk poly(A) tails by northern blot, the RNA was run on 1.8% formaldehyde-
agarose gels using standard laboratory techniques and transferred to Zeta-Probe nylon 
membranes (Bio-Rad). An RNA marker (0.1-2kb; Invitrogen) was run as a size standard. 
The blots were probed 3hr to overnight at 42 °C in ExpressHybe (Clontech) with a 5´ 
end-labeled oligonucleotide dT40 probe. The membranes were washed twice in 2X saline-
sodium citrate buffer, 0.1% SDS, twice in 1X SSC, 0.1% SDS at room temperature and 
detected by Phosphorimager.  
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8 Discussion and future outlook 
In the past decade bioorthogonal chemistries and the resulting idea of chemical reporters 
has effectively shaped the modern field of chemical biology. The strategy of using highly 
selective non-perturbing, or at least selectively perturbing, chemistry to investigate basic 
biological phenomena, develop new pharmacophores, and identify drug targets was truly 
invigorated or maybe even completely new defined by a set of new chemical 
transformations. This thesis work set out to contribute to this still growing field by 
investigating the possibilities chemical reporters provide to analyze pathogen-host 
interactions. While I recognize the current limitations of these approaches, some of the 
discoveries I have made during my thesis work have strong potential to contribute to the 
current line of investigation and transcend the topic of bacterial pathogenesis. Most 
notably, various other laboratories are already applying the chemical reporters I have 
developed for protein AMPylation and RNA synthesis to identify new AMPylation 
substrates and investigate mRNA polyadenylation. Other explorations, as for example the 
serendipitous discovery of a somewhat intrinsically cell-selective amino acid reporter (i.e. 
EME), on the other hand, are only first steps towards more valuable research tools. 
8.1 Development of cell-selective amino acid reporters for the investigation of 
bacterial protein synthesis and secretion during infection 
Bacterial pathogens dramatically change their gene expression pattern during the course 
of an infection (Eriksson et al. 2003; Shi et al. 2006). It is believed that many genes that 
are selectively expressed during infection, contribute to disease. The identification of 
these genes or proteins has been a major interest in the field of bacterial pathogenesis, 
especially in face of more rapidly emerging multi-resistant strains and the growing need 
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for new antibiotics. Many bacterial pathogens, such as S. typhimurium, secrete effector 
proteins into the mammalian host cell, which are important factors of infectivity, through 
elaborate and complex secretion apparatuses. These secretion systems and their substrates 
are of major interest for the development of new antibiotics. Proteomics has the theoretic 
potential to identify bacterial proteins, selectively expressed or secreted during infection 
and their respective posttranslational modifications. Proteomic interrogation of the 
mammalian cytosol should reveal secreted bacterial effector proteins. Modern mass 
spectrometry-based proteomics also has the potential to allow a quantitative and dynamic 
analysis of these processes (J. Cox & Mann 2007). However, the confounding problem of 
the direct proteomic interrogation of the bacterial proteome during infection is the 
abundance and complexity of the mammalian proteome, which, by today’s dynamic 
range standards of mass spectrometry, makes robust detection of the bacterial proteome, 
especially of the secreted fraction, very difficult or even impossible (C. G. Zhang et al. 
2005).  
To address this issue we developed a cell-selective labeling strategy, based on 
previous work of the Tirell group (Tanrikulu et al. 2009; Ngo et al. 2009) that allows 
selective labeling of the S. typhimurium proteome during infection with alkyne (AOA) or 
azide (ANL) bearing amino acids (Grammel et al. 2010). These amino acids are co-
translationally incorporated into the bacterial proteome upon expression of a mutant 
methionyl-tRNA synthetase (MetRS) and replace methionine (Met) throughout the 
bacterial proteome. The incorporated alkyne or azide groups serve chemical reporters that 
allow visualization or enrichment of newly synthesized bacterial proteins. However, this 
approach bears two intrinsic limitations; first, only cells in which the described MetRS 
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mutant is active can be targeted with AOA or ANL, second only proteins that possess 
Met residues can be labeled.  
The first limitation will likely preclude the application in many more distantly 
related (from E. coli) bacteria, even though sometimes striking cross reactivity has been 
observed (Ripmaster et al. 1995). It will be interesting to see, whether these E. coli 
derived MetRS mutants will be active in eukaryotic cells. This thesis presented some 
experimental evidence that this is the case. The translation of the E. coli MetRS/AOA 
system to eukaryotes could allow labeling of individual cell populations in multi-cellular 
organisms (e.g. C. elegans) in the future. Towards this goal, it has been recently shown 
that multi-cellular organisms, such as the zebrafish, can be labeled with methionine 
amino acid reporters that do not depend on mutant MetRS activity (Hinz et al. 2012). If 
the inhere used E. coli MetRS mutants do not possess activity in other model systems, 
similar approaches of protein engineering, as the one used for the identification of the 
current E. coli MetRS mutants, could be applied to the corresponding MetRS (Dieterich 
et al. 2006).  
The second limitation was addressed in this thesis by developing para-
ethynylphenylalanine (PEP) as a cell-selective amino acid reporter (Grammel et al. 
2012). Since phenylalanine (Phe) is present at higher frequencies in many proteomes than 
Met, the replacement of Phe with PEP could provide better coverage of the proteome. 
Indeed we could detect better overall incorporation of PEP compared to AOA. A 
combination of AOA and PEP provided even further improved labeling intensity. 
Unfortunately, these results did not translate to the infection setting. Suboptimal PEP 
incorporation upon dual bicistronic expression of MetRS and phenylalanyl-tRNA-
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synthetase (PheRS) should be overcome by generating a non-bicistronic expression 
system for PheRS. In general, however, this proofs that the strategy that was initially 
applied to ANL and E. coli MetRS could be also applied to other aminoacyl-tRNA-
synthetases (aaRS). In fact, Met is one of the least frequent amino acids, while some 
other amino acids, such as alanine, can make up 10% of a proteome or more 
(http://www.pasteur.fr/~tekaia/aafreq.html) (Tekaia et al. 2002; Tekaia & Yeramian 
2006). The engineering of an orthogonal amino acid reporter aaRS pair of one of these 
aaRSs could dramatically increase labeling efficiencies.  
While exploring alternative alkynyl amino acid reporters of Met we discovered 
that EME has a certain intrinsic selectivity for S. typhimurium over mammalian cells. 
Whereas its selectivity is currently not sufficient for proteomics studies, it provides a 
mode for bacterial visualization during infection. In a first attempt to improve the 
selectivity by extending the alkyl chain by one methylene unit, our laboratory tried to 
improve the selectivity for S. typhimurium. However, this amino acid is still incorporated 
into the mammalian proteome. Nevertheless, these observations at least demonstrated that 
the differential intrinsic affinity of aaRSs of different organisms for an amino acid 
reporter could be exploited to achieve cell-selective labeling.  
Our proteomics studies revealed that cell-selective (orthogonal) amino acid 
reporters can be used to enrich bacterial proteins from infected mammalian cells and 
identify them by mass spectrometry. Yet, even though this method provides a facile way 
to separate these two proteomes the dynamic range of amino acid reporter incorporation 
is still not completely represented by the dynamic range of the subsequent enrichment 
and mass spectrometry detection. Many of the identified bacterial proteins are proteins of 
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high abundance, such as components of the translational machinery. This became 
particularly clear when looking at the mammalian cytosolic fractions, which should 
contain secreted bacterial effector proteins. Whereas we could show that the SPI-2 
effector protein SseJ is labeled with amino acid reporter during infection and effector 
proteins can be generally secreted by the type three secretion system (TTSS) after they 
have incorporated amino acid reporters, we could not detect any effector proteins in the 
mammalian cytosolic fraction by mass spectrometry. In these fractions we only detected 
the most abundant bacterial proteins also detected in the pellet fraction, even with the 
most selective lysis conditions.  
The aim of enriching and detecting secreted effector proteins from infected 
mammalian cells by mass spectrometry is pushing the boundaries of the theoretical 
detection limit of current mass spectrometry based proteomics work-flows. Estimates for 
secreted bacterial effector proteins range from a few hundred to a few thousand 
molecules per cells, in some cases this number might even be lower (Winnen et al. 2008). 
Other data suggest that in a typical cell the abundance of proteins ranges from a few 
dozen to more then 106 molecules (Ghaemmaghami et al. 2003). This dynamic range has 
to be compared with the current dynamic range of modern mass spectrometers, that is the 
range of the least abundant and the most abundant molecule detected in a single 
experiment, which is currently 4 to 5 orders of magnitude under optimal conditions (de 
Godoy et al. 2008). The dynamic range of a particular mass spectrometry run is however 
dependent on countless factors that all have to be optimized (Andrews et al. 2011). These 
numbers show, that even under optimal conditions, the robust and reproducible detection 
of secreted bacterial effector proteins is a daunting task. The complexity of the current 
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workflow, that consists of the infection experiment, amino acid reporter pulse-labeling, 
lysis, CuAAC, affinity enrichment, proteomics sample preparation, mass spectrometry, 
leaves plenty of room for improvements. However, quantitative analysis of the 
bottlenecks in the future will be indispensable, before addressing the current 
shortcomings.   
8.2 A chemical reporter for protein AMPylation 
Protein AMPylation is emerging as an important posttranslational modification (PTM), 
especially in the context of pathogen-host interactions. Genome data suggest that protein 
AMPylation could be a ubiquitous PTM in prokaryotes as well as eukaryotes. To 
determine its prevalence in different organisms we have developed an alkynyl chemical 
reporter (N6pATP) for protein AMPylation that can be used by all known classes of 
AMPylation enzymes and allows unbiased detection of substrates in cell lysates at 
endogenous levels (Grammel et al. 2011). We demonstrated its utility by detecting the 
known VopS substrate Cdc42 in Hela cell lysates by mass spectrometry. Addition of 
recombinant AMPylation enzyme and N6pATP to cell lysates allows the enzyme specific 
identification of substrates, an approach that our lab has also applied to other PTMs, such 
as acetylation (Y.-Y. Yang et al. 2011). A general draw back of cofactor analogs as 
N6pATP is its charged character and the resulting lack of cell permeability. Caged 
cofactor analogs could circumvent this issue in the future (Ellis-Davies 2007). Caging 
charged phosphate groups with esters results in a neutral net charge and enhances cell 
permeability (Schultz et al. 1993). Such caging strategies could allow metabolic labeling 
with cofactor analogs in the future. In addition to the current application in cell lysates, 
N6pATP can be used for enzyme specific substrate identification with protein arrays. Our 
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collaborators are currently establishing a screening assay for AMPylation substrates using 
N6pATP and a nucleic acid programmable protein array (NAPPA)(Ramachandran et al. 
2008). This assay provides the opportunity to screen thousands of proteins in high-
throughput as potential AMPylation substrates using a combination of NAPPA and 
CuAAC for substrate detection by fluorescence. Preliminary data has show that this 
approach can be used to detect VopS substrates (RhoA, Rac3, Cdc42) and auto 
AMPylation (HYPE) in array format. This approach is independent of the individual 
expression patterns of cell lines and its reduced complexity might allow the detection of 
substrates that would go undetected in cell lysates.  
8.2.1 An adenosine based chemical reporter 
Numerous alkynyl chemical reporters for nucleic acid biosynthesis have been introduced 
in recent years (Salic & Mitchison 2008; Jao & Salic 2008; Neef & Luedtke 2011; Guan 
et al. 2011). This thesis work has shown that N6-propargyl-adenosine (N6pA) also serves 
as a chemical reporter for RNA biosynthesis, which is metabolically incorporated by 
RNA polymerase I, II, and III (pol I, II, or III). In contrast to previous chemical reporters 
of RNA biosynthesis, N6pA is also incorporated into polyadenylation (polyA) tails of 
mRNA molecules. In the absence of transcriptional activity of pol I, II, and III polyA 
modification of mRNA could be selectively studied with N6pA. However, the activated 
triphosphate N6pATP does not seem to be an adequate substrate for polyA polymerase in 
vitro.  
As is indicated by its incorporation into RNA, N6pA is intracellularly transformed into its 
triphosphate N6pATP, most likely, by the purine ribonucleoside salvage pathway. In 
addition to nucleic acid biosynthesis, N6pATP could also be used as a co-factor/co-
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substrate in other transformations. As we have seen, isolated AMPylation enzymes in 
vitro as well as in cell lysates use N6pATP to modify their substrates. Hence, 
intracellularly formed N6pATP might serve as a chemical reporter for potential 
AMPylation enzymes. Indeed, in addition to the labeling of RNA, we have also observed 
labeling of the proteome in mammalian and bacterial cells, when incubated with N6pA 
(data not shown). However, these observed protein modifications could also be of 
different origin, e.g. ADP-ribosylation. Provided the intracellularly formed N6pATP is 
integrated into nicotinamide adenine dinucleotide (NAD), the co-substrate for ADP-
ribosyl transferases and poly ADP-ribose polymerases, by the enzyme NAD 
pyrophosphorylase, N6pA could potentially serve as chemical reporter for protein ADP-
ribosylation.  
This shows that N6pA is a facile chemical reporter for RNA biosynthesis and 
polyA mRNA modification, but potentially also for protein posttranslational 
modifications. This is particularly interesting due to the limited applicability (lack of cell-
permeability) of the cofactor based chemical reporters N6pATP and alkyne-modified 







































Figure 58 Current stepwise model of the Cu(I)-catalyzed azide-alkyne cycloaddition 












9.2 Proteomics data 
Table 3 S. typhimurium proteins identified from infected RAW264.7 cells (red – only 
detected from infected RAW264.7 cells and not from in vitro labeled S. typhimurium). # 
SC: number of spectral counts. 
# UniProt Name # SC 
1 P0A1D3 60 kDa chaperonin  763 
2 Q56073 Chaperone protein dnaK  271 
3 P0A1H5 Elongation factor Tu  261 
4 P0A1P0 Glyceraldehyde-3-phosphate dehydrogenase  152 
5 P64076 Enolase  132 
6 P0A1E3 Cysteine synthase A  122 
7 P0A1H3 Elongation factor G  109 
8 P58480 Chaperone protein htpG  74 
9 Q8ZNN4 Methionyl-tRNA synthetase  71 
10 Q7CQ01 Chaperone protein clpB  69 
11 Q7DAP2 Putative carbonic anhydrase  57 
12 P14146 Virulence transcriptional regulatory protein p  56 
13 Q7CR42 Putative thiol-alkyl hydroperoxide reductase  51 
14 Q7CPX8 Fur regulated Salmonella iron transporter  50 
15 P64052 Elongation factor Ts  49 
17 Q9L6N1 5-methyltetrahydropteroyltriglutamate--homocys  46 
16 P0A1D5 10 kDa chaperonin  46 
18 Q8ZP03 Mannose-specific enzyme IIAB  45 
19 Q8ZRT0 Dihydrolipoyl dehydrogenase  44 
20 Q7CPE2 ATP synthase subunit beta  43 
22 P02936 Outer membrane protein A  41 
23 P0A7W4 30S ribosomal protein S5  41 
21 O30911 ATP-dependent hsl protease ATP-binding subunit  41 
24 P26976 Non-specific acid phosphatase  41 
25 P77983 Pyruvate kinase I  41 
27 P62405 50S ribosomal protein L5  40 
26 P0A251 Alkyl hydroperoxide reductase subunit C  40 
29 Q8ZRT2 Pyruvate dehydrogenase, decarboxylase componen  39 
28 Q7CQV9 DNA protection during starvation protein  39 
30 Q7CPE1 ATP synthase subunit alpha  36 
31 Q93DX3 Putative LysR family transcriptional regulator  34 
32 P06173 DNA-directed RNA polymerase subunit beta  32 
33 P66932 Trigger factor  31 
34 Q7CPK0 sn-glycerol-3-phosphate-binding periplasmic pr  31 
36 P65702 Phosphoglycerate kinase  30 
35 P16657 Enoyl-[acyl-carrier-protein] reductase [NADH]  30 
37 P0A7Z7 DNA-directed RNA polymerase subunit alpha  29 
38 Q8ZRU0 Cell division protein ftsZ  29 
39 P25077 Malate dehydrogenase  28 
40 P60446 50S ribosomal protein L3  28 
41 Q7CQT9 30S ribosomal subunit protein S1  26 
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42 Q9XCS1 Fur regulated Salmonella iron transporter  26 
44 Q7CQU1 Pyruvate formate lyase I, induced anaerobicall  25 
43 P0A7K0 50S ribosomal protein L11  25 
45 P0A2R4 DNA-directed RNA polymerase subunit beta'  24 
46 Q8ZN59 Inosine-5'-monophosphate dehydrogenase  24 
47 P0A1S2 DNA-binding protein H-NS  22 
48 P66541 30S ribosomal protein S2  21 
49 P67093 Universal stress protein G  21 
50 P0A2A3 50S ribosomal protein L1  20 
51 Q8ZRB9 ATP-dependent protease La  20 
52 Q8ZQS2 2,3-bisphosphoglycerate-dependent phosphoglyce  19 
54 Q8ZRT1 Pyruvate dehydrogenase  18 
55 Q93DX1 Putative acetyl-CoA hydrolase  18 
53 P0A7V6 30S ribosomal protein S3  18 
58 Q7CQN4 Major outer membrane lipoprotein 1  17 
56 P0A295 Transcription termination factor rho  17 
57 Q7CPU6 Fructose-bisphosphate aldolase  17 
63 Q8ZP45 Iron-dependent alcohol dehydrogenase of the mu  16 
60 P28354 Lysyl-tRNA synthetase  16 
59 P0A2B3 30S ribosomal protein S7  16 
61 P33321 Translation initiation factor IF-3  16 
62 P66593 30S ribosomal protein S6  16 
64 Q8ZPZ0 Isocitrate dehydrogenase [NADP]  16 
69 Q8ZLM1 30S ribosomal protein S13  15 
65 P0A249 Phosphoenolpyruvate-protein phosphotransferase  15 
66 P0A2C9 3-oxoacyl-[acyl-carrier-protein] reductase  15 
67 P26219 CDP-diacylglycerol pyrophosphatase  15 
68 Q7CPZ4 Protein grpE  15 
73 P65977 Protein recA  14 
70 P0A297 50S ribosomal protein L10  14 
72 P26982 Protease do  14 
71 P14846 Carbamoyl-phosphate synthase large chain  14 
74 Q8ZQE3 ATP-binding subunit of serine protease  14 
78 Q7CPL5 50S ribosomal protein L14  13 
77 P60726 50S ribosomal protein L4  13 
75 P0A2E1 Serine hydroxymethyltransferase  13 
76 P19480 Alkyl hydroperoxide reductase subunit F  13 
79 Q8ZS18 Threonine synthase  13 
80 P37430 Transcription elongation protein nusA  12 
81 P61179 50S ribosomal protein L22  12 
82 Q8ZLD5 Putative phosphatase  12 
83 Q8ZRC0 ATP-dependent Clp protease ATP-binding subunit  12 
84 O54297 30S ribosomal protein S4  11 
85 P0A283 Glucose-specific phosphotransferase enzyme IIA  11 
86 P67904 30S ribosomal protein S10  11 
87 Q8ZK71 Peptide methionine sulfoxide reductase msrA  11 
88 Q9F2E0 GTP-binding elongation factor family protein  11 
92 Q7CPF1 Small heat shock protein ibpA  10 
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93 Q8ZLT3 Polyribonucleotide nucleotidyltransferase  10 
90 P0A1Z2 Chaperone protein skp  10 
89 O84944 Secretion system effector  10 
91 Q7CP63 Response regulator  10 
94 Q8ZRJ5 Aminoacyl-histidine dipeptidase  10 
98 Q08016 Ornithine carbamoyltransferase  9 
102 Q8ZK80 50S ribosomal protein L9  9 
95 P0A1P6 Glutamine synthetase  9 
101 Q7CQV2 Arginine 3rd transport system  9 
100 Q7CQU5 Thioredoxin reductase  9 
96 P0A2B1 30S ribosomal protein S20  9 
97 P63411 Acetate kinase  9 
99 Q7CPJ3 Putative inner membrane lipoprotein  9 
103 Q8ZN40 Cysteine desulfurase  9 
110 Q7CPL7 50S ribosomal protein L17  8 
112 Q8ZKI4 Glucose-6-phosphate isomerase  8 
104 O68883 Citrate synthase  8 
108 P64222 Aminomethyltransferase  8 
105 P27237 Oligopeptidase A  8 
106 P63557 Acetylglutamate kinase  8 
107 P63923 Phosphopentomutase  8 
109 Q7CP96 Component of modulator for protease specific f  8 
111 Q7CR87 Chaperone surA  8 
113 Q8ZRP0 Outer membrane protein assembly factor yaeT  8 
114 Q93GL9 Conjugative transfer: surface exclusion  8 
117 P53636 Superoxide dismutase [Cu-Zn] 1  7 
119 P66869 Succinyl-CoA ligase [ADP-forming] subunit beta  7 
122 Q8ZMM8 Effector protein pipB2  7 
123 Q8ZND6 Phosphotransacetylase  7 
115 P0A1S4 DNA-binding protein stpA  7 
125 Q8ZPG8 Putative hydrolase  7 
116 P40732 Acetylornithine/succinyldiaminopimelate aminot  7 
118 P65882 Adenylosuccinate synthetase  7 
120 Q8ZKP7 Triosephosphate isomerase  7 
121 Q8ZL96 Glycyl-tRNA synthetase beta subunit  7 
124 Q8ZNW0 Pyruvate kinase II  7 
126 Q8ZRB8 Peptidyl prolyl isomerase  7 
127 Q8ZRP4 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N  7 
132 P41033 Phosphoenolpyruvate carboxykinase [ATP]  6 
137 Q8ZM63 Transketolase 1 isozyme  6 
133 Q7CQM5 Secretion system regulator: transcriptonal act  6 
134 Q8ZKW4 Aspartate--ammonia ligase  6 
135 Q8ZL03 Small heat shock protein ibpB  6 
136 Q8ZLT4 Cysteine sulfinate desulfinase  6 
131 P37411 DNA gyrase subunit A  6 
128 P0A1F6 Uridine phosphorylase  6 
129 P0A7X0 30S ribosomal protein S8  6 
130 P14062 6-phosphogluconate dehydrogenase, decarboxylat  6 
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138 Q8ZM69 D-3-phosphoglycerate dehydrogenase  6 
139 P0A1D7 ATP-dependent Clp protease proteolytic subunit  5 
140 P0A2M5 Uracil phosphoribosyltransferase  5 
147 Q7CQ97 3-oxoacyl-[acyl-carrier-protein] synthase I  5 
141 P43019 Superoxide dismutase [Mn]  5 
142 P66409 30S ribosomal protein S14  5 
143 P66738 Ribosome-recycling factor  5 
144 P66764 S-adenosylmethionine synthetase  5 
145 Q7CPC8 Putative enzyme  5 
146 Q7CPY9 Transcriptional repressor of emrAB operon  5 
148 Q8XFG8 Peptidyl-prolyl cis-trans isomerase  5 
149 Q8ZKN5 Cystathionine gamma-synthase  5 
150 Q8ZMF5 Sulfate adenylyltransferase subunit 1  5 
151 Q8ZPT7 Putative enzyme  5 
152 Q9ZF31 Translation initiation factor IF-2  5 
154 P15111 NADP-specific glutamate dehydrogenase  4 
157 P65692 6-phosphofructokinase  4 
158 P66313 50S ribosomal protein L6  4 
163 Q8ZKA4 Component of modulator for protease specific f  4 
153 P0A263 Outer membrane protein C  4 
167 Q8ZP57 Putative inner membrane protein  4 
155 P26978 Bifunctional purine biosynthesis protein purH  4 
156 P60428 50S ribosomal protein L2  4 
159 Q7CPE7 Regulatory gene for high affinity phosphate up  4 
160 Q7CPH6 Putative rhodanese-related sulfurtransferases  4 
161 Q7CPM0 Acetyl CoA carboxylase  4 
162 Q7CQ36 3-oxoacyl-[acyl-carrier-protein] synthase I  4 
164 Q8ZKN4 Aspartokinase II  4 
165 Q8ZLT0 Argininosuccinate synthase  4 
166 Q8ZNV2 Aspartyl-tRNA synthetase  4 
175 Q04873 UDP-glucose 6-dehydrogenase  3 
176 Q8ZLX5 Ribosomal RNA large subunit methyltransferase   3 
168 O33921 Glucose-1-phosphatase  3 
172 P64046 Elongation factor P-like protein  3 
177 Q8ZPC9 Gamma-aminobutyraldehyde dehydrogenase  3 
179 Q9ZFV8 NADP-dependent malic enzyme  3 
173 P64394 Integration host factor subunit beta  3 
174 P67557 Glucans biosynthesis protein G  3 
169 P0A2I3 DNA gyrase subunit B  3 
170 P0AA19 Transcriptional regulatory protein ompR  3 
171 P15434 Phenylalanyl-tRNA synthetase beta chain  3 
178 Q8ZQ76 Aminopeptidase N  3 
182 Q8ZPQ3 Putative transport protein  2 
181 P65215 2-dehydro-3-deoxyphosphooctonate aldolase  2 
180 P14845 Carbamoyl-phosphate synthase small chain  2 
183 Q8ZQT5 Protein tolB  2 
184 Q8ZRT7 Protein translocase subunit secA  2 
185 Q9X523 Periplasmic dipeptidase  2 
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1 Q8ZQE3 ATP-binding subunit of serine protease  138 
2 P64076 Enolase  136 
3 Q7CPE2 ATP synthase subunit beta  105 
4 P66932 Trigger factor  96 
5 Q8ZRT0 Dihydrolipoyl dehydrogenase  95 
6 Q7CPA1 Aspartate ammonia-lyase  89 
7 Q8ZRU0 Cell division protein ftsZ  83 
8 Q8ZM07 Putative alcohol dehydrogenase  76 
9 Q8ZQS2 2,3-bisphosphoglycerate-dependent phosphoglyce  73 
10 Q8ZRC0 ATP-dependent Clp protease ATP-binding subunit  73 
11 Q8ZKP3 Glycerol kinase  70 
12 P14146 Virulence transcriptional regulatory protein p  68 
13 Q8ZM88 Putative periplasmic protein  66 
14 P40732 Acetylornithine/succinyldiaminopimelate aminot  63 
15 P63557 Acetylglutamate kinase  61 
17 Q7CP63 Response regulator  60 
16 P00929 Tryptophan synthase alpha chain  60 
18 Q8ZJZ3 Putative NAD-dependent aldehyde dehydrogenase  55 
19 Q8ZRB9 ATP-dependent protease La  54 
20 P77983 Pyruvate kinase I  52 
21 Q7CR62 Prolyl-tRNA synthetase  52 
22 P0AA19 Transcriptional regulatory protein ompR  49 
23 Q8ZMB8 Amino-acid acetyltransferase  48 
24 P27237 Oligopeptidase A  47 
25 Q7CQ00 Ribosome associated factor  46 
26 P38039 Sulfite reductase [NADPH] flavoprotein alpha-c  45 
27 Q7DAP2 Putative carbonic anhydrase  45 
28 Q7CQ10 HTH-type transcriptional regulator iscR  44 
29 Q8ZRJ5 Aminoacyl-histidine dipeptidase  44 
30 Q8ZMF5 Sulfate adenylyltransferase subunit 1  43 
31 P0A2E5 RNA polymerase sigma factor rpoS  42 
32 Q8ZQT9 Cytochrome d terminal oxidase, polypeptide sub  42 
33 P0A1F6 Uridine phosphorylase  41 
34 P58661 Aspartate aminotransferase  40 
35 P06202 Periplasmic oligopeptide-binding protein  39 
36 Q8ZQW9 Phosphoglucomutase  38 
38 P37430 Transcription elongation protein nusA  36 
37 P15434 Phenylalanyl-tRNA synthetase beta chain  36 
40 Q8ZJU9 Putative transport protein  35 
39 Q7CQP3 Transcriptional activator of ntrL gene  35 
41 Q8ZLZ4 Outer membrane channel  33 
42 Q7CPE7 Regulatory gene for high affinity phosphate up  32 
43 Q8ZPM0 Putative oxidoreductase  32 
44 Q8ZQ40 Flavoprotein wrbA  32 
45 P00905 Anthranilate synthase component II  31 
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47 P16657 Enoyl-[acyl-carrier-protein] reductase [NADH]  31 
48 Q8ZPM7 Glutathionine S-transferase  31 
46 P0A2C9 3-oxoacyl-[acyl-carrier-protein] reductase  31 
52 Q8ZL96 Glycyl-tRNA synthetase beta subunit  30 
51 Q7CQ36 3-oxoacyl-[acyl-carrier-protein] synthase I  30 
50 P0A2F4 Superoxide dismutase [Fe]  30 
53 Q8ZQL1 D-alanyl-D-alanine carboxypeptidase penicilli  30 
49 P0A1V4 Adenylate kinase  30 
55 Q8ZLT0 Argininosuccinate synthase  29 
54 Q7CPU6 Fructose-bisphosphate aldolase  29 
56 Q8ZPZ0 Isocitrate dehydrogenase [NADP]  29 
57 O54297 30S ribosomal protein S4  28 
58 P0A283 Glucose-specific phosphotransferase enzyme IIA  28 
59 Q8ZNW8 Putative inner membrane protein  28 
60 Q8ZP21 Putative homolog of glutamic dehydrogenase  28 
61 Q8ZRP4 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N  28 
66 Q8ZLL6 Peptidyl-prolyl cis-trans isomerase  27 
62 P09384 Chemotaxis protein cheA  27 
67 Q8ZP60 Phage shock protein  27 
63 P33321 Translation initiation factor IF-3  27 
64 P67366 UPF0227 protein ycfP  27 
65 Q7CR64 UPF0325 protein yaeH  27 
69 P66409 30S ribosomal protein S14  26 
68 P0A249 Phosphoenolpyruvate-protein phosphotransferase  26 
70 Q8ZP10 Cell division inhibitor  26 
72 Q8ZLX9 Putative methyl-accepting chemotaxis protein  25 
71 P66764 S-adenosylmethionine synthetase  25 
77 Q7CP68 Hyperosmotically inducible periplasmic protein  24 
79 Q9F2E0 GTP-binding elongation factor family protein  24 
78 Q8ZL72 Aldehyde dehydrogenase B  24 
76 P20753 Peptidyl-prolyl cis-trans isomerase A  24 
75 P0A2T6 Catabolite gene activator  24 
80 Q9ZF31 Translation initiation factor IF-2  24 
74 P0A2E1 Serine hydroxymethyltransferase  24 
73 P00910 Tryptophan biosynthesis protein trpCF  24 
81 P0AA02 Transcription antitermination protein nusG  23 
82 P22037 Protein mgtC  23 
83 Q8ZNV2 Aspartyl-tRNA synthetase  23 
86 Q8ZK81 30S ribosomal protein S18  22 
85 P40860 Sulfate/thiosulfate import ATP-binding protein  22 
84 P02910 Histidine-binding periplasmic protein  22 
87 Q8ZP52 Aconitate hydratase 1  22 
88 Q8ZQT5 Protein tolB  22 
89 Q8ZQU2 Succinate dehydrogenase iron-sulfur subunit  22 
93 P26264 3'(2'),5'-bisphosphate nucleotidase cysQ  21 
96 Q8ZKB4 Fumarate reductase  21 
90 P0A273 LexA repressor  21 
97 Q8ZKL9 Acetylornithine deacetylase  21 
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91 P0A2B3 30S ribosomal protein S7  21 
94 P60659 Biosynthetic arginine decarboxylase  21 
98 Q8ZM76 Glycine dehydrogenase [decarboxylating]  21 
95 P69936 NADP-dependent L-serine/L-allo-threonine dehyd  21 
99 Q8ZPV9 Putative enzyme related to aldose 1-epimerase  21 
92 P14846 Carbamoyl-phosphate synthase large chain  21 
100 O30911 ATP-dependent hsl protease ATP-binding subunit  20 
103 Q7CPI5 Putative outer membrane lipoprotein  20 
104 Q8ZLQ5 Stringent starvation protein A  20 
105 Q8ZNC8 Putative sugar nucleotide epimerase  20 
101 P55900 Phosphoserine aminotransferase  20 
102 P66738 Ribosome-recycling factor  20 
106 Q8ZS18 Threonine synthase  20 
108 P61179 50S ribosomal protein L22  19 
110 Q8ZNW0 Pyruvate kinase II  19 
109 Q7CQW0 Glutamine high-affinity transporter  19 
107 P0A251 Alkyl hydroperoxide reductase subunit C  19 
111 P65921 CTP synthase  18 
112 Q8ZN40 Cysteine desulfurase  18 
113 Q8ZQ76 Aminopeptidase N  18 
114 Q8ZR95 Copper-exporting P-type ATPase A  18 
115 Q8ZS19 Aspartokinase I  18 
117 P0A295 Transcription termination factor rho  17 
122 Q8ZK29 Probable cytosol aminopeptidase  17 
123 Q8ZKF6 Acetyl-coenzyme A synthetase  17 
124 Q8ZKP7 Triosephosphate isomerase  17 
118 P0A7V6 30S ribosomal protein S3  17 
120 P66692 Ribose-5-phosphate isomerase A  17 
119 P10370 Histidinol dehydrogenase  17 
125 Q8ZP02 Mannose-specific enzyme IID  17 
116 P00898 Anthranilate synthase component 1  17 
126 Q8ZPS9 Threonyl-tRNA synthetase  17 
121 P67270 UPF0135 protein ybgI  17 
138 Q9L6M9 Putative carboxymethylenebutenolidase  16 
131 P66073 50S ribosomal protein L15  16 
134 Q8ZLR6 Sigma cross-reacting protein 27A  16 
129 P17845 Sulfite reductase [NADPH] hemoprotein beta-com  16 
137 Q9F5L2 Putative serine/threonine protein kinase  16 
130 P26398 Lipopolysaccharide biosynthesis protein rfbH  16 
127 P06179 Flagellin  16 
139 Q9ZNM2 FliY  16 
135 Q8ZNZ7 Putative IclR family transcriptional repressor  16 
136 Q8ZPS3 Phosphoenolpyruvate synthase  16 
132 Q7CQT1 Putative cytoplasmic protein  16 
133 Q8XFG8 Peptidyl-prolyl cis-trans isomerase  16 
128 P0A1G5 DnaK suppressor protein  16 
143 P26219 CDP-diacylglycerol pyrophosphatase  15 
147 Q8ZL68 Putative glutathione S-transferase  15 
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148 Q8ZLI7 Fe/S biogenesis protein nfuA  15 
145 Q7CPU8 Putative periplasmic immunogenic protein  15 
140 P0A1N0 Surface presentation of antigens protein spaK  15 
146 Q7CPZ4 Protein grpE  15 
141 P0A1W4 GTP-binding protein lepA  15 
142 P0A2D1 Oxidoreductase ucpA  15 
144 P37426 Ribonucleoside-diphosphate reductase 1 subunit  15 
158 Q8ZJV7 Purine nucleoside phosphorylase deoD-type  14 
159 Q8ZJV8 Deoxyribose-phosphate aldolase  14 
154 P65748 Inorganic pyrophosphatase  14 
155 Q7CP94 Putative exoribonuclease  14 
151 P0A2F6 Single-stranded DNA-binding protein  14 
160 Q8ZKL6 Argininosuccinate lyase  14 
161 Q8ZLQ1 Serine endoprotease  14 
150 P0A2E3 RNA polymerase sigma factor rpoD  14 
156 Q7CPY9 Transcriptional repressor of emrAB operon  14 
162 Q8ZN59 Inosine-5'-monophosphate dehydrogenase  14 
152 P14062 6-phosphogluconate dehydrogenase, decarboxylat  14 
149 P02941 Methyl-accepting chemotaxis protein II  14 
163 Q8ZNW2 Glucose-6-phosphate 1-dehydrogenase  14 
164 Q8ZNW4 2-keto-3-deoxygluconate 6-phosphate aldolase  14 
157 Q7CR25 Morphogene putative regulator of murein genes  14 
153 P15875 2-isopropylmalate synthase  14 
171 Q7CPD8 UPF0438 protein yifE  13 
170 P64036 Elongation factor P  13 
169 P63365 Phosphate import ATP-binding protein pstB  13 
172 Q7CPL6 50S ribosomal protein L18  13 
174 Q8ZM69 D-3-phosphoglycerate dehydrogenase  13 
173 Q7CQ04 Putative tRNA/rRNA methyltransferase  13 
175 Q8ZNE6 Putative chemotaxis signal transduction protei  13 
165 P0A1Q0 Alpha,alpha-trehalose-phosphate synthase [UDP-  13 
166 P0A2K1 Tryptophan synthase beta chain  13 
167 P37439 PTS system glucose-specific EIICB component  13 
176 Q8ZR22 Periplasmic disulfide isomerase, thiol-disulph  13 
168 P60217 5'-methylthioadenosine/S-adenosylhomocysteine   13 
189 Q8ZKR6 Response reguator in two-component regulatory   12 
182 P43019 Superoxide dismutase [Mn]  12 
181 P37419 Putative 8-amino-7-oxononanoate synthase/2-ami  12 
184 P67904 30S ribosomal protein S10  12 
186 Q7CPQ3 Putative ABC superfamily transport protein  12 
187 Q7CPU7 Putative membrane protein  12 
190 Q8ZML4 Putative inner membrane protein  12 
188 Q7CQ54 Putative acyltransferase  12 
177 P0A1R2 Imidazole glycerol phosphate synthase subunit   12 
183 P60317 ProP effector  12 
178 P0A2I1 DNA topoisomerase 1  12 
191 Q8ZPD4 Putative NADP-dependent oxidoreductase  12 
179 P0A2S0 Leucine-responsive regulatory protein  12 
176 
# UniProt Name # SC 
192 Q8ZRB1 Glycoprotein/polysaccharide metabolism  12 
185 Q56062 Methylisocitrate lyase  12 
193 Q8ZRP0 Outer membrane protein assembly factor yaeT  12 
180 P14845 Carbamoyl-phosphate synthase small chain  12 
195 P0A2A3 50S ribosomal protein L1  11 
201 P63923 Phosphopentomutase  11 
207 Q8ZJZ8 Isoaspartyl dipeptidase  11 
203 Q7CP78 Putative translation initiation inhibitor  11 
212 Q9F173 DNA polymerase I  11 
197 P0A2H9 Thiol:disulfide interchange protein dsbA  11 
208 Q8ZKX9 Putative oxidoreductase  11 
196 P0A2A5 50S ribosomal protein L28  11 
199 P50335 Protein yhjJ  11 
202 P69066 Chaperone protein sicA  11 
209 Q8ZN71 Dihydrodipicolinate synthase  11 
194 P06185 Outer membrane protease E  11 
210 Q8ZNF3 UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate   11 
200 P58663 Capsular synthesis regulator component B  11 
211 Q8ZNM0 Cytidine deaminase  11 
204 Q7CQE8 Putative GTP-binding protein  11 
205 Q7CQK9 Putative glutaredoxin protein  11 
206 Q7CQP4 Putative oxidoreductase  11 
198 P0A6B1 Acyl carrier protein  11 
220 Q8ZJU7 Transcriptional regulator  10 
215 P60829 UPF0307 protein yjgA  10 
214 P0A2I3 DNA gyrase subunit B  10 
221 Q8ZL67 Mannitol-1-phosphate 5-dehydrogenase  10 
222 Q8ZL95 Glycyl-tRNA synthetase alpha subunit  10 
217 Q7CPN9 Putative ABC superfamily transport protein  10 
223 Q8ZM41 Putative cytoplasmic protein  10 
213 P0A1Y6 NADH-quinone oxidoreductase subunit C/D  10 
224 Q8ZNN5 Putative ATP-binding protein  10 
216 Q04866 Chain length determinant protein  10 
225 Q8ZNS0 AMP nucleosidase  10 
218 Q7CQF9 Putative cytoplasmic protein  10 
227 Q9X523 Periplasmic dipeptidase  10 
226 Q8ZPE8 NAD-dependent malic enzyme  10 
219 Q7CR43 Response regulator in two-component regulatory  10 
230 P0A299 50S ribosomal protein L7/L12  9 
238 Q8ZK71 Peptide methionine sulfoxide reductase msrA  9 
239 Q8ZKI5 Aspartokinase  9 
240 Q8ZKM0 Phosphoenolpyruvate carboxylase  9 
241 Q8ZKN4 Aspartokinase II  9 
242 Q8ZKX1 Glucosamine--fructose-6-phosphate aminotransfe  9 
234 Q02755 Methyl-accepting chemotaxis citrate transducer  9 
233 P77980 3-dehydroquinate synthase  9 
235 Q7CPR8 Putative SH3 domain protein  9 
236 Q7CPR9 Bifunctional protein hldE  9 
177 
# UniProt Name # SC 
228 O68838 Glutamate--cysteine ligase  9 
243 Q8ZN45 Putative sulfurtransferase  9 
244 Q8ZN60 GMP synthase [glutamine-hydrolyzing]  9 
245 Q8ZND4 Putative transketolase  9 
231 P16328 Flagellar hook-associated protein 2  9 
246 Q8ZNZ5 Putative GAF domain-containing protein  9 
247 Q8ZP37 Nitrate reductase 1, alpha subunit  9 
248 Q8ZPL8 Putative periplasmic protein  9 
229 O84944 Secretion system effector  9 
249 Q8ZPT7 Putative enzyme  9 
253 Q9L328 Catalase  9 
250 Q8ZQ14 3-oxoacyl-[acyl-carrier-protein] synthase II  9 
232 P58696 Asparaginyl-tRNA synthetase  9 
252 Q935S7 Chromosome partition protein mukB  9 
237 Q7CQY3 Transcriptional repressor of iron-responsive g  9 
251 Q8ZQX5 Glutaminyl-tRNA synthetase  9 
259 P26978 Bifunctional purine biosynthesis protein purH  8 
256 P0AA28 Thioredoxin-1  8 
264 P65882 Adenylosuccinate synthetase  8 
271 Q8ZKN5 Cystathionine gamma-synthase  8 
268 Q7CPH6 Putative rhodanese-related sulfurtransferases  8 
257 P17215 Leu/Ile/Val/Thr-binding protein  8 
272 Q8ZLK3 Membrane protein  8 
266 P67347 UPF0190 protein yedY  8 
267 P68684 30S ribosomal protein S21  8 
273 Q8ZM21 Putative glutathione S-transferase  8 
274 Q8ZME2 (P)ppGpp synthetase I  8 
255 P0A2A9 30S ribosomal protein S16  8 
269 Q7CQ05 Autonomous glycyl radical cofactor  8 
270 Q7CQ15 Putative inner membrane protein  8 
262 P60802 Erythronate-4-phosphate dehydrogenase  8 
263 P63411 Acetate kinase  8 
254 O52325 Bifunctional polymyxin resistance protein arnA  8 
260 P37592 Outer membrane porin protein ompD  8 
261 P40676 Transcriptional regulator slyA  8 
275 Q8ZPN7 N-ethylmaleimide reductase  8 
276 Q8ZPP1 Riboflavin synthase, alpha chain  8 
265 P67341 UPF0189 protein ymdB  8 
277 Q8ZQL2 Putative glutathione S-transferase  8 
278 Q8ZQX7 Glucosamine-6-phosphate deaminase  8 
258 P19480 Alkyl hydroperoxide reductase subunit F  8 
279 Q8ZR92 Putative thioredoxin protein  8 
280 Q8ZRA7 RND family, acridine efflux pump  8 
281 Q8ZRJ9 Homolog of sapA  8 
282 Q8ZRT7 Protein translocase subunit secA  8 
286 P0A1R6 DNA-binding protein HU-alpha  7 
300 Q8ZJY6 Putative cobalamin synthesis protein  7 
301 Q8ZK31 Valyl-tRNA synthetase  7 
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290 P26976 Non-specific acid phosphatase  7 
294 Q7CPI1 PTS family, mannitol-specific enzyme IIABC com  7 
302 Q8ZL99 Putative periplasmic or exported protein  7 
303 Q8ZLD5 Putative phosphatase  7 
292 P67686 Universal stress protein B  7 
295 Q7CPJ6 Putative ATPase involved in cell division  7 
289 P0A2P2 Tryptophanyl-tRNA synthetase  7 
296 Q7CPM0 Acetyl CoA carboxylase  7 
297 Q7CPM2 Putative oxidoreductase  7 
304 Q8ZLQ6 N-acetylneuraminate lyase  7 
305 Q8ZLR3 Glutamate synthase, small subunit  7 
306 Q8ZM16 Hydrogenase-2, large subunit  7 
293 Q56026 Cell invasion protein sipD  7 
307 Q8ZN42 Chaperone protein hscA  7 
288 P0A2K3 Glutamyl-tRNA synthetase  7 
308 Q8ZND5 Putative transketolase  7 
287 P0A1Y4 NADH-quinone oxidoreductase subunit G  7 
284 P06614 HTH-type transcriptional regulator cysB  7 
309 Q8ZPA8 Alcohol dehydrogenase class III  7 
310 Q8ZPL7 Fumarate hydratase class II  7 
298 Q7CQK7 Tyrosyl-tRNA synthetase  7 
283 O85139 3-oxoacyl-[acyl-carrier-protein] synthase 3  7 
311 Q8ZQF0 Pyruvate dehydrogenase/oxidase FAD and thiamin  7 
312 Q8ZQX6 Sugar Specific PTS family, n-acetylglucosamine  7 
299 Q7CQY5 Putative phosphatase in N-acetylglucosamine me  7 
313 Q8ZQZ2 Putative cytoplasmic protein  7 
291 P63223 Phosphoheptose isomerase  7 
314 Q8ZRT5 GMP reductase  7 
285 P0A1G7 Chaperone protein dnaJ  7 
339 Q9L9I6 Regulator of sigma D  6 
324 Q56121 Peptide chain release factor 3  6 
317 P0A2L1 UPF0047 protein yjbQ  6 
323 P74861 Aromatic-amino-acid aminotransferase  6 
329 Q8ZLK4 D-ribulose-5-phosphate 3-epimerase  6 
330 Q8ZLR4 Glutamate synthase, large subunit  6 
321 P63343 Cell division protease ftsH  6 
325 Q7CPQ6 Putative periplasmic protein  6 
319 P58537 Inositol-1-monophosphatase  6 
326 Q7CQ27 Putative iron-dependent peroxidase  6 
327 Q7CQ39 Putative aspartate-semialdehyde dehydrogenase  6 
328 Q7CQ71 50S ribosomal protein L25  6 
322 P65363 Cell division topological specificity factor  6 
331 Q8ZPC4 Putative outer membrane lipoprotein  6 
316 P0A1A9 Exodeoxyribonuclease III  6 
332 Q8ZPY6 Putative molecular chaperone  6 
315 O30916 Inositol phosphate phosphatase sopB  6 
333 Q8ZQC4 Cytidylate kinase  6 
334 Q8ZR27 Putative glycerol dehydrogenase  6 
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320 P58688 Bifunctional protein folD  6 
335 Q8ZR86 HTH-type transcriptional repressor allR  6 
336 Q8ZRA6 Acridine efflux pump  6 
337 Q8ZRB2 Acyl-CoA thioesterase II  6 
338 Q8ZRB8 Peptidyl prolyl isomerase  6 
318 P37412 3-isopropylmalate dehydrogenase  6 
380 Q9L6L5 Fatty acid oxidation complex subunit alpha  5 
363 Q8ZJY1 Putative PTS permease  5 
364 Q8ZK42 Putative periplasmic protein  5 
354 P66593 30S ribosomal protein S6  5 
348 P36936 Peptidase E  5 
356 P67651 Regulator of ribonuclease activity A  5 
365 Q8ZL52 L-threonine 3-dehydrogenase  5 
359 Q7CPJ3 Putative inner membrane lipoprotein  5 
341 P05415 Glucose-1-phosphate adenylyltransferase  5 
366 Q8ZLJ1 Putative RNase R  5 
367 Q8ZLJ4 33 kDa chaperonin  5 
345 P0A7X0 30S ribosomal protein S8  5 
368 Q8ZLN3 Putative ferripyochelin binding protein  5 
369 Q8ZLP6 Putative outer membrane protein  5 
353 P66431 30S ribosomal protein S15  5 
349 P58580 Glutathione synthetase  5 
370 Q8ZMD2 Putative nucleotide binding  5 
381 Q9XCS1 Fur regulated Salmonella iron transporter  5 
358 P74881 Phosphoribosylformylglycinamidine synthase  5 
350 P58671 4-hydroxy-3-methylbut-2-en-1-yl diphosphate sy  5 
340 O52765 Histidyl-tRNA synthetase  5 
347 P33901 NADH-quinone oxidoreductase subunit F  5 
371 Q8ZNM5 Putative oxidoreductase  5 
352 P63905 Deoxycytidine triphosphate deaminase  5 
357 P74871 Arginyl-tRNA synthetase  5 
360 Q7CQG1 Putative translation factor  5 
361 Q7CQG2 Putative oxoacyl-(Acyl carrier protein) reduct  5 
372 Q8ZP85 Putative Smr domain protein  5 
373 Q8ZPD7 Putative cytoplasmic protein  5 
342 P06204 Dihydroorotase  5 
355 P67563 Seryl-tRNA synthetase  5 
362 Q8XG72 Arginine transport system  5 
374 Q8ZQQ4 UvrABC system protein B  5 
375 Q8ZR26 Putative aminotransferase  5 
376 Q8ZRC1 Putative lipoprotein  5 
351 P63603 Shikimate kinase 2  5 
343 P0A277 Xanthine phosphoribosyltransferase  5 
346 P32200 Acyl-[acyl-carrier-protein]--UDP-N-acetylgluco  5 
377 Q8ZRS0 Carbonic anhydrase  5 
378 Q8ZRU8 S-adenosyl-L-methionine-dependent methyltransf  5 
344 P0A2B1 30S ribosomal protein S20  5 
379 Q93GL9 Conjugative transfer: surface exclusion  5 
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# UniProt Name # SC 
391 P40810 Dihydroxy-acid dehydratase  4 
403 Q8ZJX0 Putative cytoplasmic protein  4 
404 Q8ZK11 Putative ATPase involved in DNA repair  4 
405 Q8ZK78 Putative cell envelope opacity-associated prot  4 
397 Q7CP96 Component of modulator for protease specific f  4 
406 Q8ZKB1 Phosphatidylserine decarboxylase proenzyme  4 
407 Q8ZKE2 Fumarase B  4 
408 Q8ZKH9 Glycerol-3-phosphate acyltransferase  4 
394 P66008 Soluble pyridine nucleotide transhydrogenase  4 
398 Q7CPC8 Putative enzyme  4 
409 Q8ZL36 Putative inner membrane protein  4 
399 Q7CPK0 sn-glycerol-3-phosphate-binding periplasmic pr  4 
385 P0A1F8 Aspartate-semialdehyde dehydrogenase  4 
392 P60428 50S ribosomal protein L2  4 
382 O54296 30S ribosomal protein S11  4 
383 P0A1B3 Arginine repressor  4 
410 Q8ZLQ2 Putative periplasmic protein  4 
387 P0AA13 50S ribosomal protein L13  4 
411 Q8ZLR0 Putative cytosine deaminase  4 
400 Q7CPQ5 Putative intracellular proteinase  4 
388 P17853 Phosphoadenosine phosphosulfate reductase  4 
396 Q56019 Cell invasion protein sipB  4 
384 P0A1B5 Phospho-2-dehydro-3-deoxyheptonate aldolase, T  4 
412 Q8ZMW8 Putative lipoprotein  4 
413 Q8ZMX7 ATP-dependent RNA helicase  4 
414 Q8ZN19 Pyridoxine 5'-phosphate synthase  4 
386 P0A9Z4 Nitrogen regulatory protein P-II 1  4 
393 P65889 Phosphoribosylaminoimidazole-succinocarboxamid  4 
415 Q8ZN82 Transketolase 2 isozyme  4 
416 Q8ZNC2 Amidophosphoribosyltransferase  4 
390 P37604 D-alanyl-D-alanine carboxypeptidase dacD  4 
425 Q9RM66 Universal stress protein C  4 
417 Q8ZP20 Periplasmic trehalase  4 
418 Q8ZP34 Response regulator in two-component regulatory  4 
419 Q8ZP42 Formyltetrahydrofolate hydrolase  4 
420 Q8ZPF0 Putative alpha amylase  4 
395 P67197 Putative phosphotransferase ydiA  4 
421 Q8ZQR7 Molybdate transporter  4 
389 P22715 UDP-glucose 4-epimerase  4 
401 Q7CQX4 2-oxoglutarate dehydrogenase  4 
422 Q8ZRD1 1-deoxy-D-xylulose-5-phosphate synthase  4 
402 Q7CR87 Chaperone surA  4 
423 Q93GQ7 Plasmid partition protein B  4 
424 Q93GS8 DNA replication  4 
440 Q8ZK91 Putative hydrolase of the alpha/beta superfami  3 
430 P51066 Isocitrate lyase  3 
434 P67912 ADP-L-glycero-D-manno-heptose-6-epimerase  3 
435 Q7CPP7 50S ribosomal protein L21  3 
181 
# UniProt Name # SC 
436 Q7CPS3 Putative cytoplasmic protein  3 
441 Q8ZM45 Nucleoside-triphosphatase rdgB  3 
437 Q7CPZ7 4.5S-RNP protein  3 
426 P0A1W2 Signal peptidase I  3 
431 P63423 Acetyltransferase ypeA  3 
442 Q8ZN89 DNA ligase  3 
427 P0A1Y8 NADH-quinone oxidoreductase subunit E  3 
432 P64209 GTP cyclohydrolase 1  3 
429 P26397 CDP-glucose 4,6-dehydratase  3 
443 Q8ZP18 Putative resistance protein MccF  3 
438 Q7CQF3 Thymidine kinase  3 
444 Q8ZP75 Putative cytoplasmic protein  3 
445 Q8ZPF1 Putative glycosyl hydrolase  3 
449 Q9Z5Z2 Oxygen-insensitive NADPH nitroreductase  3 
446 Q8ZQY0 Asparagine synthetase B  3 
439 Q7CQY7 Putative phosphate starvation-inducible protei  3 
433 P65792 Glutamate 5-kinase  3 
447 Q8ZRM7 2,5-diketo-D-gluconic acid reductase B  3 
428 P21267 Glutamate-1-semialdehyde 2,1-aminomutase  3 
448 Q8ZRW0 LPS-assembly protein lptD  3 
450 P0A2Q4 HTH-type transcriptional regulator metR  2 
461 Q7CP84 Putative peptide maturation protein  2 
462 Q7CP91 Peptidyl-prolyl cis-trans isomerase  2 
454 P37413 Homoserine O-succinyltransferase  2 
453 P17750 Catalase-peroxidase  2 
457 P41789 Nitrogen regulation protein NR(I)  2 
465 Q8ZKV4 Protein for a late step of protoheme IX synthe  2 
466 Q8ZL61 L-lactate dehydrogenase [cytochrome]  2 
472 Q93IN1 Cyclic di-GMP-binding protein  2 
467 Q8ZLD4 Glutathione oxidoreductase  2 
463 Q7CPJ7 RNA polymerase sigma factor  2 
458 P65510 Glutathione-regulated potassium-efflux system   2 
451 P0A7S6 30S ribosomal protein S12  2 
460 Q56020 Cell invasion protein sipC  2 
455 P37431 3-demethylubiquinone-9 3-methyltransferase  2 
452 P10372 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino  2 
456 P37600 Thiosulfate reductase  2 
459 Q06399 Uncharacterized lipoprotein yedD  2 
468 Q8ZPC0 Acetyl transferase  2 
469 Q8ZPU3 PTS family sugar specific enzyme III for cello  2 
470 Q8ZR02 D-alanyl-D-alanine carboxypeptidase, penicilli  2 
471 Q8ZR16 RNase I  2 




Table 5 Identified S. typhimurium proteins in the Triton X-100 supernatant fraction upon 
in-gel digestion. 
UniProt	   Name	   # SC	  
P0A1H5 Elongation factor Tu 66 
Q56073 Chaperone protein dnaK 64 
P58480 Chaperone protein htpG 34 
Q7CQ01 Chaperone protein clpB 33 
P0A1H3 Elongation factor G 15 
P64052 Elongation factor Ts 14 
P0A249 Phosphoenolpyruvate-protein phosphotransferase  14 
P0A1P0 Glyceraldehyde-3-phosphate dehydrogenase 13 
O30911 ATP-dependent hsl protease ATP-binding subunit  13 
P64076 Enolase 12 
P0A1D5 10 kDa chaperonin 12 
Q7CPK0 sn-glycerol-3-phosphate-binding periplasmic pr  11 
Q7CR42 Putative thiol-alkyl hydroperoxide reductase 9 
Q7CQ36 3-oxoacyl-[acyl-carrier-protein] synthase I 9 
Q8ZS18 Threonine synthase 8 
P65702 Phosphoglycerate kinase 8 
P26976 Non-specific acid phosphatase 8 
P14062 6-phosphogluconate dehydrogenase, decarboxylat  8 
Q8ZPZ0 Isocitrate dehydrogenase [NADP] 7 
Q8ZP49 UPF0259 membrane protein yciC 7 
Q8ZL96 Glycyl-tRNA synthetase beta subunit 7 
P0A7Z7 DNA-directed RNA polymerase subunit alpha 7 
Q8ZRU0 Cell division protein ftsZ 6 
Q8ZRS8 Aconitate hydratase 2 6 
Q7CPE1 ATP synthase subunit alpha 6 
P14146 Virulence transcriptional regulatory protein p  6 
P0A2C9 3-oxoacyl-[acyl-carrier-protein] reductase 6 
Q8ZM63 Transketolase 1 isozyme 5 
Q7CR87 Chaperone surA 5 
Q7CQ11 NifU homolog 5 
P77983 Pyruvate kinase I 5 
P66738 Ribosome-recycling factor 5 
P65977 Protein recA 5 
P40732 Acetylornithine/succinyldiaminopimelate aminot  5 
P0A1E3 Cysteine synthase A 5 
Q9F2E0 GTP-binding elongation factor family protein 4 
Q8ZNV2 Aspartyl-tRNA synthetase 4 
Q7CPU6 Fructose-bisphosphate aldolase 4 
P66764 S-adenosylmethionine synthetase 4 
P64281 Transcription elongation factor greA 4 
P25077 Malate dehydrogenase 4 
P0A2E1 Serine hydroxymethyltransferase 4 
Q7CPE2 ATP synthase subunit beta 3 
P37430 Transcription elongation protein nusA 3 
183 
UniProt	   Name	   # SC	  
P0A7W4 30S ribosomal protein S5 3 
P0A7K0 50S ribosomal protein L11 3 
O85140 Malonyl CoA-acyl carrier protein transacylase 3 
Q9L6N1 5-methyltetrahydropteroyltriglutamate--homocys  2 
Q8ZQT5 Protein tolB 2 
Q8ZQS4 Putative ABC transport protein 2 
Q8ZPG8 Putative hydrolase 2 
Q7CQ22 Putative PerM family permease 2 
P65692 6-phosphofructokinase 2 
P14846 Carbamoyl-phosphate synthase large chain 2 



















Table 6 Identified S. typhimurium proteins in the Triton X-100 pellet fraction upon in-gel 
digestion. 
UniProt Name #SC 
Q56073 Chaperone protein dnaK 143 
Q7CQ01 Chaperone protein clpB 107 
P06173 DNA-directed RNA polymerase subunit beta 91 
P0A2R4 DNA-directed RNA polymerase subunit beta' 83 
P0A1H3 Elongation factor G 76 
P0A1H5 Elongation factor Tu 73 
P58480 Chaperone protein htpG 65 
Q8ZRT1 Pyruvate dehydrogenase 57 
Q8ZRT2 Pyruvate dehydrogenase, decarboxylase componen  39 
Q8ZQT9 Cytochrome d terminal oxidase, polypeptide sub  37 
P0A1P0 Glyceraldehyde-3-phosphate dehydrogenase 34 
P64076 Enolase 32 
Q8ZNN4 Methionyl-tRNA synthetase 31 
P0A1S2 DNA-binding protein H-NS 27 
P63343 Cell division protease ftsH 27 
Q7DAP2 Putative carbonic anhydrase 27 
P0A7W4 30S ribosomal protein S5 26 
P02936 Outer membrane protein A 25 
Q8ZP45 Iron-dependent alcohol dehydrogenase of the mu  25 
P64052 Elongation factor Ts 23 
Q7CQT9 30S ribosomal subunit protein S1 23 
P0A1D5 10 kDa chaperonin 22 
P0A7K0 50S ribosomal protein L11 22 
P14846 Carbamoyl-phosphate synthase large chain 21 
P0A7V6 30S ribosomal protein S3 19 
Q8ZLT3 Polyribonucleotide nucleotidyltransferase 19 
P0A1S4 DNA-binding protein stpA 18 
P0A2A3 50S ribosomal protein L1 18 
Q8ZND6 Phosphotransacetylase 18 
P0A7Z7 DNA-directed RNA polymerase subunit alpha 17 
Q7CQU1 Pyruvate formate lyase I, induced anaerobicall  17 
Q8ZRB9 ATP-dependent protease La 17 
O30911 ATP-dependent hsl protease ATP-binding subunit  16 
P40732 Acetylornithine/succinyldiaminopimelate aminot  16 
P60446 50S ribosomal protein L3 16 
P66541 30S ribosomal protein S2 16 
P66593 30S ribosomal protein S6 16 
Q9L6N1 5-methyltetrahydropteroyltriglutamate--homocys  16 
P26976 Non-specific acid phosphatase 15 
P65702 Phosphoglycerate kinase 15 
Q7CR42 Putative thiol-alkyl hydroperoxide reductase 14 
Q7CPE2 ATP synthase subunit beta 13 
Q8ZL96 Glycyl-tRNA synthetase beta subunit 13 
Q8ZRS8 Aconitate hydratase 2 13 
P37411 DNA gyrase subunit A 12 
185 
Q7CPK0 sn-glycerol-3-phosphate-binding periplasmic pr  12 
Q7CPL7 50S ribosomal protein L17 12 
Q7CQ36 3-oxoacyl-[acyl-carrier-protein] synthase I 12 
Q9ZF31 Translation initiation factor IF-2 12 
P0AA13 50S ribosomal protein L13 11 
P14146 Virulence transcriptional regulatory protein p  11 
Q8ZNV2 Aspartyl-tRNA synthetase 11 
Q8ZP03 Mannose-specific enzyme IIAB 11 
P0A1G7 Chaperone protein dnaJ 10 
P26219 CDP-diacylglycerol pyrophosphatase 10 
P60726 50S ribosomal protein L4 10 
P65977 Protein recA 10 
Q8ZK80 50S ribosomal protein L9 10 
Q8ZM76 Glycine dehydrogenase [decarboxylating] 10 
P0A297 50S ribosomal protein L10 9 
P0A2B3 30S ribosomal protein S7 9 
P26353 Flavohemoprotein 9 
P62405 50S ribosomal protein L5 9 
Q7CQV9 DNA protection during starvation protein 9 
Q8ZM63 Transketolase 1 isozyme 9 
Q8ZQE3 ATP-binding subunit of serine protease 9 
P0A1E3 Cysteine synthase A 8 
P0A9X6 Rod shape-determining protein mreB 8 
P15111 NADP-specific glutamate dehydrogenase 8 
P22036 Magnesium-transporting ATPase, P-type 1 8 
Q7CPE4 ATP synthase subunit b 8 
Q7CR87 Chaperone surA 8 
Q9F2E0 GTP-binding elongation factor family protein 8 
Q9ZFV8 NADP-dependent malic enzyme 8 
P0A1X0 Outer membrane lipoprotein slyB 7 
P0A295 Transcription termination factor rho 7 
P37586 Methionine synthase 7 
P60428 50S ribosomal protein L2 7 
Q7CP96 Component of modulator for protease specific f  7 
Q8ZK31 Valyl-tRNA synthetase 7 
Q8ZQ17 RNase E 7 
Q8ZRT7 Protein translocase subunit secA 7 
Q8ZRZ0 Isoleucyl-tRNA synthetase 7 
P0A251 Alkyl hydroperoxide reductase subunit C 6 
P15434 Phenylalanyl-tRNA synthetase beta chain 6 
P25077 Malate dehydrogenase 6 
P65882 Adenylosuccinate synthetase 6 
P66313 50S ribosomal protein L6 6 
P74881 Phosphoribosylformylglycinamidine synthase 6 
Q8ZKA4 Component of modulator for protease specific f  6 
Q8ZPZ0 Isocitrate dehydrogenase [NADP] 6 
Q8ZQZ6 Leucyl-tRNA synthetase 6 
Q8ZRB8 Peptidyl prolyl isomerase 6 
Q8ZRC0 ATP-dependent Clp protease ATP-binding subunit  6 
186 
O54297 30S ribosomal protein S4 5 
P0A2C9 3-oxoacyl-[acyl-carrier-protein] reductase 5 
P0A2E3 RNA polymerase sigma factor rpoD 5 
P65692 6-phosphofructokinase 5 
P66932 Trigger factor 5 
Q8ZKM0 Phosphoenolpyruvate carboxylase 5 
Q8ZLM1 30S ribosomal protein S13 5 
Q8ZN40 Cysteine desulfurase 5 
Q8ZRP0 Outer membrane protein assembly factor yaeT 5 
Q935S7 Chromosome partition protein mukB 5 
Q93DX3 Putative LysR family transcriptional regulator  5 
P0A1Y6 NADH-quinone oxidoreductase subunit C/D 4 
P16657 Enoyl-[acyl-carrier-protein] reductase [NADH] 4 
P63923 Phosphopentomutase 4 
Q7CPE1 ATP synthase subunit alpha 4 
Q7CQU5 Thioredoxin reductase 4 
Q7CQV8 Outer membrane protease, receptor for phage OX  4 
Q7CQW9 Tol protein required for outer membrane integr  4 
Q8ZLK3 Membrane protein 4 
Q8ZM69 D-3-phosphoglycerate dehydrogenase 4 
Q8ZPG8 Putative hydrolase 4 
Q9F173 DNA polymerase I 4 
Q9XCS1 Fur regulated Salmonella iron transporter 4 
O84944 Secretion system effector 3 
P0A2E1 Serine hydroxymethyltransferase 3 
P0AA19 Transcriptional regulatory protein ompR 3 
P65215 2-dehydro-3-deoxyphosphooctonate aldolase 3 
P66764 S-adenosylmethionine synthetase 3 
Q8ZKN4 Aspartokinase II 3 
Q8ZLJ1 Putative RNase R 3 
Q8ZLT4 Cysteine sulfinate desulfinase 3 
Q8ZMM7 VirK-like protein 3 
Q8ZPS3 Phosphoenolpyruvate synthase 3 
Q8ZQ40 Flavoprotein wrbA 3 
Q8ZR37 Enterobactin synthetase, component F  3 
Q8ZRT0 Dihydrolipoyl dehydrogenase 3 
Q8ZS19 Aspartokinase I 3 
Q93DX1 Putative acetyl-CoA hydrolase 3 
P0A1V6 Ribose-phosphate pyrophosphokinase 2 
P0A2F6 Single-stranded DNA-binding protein 2 
Q7CPL4 50S ribosomal protein L16 2 
Q7CPL6 50S ribosomal protein L18 2 
Q7CQ11 NifU homolog 2 
Q7CQY7 Putative phosphate starvation-inducible protei  2 
Q8ZLT0 Argininosuccinate synthase 2 
Q8ZRB4 Putative ABC superfamily  2 
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